Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
J Neurooncol
    June 2026
  1. BASARAN AE, Braune M, Barrantes-Freer A, Muller WC, et al
    FOXC1 as a molecular predictor of postoperative peritumoral edema resolution in meningiomas.
    J Neurooncol. 2026;178:59.
    >> Share

  2. LIU L, Huang S, Huang Y, Xu J, et al
    Development and validation of a machine learning-based model for predicting delirium risk in postoperative brain tumor patients in the Intensive Care Unit.
    J Neurooncol. 2026;178:57.
    >> Share

  3. SEIFERT AM, Richter S, Sagerer A, Lemnian I, et al
    Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.
    J Neurooncol. 2026;178:58.
    >> Share

  4. MIZUTANI Y, Hori YS, Kattaa AH, Harary PM, et al
    Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.
    J Neurooncol. 2026;178:56.
    >> Share

  5. PARKER M, Carmichael A, Lucas CG Jr, Schreck KC, et al
    Survival after hypofractionated radiation versus standard radiation in glioblastoma by MGMT promoter methylation status and age: an analysis of the national cancer database.
    J Neurooncol. 2026;178:55.
    >> Share

  6. LANMAN TA, Gonzalez Castro LN, Perlow HK, Youssef G, et al
    Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.
    J Neurooncol. 2026;178:54.
    >> Share

  7. ZHANG Y, Wang H, Wang J, Sui Y, et al
    Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression.
    J Neurooncol. 2026;178:50.
    >> Share

  8. JIANG LQ, Wan CY, Kang J, Fu R, et al
    Survival outcomes and molecular predictors in small cell lung cancer with brain metastases receiving immunotherapy.
    J Neurooncol. 2026;178:51.
    >> Share

  9. BEA SINTES M, Velilla-Alonso G, Herrero-San Martin A, Gallego Perez-Larraya J, et al
    Risk factors and long-term outcomes in smart syndrome: a multicenter study.
    J Neurooncol. 2026;178:53.
    >> Share

  10. FARAJ CA, McCutcheon IE
    Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management.
    J Neurooncol. 2026;178:48.
    >> Share

  11. BENITEZ-ROCHA RD, Cabrera-Galeana P, Reyes JA, Villasenor-Navarro Y, et al
    Prognostic impact of concomitant leptomeningeal disease in breast cancer patients with brain metastases: a large single-center cohort study.
    J Neurooncol. 2026;178:49.
    >> Share

  12. ZHANG S, Sun Z, Jiang S, Meng L, et al
    Invasion/metastasis-related differentially methylated genes predict prognosis in diffuse gliomas.
    J Neurooncol. 2026;178:46.
    >> Share

  13. KUMAR S, Benavides-Serrato A, Saunders JT, Nishimura RN, et al
    PKA signaling modulates PRMT5/hnRNP A1-mediated IRES translation and dictates responses to mTOR inhibition in glioblastoma.
    J Neurooncol. 2026;178:45.
    >> Share

  14. HIMIC V, Johnson ML, Ratnaparkhi A, Mayrand RC, et al
    Butterfly gliomas: to biopsy or to ablate - a longitudinal cohort study.
    J Neurooncol. 2026;178:44.
    >> Share

  15. WILLIAMS ST, Kingdon S, Rominiyi O, Lorimer C, et al
    Report of treatment intensity and survival outcomes in older patients with glioblastoma diagnosed according to WHO CNS 5 classification.
    J Neurooncol. 2026;178:41.
    >> Share

  16. SUREN D, Nergiz D, Topsoy C, Unal SEP, et al
    The role of tumor-associated macrophages in the progression and recurrence of meningiomas.
    J Neurooncol. 2026;178:40.
    >> Share

  17. SHIDOH-KAZUKI R, Fujikawa Y, Kawabata S, Tsujino K, et al
    Correction: Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases.
    J Neurooncol. 2026;178:42.
    >> Share

  18. HIGASHINO M, Tanaka K, Ishihara T, Nagashima H, et al
    Long-term clinical outcomes and recurrence factors in intracranial germinoma.
    J Neurooncol. 2026;178:43.
    >> Share

  19. TROY C, Laird DG, Brimley C, Pinto S, et al
    Neoadjuvant chemotherapy for pineal region tumors.
    J Neurooncol. 2026;178:37.
    >> Share

  20. ZHANG L, Feng M, Yang Y, Qi Z, et al
    A comparative study of Ommaya reservoir versus lumbar puncture for intrathecal chemotherapy in patients with leptomeningeal metastasis: a systematic review and meta-analysis.
    J Neurooncol. 2026;178:38.
    >> Share

    May 2026
  21. WANG D, Liu X, Wang J, Zhang B, et al
    Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data.
    J Neurooncol. 2026;178:36.
    >> Share

  22. ROSUEL J, Duffau H
    What is the actual role of intraoperative MRI on long-term onco-functional outcome of surgery for low-grade glioma? A systematic review.
    J Neurooncol. 2026;178:35.
    >> Share

  23. GARCIA-HIDALGO C, Garcia Kempf AM, Galdo Galian D, Consentino Hernandez JA, et al
    Candidate MRI biomarkers for CD79B status in primary CNS lymphoma: an exploratory radiogenomic analysis of the UCSF-PCNSL cohort.
    J Neurooncol. 2026;178:33.
    >> Share

  24. PICHARDO-ROJAS PS, Garcia-Torrico F, Andrade-Arbaiza EA, Calderon Magdaleno LF, et al
    Radiotherapeutic management of metastatic brain disease: a two-decade meta-analysis of tumor control and neurocognitive outcomes with SRS alone versus SRS plus WBRT.
    J Neurooncol. 2026;178:32.
    >> Share

  25. ZHOU W, Yu M, Cheng S, Zhu H, et al
    Pituitary adenomas associated with hydrocephalus: clinical characteristics, risk stratification, and clinical management.
    J Neurooncol. 2026;178:31.
    >> Share

  26. LEON S, Maity A, Gluski J, Brown EDL, et al
    Intramedullary or invasive characteristics of spinal melanocytomas: a PRISMA compliant systematic review and pooled case analysis.
    J Neurooncol. 2026;178:30.
    >> Share

  27. HICKMAN-CHOW DA, Luckett PH, Olufawo M, Dierker D, et al
    Predicting progression-free survival in glioblastoma with neuroimaging and machine learning.
    J Neurooncol. 2026;178:29.
    >> Share

  28. BREHMER S, Sarria GR, Wurfel S, Sulejmani A, et al
    Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET).
    J Neurooncol. 2026;178:28.
    >> Share

  29. TUOHY K, Badani A, Franklin A, Zacharia B, et al
    Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
    J Neurooncol. 2026;178:26.
    >> Share

  30. ZHANG J, Zhang J, Qiu W, Zhang J, et al
    Retraction Note: MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
    J Neurooncol. 2026;178:27.
    >> Share

  31. MALGULWAR PB, Nambirajan A, Pathak P, Faruq M, et al
    Retraction Note: Study of beta-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
    J Neurooncol. 2026;178:22.
    >> Share

  32. TZENG CC, Chung MW, Huang YC, Chen KT, et al
    Peripheral hematological landscapes as biomarkers for detecting postoperative progression in glioblastoma multiforme: a multivariable risk scoring approach.
    J Neurooncol. 2026;178:24.
    >> Share

  33. MAI YY, Liu ZM, Zhou H, Jiang K, et al
    Role of tumor momentum in neurocognitive deficits among pediatric brainstem glioma prior to treatment: a pilot study.
    J Neurooncol. 2026;178:23.
    >> Share

  34. IZHAR M, Hori YS, Lam FC, Kalra N, et al
    Clinical utility of liquid biopsy in distinguishing true progression from radiation necrosis and pseudoprogression in malignant brain tumor.
    J Neurooncol. 2026;178:21.
    >> Share

  35. GLYNN SE, D'Agostino R Jr, Lanier CM, R Choi A, et al
    Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
    J Neurooncol. 2026;178:20.
    >> Share

  36. HWANG S, Kim PH, Kim H, Kim D, et al
    Therapeutic effects of selumetinib on diffuse neurofibroma and optic pathway glioma in neurofibromatosis type 1.
    J Neurooncol. 2026;178:18.
    >> Share

  37. JUNG IH, Yoo J, Choi S, Roh TH, et al
    Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.
    J Neurooncol. 2026;178:17.
    >> Share

  38. ARJUNA S, Pirhoushiaran M, Bueno A, Sanchez-Espitia A, et al
    CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.
    J Neurooncol. 2026;178:14.
    >> Share

  39. WONG DKK, Pu JKS, Li LF, Hui VKH, et al
    Health-related quality-of-life of WHO grade 4 astrocytoma patients receiving alternating electrical field therapy: a prospective real-world multi-centre study.
    J Neurooncol. 2026;178:16.
    >> Share

  40. PALIT SR, Shinya Y, Celda MP, Karsy M, et al
    Risk factors for postoperative cerebrospinal fluid leak following endoscopic transsphenoidal surgery for craniopharyngioma: a multicenter cohort study with a contemporary surgeon practice survey.
    J Neurooncol. 2026;178:13.
    >> Share

  41. SKARIN N, Hallbeck M, Werlenius K, Rohan Z, et al
    MGMT promoter methylation status for glioblastoma: defining the clinically relevant cut-off value for pyrosequencing.
    J Neurooncol. 2026;178:12.
    >> Share

  42. JIA JL, Alshamsan B, Andronic C, Fazzari F, et al
    Treatment patterns and outcomes in high-risk WHO grade 2 diffuse glioma: a multicentre retrospective cohort study.
    J Neurooncol. 2026;178:10.
    >> Share

  43. ZEYEN T, Decker A, Krause I, Kroh F, et al
    APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.
    J Neurooncol. 2026;178:9.
    >> Share

  44. VENTURA E, Alanesi A, Achterling M, Fistouris P, et al
    Impact of postoperative tumor volume and relative volume reduction to predict meningioma recurrence - a retrospective analysis.
    J Neurooncol. 2026;178:7.
    >> Share

  45. SHIDOH-KAZUKI R, Fujikawa Y, Kawabata S, Tsujino K, et al
    Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases.
    J Neurooncol. 2026;178:8.
    >> Share

  46. BINDAL K, Dono A, Tandon N, Esquenazi Y, et al
    Laser interstitial thermal therapy versus stereotactic radiosurgery for first-time treatment of recurrent glioblastoma: a retrospective single-center study.
    J Neurooncol. 2026;178:6.
    >> Share

  47. WIERZBICKI M, Bowden SG, Robert SM, Wang SY, et al
    Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settings.
    J Neurooncol. 2026;178:5.
    >> Share

  48. IZHAR M, Hori YS, Kattaa AH, Harary PM, et al
    Outcome of CyberKnife stereotactic radiosurgery for the brain metastases in patients with Li Fraumeni syndrome.
    J Neurooncol. 2026;178:4.
    >> Share

  49. LEVIN-CARRION Y, Bhasin J, Titkov K, Anne S, et al
    Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?
    J Neurooncol. 2026;178:2.
    >> Share

  50. PALUMBO C, De Schlichting E, Le Lann F, Leboucher A, et al
    Timing of adjuvant chemoradiotherapy after resection and survival in glioblastoma: a single-centre cohort analysis.
    J Neurooncol. 2026;177:150.
    >> Share

  51. BECHT K, Lindsay ME, Soulos PR, Singh C, et al
    Disparities in stereotactic radiosurgery receipt in patients with brain metastases from non-small cell lung cancer.
    J Neurooncol. 2026;177:151.
    >> Share

  52. HEBDA A, Wawrzyniak P, Heinze S, Mazgaj P, et al
    Diagnostic accuracy of 1H-MRS in detecting the oncometabolite 2-hydroxyglutarate (2HG) in adult-type diffuse gliomas.
    J Neurooncol. 2026;177:149.
    >> Share

  53. MUSHTAQ N, Bashir F, Zahid S, Shafique MA, et al
    Pediatric low-grade gliomas; a 12-year retrospective review from a tertiary care hospital in LMIC.
    J Neurooncol. 2026;177:148.
    >> Share

  54. HERSH DS, Asher AL, Bydon M, Delawan M, et al
    Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.
    J Neurooncol. 2026;177:147.
    >> Share

  55. ALBANO L, Losa M, Vitale GG, Reyes JS, et al
    Stereotactic radiosurgery for pediatric craniopharyngiomas: a multicenter retrospective study.
    J Neurooncol. 2026;177:146.
    >> Share

  56. LAPTEVA K, Gavrjushin A, Veselkov A
    Intraoperative tract mapping through the biopsy cannula during stereotactic biopsy of brainstem lesions: a prospective feasibility study.
    J Neurooncol. 2026;177:145.
    >> Share

  57. MOHL S, Tenhoeve SA, King S, Zhao Y, et al
    The impact of distance in treating glioblastoma: a retrospective single-center study.
    J Neurooncol. 2026;177:144.
    >> Share

  58. SAMPATH SG, Tang AJ, Chen AX, Viswanathan A, et al
    cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes.
    J Neurooncol. 2026;177:142.
    >> Share

  59. CHUCK C, Teshome A, Lin A, Sayeed S, et al
    Correction to: Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
    J Neurooncol. 2026;177:137.
    >> Share

  60. GOEL K, Qian Y, Pollom E
    Cost-effectiveness analysis of upfront HA-WBRT vs. SRS for treatment of brain metastases due to SCLC.
    J Neurooncol. 2026;177:139.
    >> Share

  61. SARFRAZ Z, Ranjan T, Mustafayev FNA, Luzarraga J, et al
    Treatment patterns and survival outcomes in neuroendocrine neoplasms presenting with brain metastases.
    J Neurooncol. 2026;177:141.
    >> Share

  62. KLAUS FL, Maragkou T, Delbridge C, Eberhardt CG, et al
    Subtype-specific prognostic impact of TNIK in medulloblastoma.
    J Neurooncol. 2026;177:140.
    >> Share

  63. LI M, Zhu J, Huang R, Yao X, et al
    Virus-like particle vaccine targeting meningeal lymphatic vessels via intradural delivery activates anti-glioma immunity.
    J Neurooncol. 2026;177:138.
    >> Share

  64. ANDRADE A, Mureb M, Karaman N, Liu C, et al
    Evaluating the efficacy of G12C inhibitors in conjunction with Gamma Knife radiosurgery for KRAS-mutant non-small cell lung cancer brain metastases.
    J Neurooncol. 2026;177:135.
    >> Share

  65. SHIREMAN JM, Xie E, Lebakken CS, Damodharan S, et al
    Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors.
    J Neurooncol. 2026;177:136.
    >> Share

  66. MITTELMAN L, Sistiaga IL, Seenarine N, Syed SA, et al
    Correction to: Connectome-guided resection of deep-seated brain tumors using tubular retractors: matched cohort outcomes and exploratory quantitative tractometry.
    J Neurooncol. 2026;177:134.
    >> Share

  67. DEMIRCAN V, Senturk E, Tezcanli E, Erpolat P, et al
    Outcomes of early versus late radiotherapy in grade 2 meningiomas: a National retrospective analysis from the TROD neuro-oncology group.
    J Neurooncol. 2026;177:133.
    >> Share

    April 2026
  68. GOODIN DA, Chen J, Williams BJ, Frieboes HB, et al
    Glioblastoma region-specific metabolic signatures reflect patient survival duration.
    J Neurooncol. 2026;177:130.
    >> Share

  69. GOULENKO V, Sinha S, Gulzar B, Madhugiri VS, et al
    Longitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery.
    J Neurooncol. 2026;177:129.
    >> Share

  70. MA Y, Zhou R, Ma Y, Mou C, et al
    Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment.
    J Neurooncol. 2026;177:128.
    >> Share

  71. FRIEDES C, Berger M, Linkowski L, Hollawell C, et al
    Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
    J Neurooncol. 2026;177:125.
    >> Share

  72. MAURICAITE R, Calvez KL, Robinson SD, Camp S, et al
    Variation in rates of post-operative oncological treatment for patients with glioblastoma in England: a comprehensive multi-year National cohort study from the GlioCova project.
    J Neurooncol. 2026;177:126.
    >> Share

  73. YOMO S, Yako T, Kitazawa K, Oda K, et al
    Long-term safety and efficacy of staged stereotactic radiosurgery with Ommaya reservoir aspiration for large cystic brain metastases.
    J Neurooncol. 2026;177:121.
    >> Share

  74. KOKETSU Y, Deguchi S, Ohka F, Aoki K, et al
    Feasibility of perampanel monotherapy for seizure management during awake craniotomy for glioma.
    J Neurooncol. 2026;177:122.
    >> Share

  75. GAGLIARDI F, De Domenico P, Roncelli F, Snider S, et al
    Circulating Angiopoietin-1/Angiopoietin-2 ratio may reflect pre- and post-treatment vascular states in Glioblastoma and improve discrimination between tumor recurrence and radiation necrosis.
    J Neurooncol. 2026;177:123.
    >> Share

  76. RYAN D, Peters KB, Sengupta S, Feng W, et al
    Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia.
    J Neurooncol. 2026;177:118.
    >> Share

  77. KENNEDY JC, Price SJ, Manly T, Woodberry E, et al
    Returning to work after treatment for a low-grade glioma: analysing return-to-work rates and exploring barriers experienced by patients.
    J Neurooncol. 2026;177:117.
    >> Share

  78. GAN T, Li M, Zhang J, Yao Y, et al
    Structural organization of neurosurgical care and its influence on long-term outcomes in glioma: evidence from a large single-center cohort in China.
    J Neurooncol. 2026;177:115.
    >> Share

  79. CHAO Y, Wang Y, Liu X, Ma P, et al
    Retraction Note: Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.
    J Neurooncol. 2026;177:114.
    >> Share

  80. MATSUDA R, Yamada K, Yokoyama S, Uemura K, et al
    Awake mapping-guided salvage resection for local recurrence or radiation necrosis after stereotactic radiosurgery and radiotherapy for brain metastases.
    J Neurooncol. 2026;177:113.
    >> Share

  81. MITTELMAN L, Sistiaga IL, Seenarine N, Syed SA, et al
    Connectome-guided resection of deep-seated brain tumors using tubular retractors: matched cohort outcomes and exploratory quantitative tractometry.
    J Neurooncol. 2026;177:109.
    >> Share

  82. HOU Z, Liu X, Zhang C, Sun S, et al
    Alterations in cerebral iron deposition in low-grade glioma-related epilepsy.
    J Neurooncol. 2026;177:108.
    >> Share

  83. NAKANO H, Shiinoki T
    Radiosensitivity index stability across glioma progression: a longitudinal bulk and single-cell analysis.
    J Neurooncol. 2026;177:107.
    >> Share

  84. LIU X, Zeng M, Zhang J, Richard SA, et al
    Microsurgical outcomes and prognostic analysis of cerebellar gliomas; pathology, molecular biomarkers, and novel clinical insights: a retrospective study.
    J Neurooncol. 2026;177:106.
    >> Share

  85. KULAKAUSKIENE D, Kriauciunaite K, Balion Z, Stankevicius E, et al
    Small and medium/large glioblastoma extracellular vesicles differentially regulate endothelial and mitochondrial function in blood-brain barrier and peripheral vasculature models.
    J Neurooncol. 2026;177:103.
    >> Share

  86. SALIM HA, Agosto S, Qudah HA, Learned K, et al
    A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.
    J Neurooncol. 2026;177:105.
    >> Share

  87. DUZKALIR AH, Yildirim DC, Askeroglu MO, Peker S, et al
    Single-fraction Gamma Knife radiosurgery for pineal region meningiomas: a retrospective single-center cohort of 44 patients.
    J Neurooncol. 2026;177:104.
    >> Share

  88. SANTHUMAYOR BA, Domogauer JD, Bernstein K, Donahue B, et al
    Evaluation of disparities in timely stereotactic radiosurgery for brain metastases in a safety net hospital system through a centralized workflow.
    J Neurooncol. 2026;177:102.
    >> Share

  89. SAHU AP, Palsa K, Shenoy G, Slagle-Webb B, et al
    Tumor-associated macrophages promote ferroptosis resistance in glioblastoma by stimulating iron-loaded extracellular vesicle release.
    J Neurooncol. 2026;177:99.
    >> Share

  90. XU Y, Zhao P, Yao Z, Shen T, et al
    CRYM suppresses glioblastoma progression by inhibiting the TGFbeta1/Smad-EMT signaling pathway.
    J Neurooncol. 2026;177:101.
    >> Share

  91. WANG Y, Chan WL, Li F, Cai J, et al
    Neurobehavioral outcomes and associated risk factors in pediatric brain tumor survivors.
    J Neurooncol. 2026;177:98.
    >> Share

  92. D'ANTONIO F, Rossi S, Carai A, Colafati GS, et al
    Pubertal development and hormonal modulation in pediatric low-grade gliomas: a retrospective cohort study.
    J Neurooncol. 2026;177:96.
    >> Share

  93. BOUFFET E, Ramaswamy V, Lafay-Cousin L
    Radiation-sparing management of WNT medulloblastoma of early childhood with high dose chemotherapy: In response to Gupta et al.
    J Neurooncol. 2026;177:95.
    >> Share

  94. BOUX F, Mercier A, Talba D, Giraud JY, et al
    Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases.
    J Neurooncol. 2026;177:91.
    >> Share

  95. SAITO K, Kawauchi D, Ono Y, Ohno M, et al
    Significance of shunt placement for secondary communicating hydrocephalus in patients with high-grade glioma.
    J Neurooncol. 2026;177:92.
    >> Share

  96. SHIN CJ, Mahammedi A, Massoud TF
    Intraventricular meningiomas show size-dependent increases in peak ASL-MRI perfusion reflecting vascular heterogeneity.
    J Neurooncol. 2026;177:89.
    >> Share

  97. OWENS GC, Contreras EM, Kienzler JC, Treger J, et al
    Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
    J Neurooncol. 2026;177:88.
    >> Share

  98. GRIGORIAN J, Chandler KE, Miller K, Mehta A, et al
    Young adults with primary brain tumors: predictors of referral to a fertility specialist for fertility preservation counseling and the impact on tumor treatment.
    J Neurooncol. 2026;177:87.
    >> Share

  99. DUFAULT ME, Akhavan-Sigari A, Pachon-Londono MJ, Olson VA, et al
    From barrier to bridge: a scoping review on the methods, clinical efficacy, and safety of blood-brain barrier disruption in treating high-grade glioma.
    J Neurooncol. 2026;177:86.
    >> Share

  100. BALDINI C, Cassier PA, Delord JP, Simonelli M, et al
    Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.
    J Neurooncol. 2026;177:85.
    >> Share

    March 2026
  101. FUKAMI S, Akimoto J, Nagai K, Nakajima N, et al
    Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes.
    J Neurooncol. 2026;177:84.
    >> Share

  102. LESKINEN S, Coelho A, Mittelman L, Haile H, et al
    Low-energy X-ray intraoperative radiotherapy for brain metastases: a systematic review of efficacy and safety.
    J Neurooncol. 2026;177:81.
    >> Share

  103. RONCELLI F, Snider S, Boselli D, De Domenico P, et al
    Correction to: Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.
    J Neurooncol. 2026;177:78.
    >> Share

  104. KIM Y, Seo Y, Kim J
    Novel cilengitide derivatives suppress migration and invasion of temozolomide-resistant glioblastoma cells via MAPK/Akt pathway inhibition.
    J Neurooncol. 2026;177:77.
    >> Share

  105. SANKAR BS, Johnson D, Boasiako PA, Vargas LO, et al
    Cerebrospinal fluid ctDNA as a prognostic and disease-activity biomarker in leptomeningeal metastases: systematic review, meta-analysis, and implications for CSF-guided care.
    J Neurooncol. 2026;177:75.
    >> Share

  106. REUTER J, Werfel T, Ruhle A, Wurschi G, et al
    Regret concerning treatment decisions in patients with primary or secondary brain tumors - a cross-sectional exploratory bicentric analysis.
    J Neurooncol. 2026;177:74.
    >> Share

  107. IZHAR M, Kattaa AH, Hori YS, Lam FC, et al
    Treatment outcomes of stereotactic radiosurgery for sarcoma brain metastases-systematic review.
    J Neurooncol. 2026;177:70.
    >> Share

  108. MULLER S, Hendricks A, Uttinger K, Kostatin M, et al
    Brain metastases from colorectal cancer - a retrospective dual center study.
    J Neurooncol. 2026;177:71.
    >> Share

  109. AYDIN HA, Keskin E, Kalayci M
    Perioperative risk stratification after resection of brain metastases: internal development and validation of the dominant lesion surgery score in a 20-year single-center cohort.
    J Neurooncol. 2026;177:69.
    >> Share

  110. DELBRIDGE C, Hou HX, Hielscher T, Wiestler B, et al
    Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification.
    J Neurooncol. 2026;177:67.
    >> Share

  111. BANSON M, Lear G, Darko K, Moor RSF, et al
    Leveraging biometric data for meaningful outcome assessments in the care of patients with brain tumors: a systematic review.
    J Neurooncol. 2026;177:66.
    >> Share

  112. NADEL JL, Gamboa NT, Botros D, Crabb BT, et al
    Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI.
    J Neurooncol. 2026;177:63.
    >> Share

  113. LU Y, Cao J, Liu X, Wang H, et al
    The predictive value of serum neurofilament light chain combined with inflammatory biomarkers for post-surgical epilepsy after brain tumor resection: a retrospective diagnostic study.
    J Neurooncol. 2026;177:61.
    >> Share

  114. CHEHADE R, Al-Humiqani A, Hanna L, Sahgal A, et al
    Brain metastases among patients with gynecologic cancers: a single-centre retrospective study of patients treated with brain radiotherapy.
    J Neurooncol. 2026;177:58.
    >> Share

  115. SARKAR MM, Gonsalves N, Davarzani A, Mitchell E, et al
    Disrupting Akt-Wnt/beta-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice.
    J Neurooncol. 2026;177:56.
    >> Share

  116. BINDAL S, Gonzalez B, Dono A, Riascos R, et al
    Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma.
    J Neurooncol. 2026;177:55.
    >> Share

  117. LIU J, Abikenari M, Annagiri S, Ha JH, et al
    Endogenous immune recruitment in glioblastoma CAR T therapy: cytokine, myeloid, and chemokine circuitry.
    J Neurooncol. 2026;177:50.
    >> Share

  118. ELIA A, Roux A, Demasi M, Debacker C, et al
    Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas.
    J Neurooncol. 2026;177:53.
    >> Share

  119. PRINS TJ, Lai TJ, Li T, Fisher A, et al
    MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.
    J Neurooncol. 2026;177:48.
    >> Share

  120. SARAF A, Ford J, Parsons M, Sherman J, et al
    Longitudinal changes of neurocognitive function and ALPS-index in patients with brain tumors receiving brain irradiation.
    J Neurooncol. 2026;177:47.
    >> Share

  121. ZENG W, Jedwood C, Chung R, Cote DJ, et al
    Associations of surgical menopause and hormone replacement therapy with meningioma development.
    J Neurooncol. 2026;177:49.
    >> Share

  122. ABU-ARJA MH, Stuckert A, Ghebrelul RT, Chintagumpala M, et al
    Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma.
    J Neurooncol. 2026;177:39.
    >> Share

  123. WANG Y, Xie K, Yang K, Luo A, et al
    Socioeconomic disparities in IDH-wildtype glioblastoma survival: interactions between age and household income in a SEER cohort.
    J Neurooncol. 2026;177:40.
    >> Share

  124. ZHENG S, Lin L, Ren G, Lan H, et al
    Correction to: Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
    J Neurooncol. 2026;177:41.
    >> Share

  125. AMPIL F, Moncrief O, Sin A, Toms J, et al
    Reduced dose single-fraction frame-based postoperative radiosurgery for large (> 10 cm(3)) brain metastases cavities: real world outcomes.
    J Neurooncol. 2026;177:43.
    >> Share

  126. CIOFFI G, Waite K, Baranova A, Barnholtz-Sloan J, et al
    Individualized prediction of survival after brain metastasis development in patients with breast cancer.
    J Neurooncol. 2026;177:44.
    >> Share

  127. JUNGK C, Goepfert K, Gluszak M, Marhaba K, et al
    Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis.
    J Neurooncol. 2026;177:42.
    >> Share

  128. AGARWAL V
    The promise and potential of porphyrin metabolite activation using sonodynamic therapy for the treatment of glioblastoma.
    J Neurooncol. 2026;177:45.
    >> Share

  129. BYTNAR JA, Robins KR, Theeler BJ, Shriver CD, et al
    The relationship between asthma and glioma: a case-control study in a universal access healthcare system.
    J Neurooncol. 2026;177:38.
    >> Share

  130. GECICI NN, Stepniak A, Ozcinar KK, Habib A, et al
    Malignant transformation in IDH-mutant gliomas: clinical drivers and survival outcomes in a histologically defined cohort.
    J Neurooncol. 2026;177:37.
    >> Share

  131. PACK E, Cifarelli CP, Bhatia S, Lewis J, et al
    Glioblastoma survival in rural America: a 10-year experience from a quaternary care center.
    J Neurooncol. 2026;177:36.
    >> Share

  132. KHATRI VM, Aboujaoude M, Karapetyan L, Tarhini AA, et al
    Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression.
    J Neurooncol. 2026;177:35.
    >> Share

  133. RONCELLI F, Snider S, Boselli D, De Domenico P, et al
    Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.
    J Neurooncol. 2026;177:34.
    >> Share

  134. GUPTA T, Dasgupta A, Chatterjee A
    Craniospinal irradiation plus tumor-bed boost with standard adjuvant chemotherapy OR high-dose chemotherapy plus autologous stem cell transplant as a radiation-sparing approach in WNT medulloblastoma of early childhood: Fire OR Ice?
    J Neurooncol. 2026;177:33.
    >> Share

  135. ROBLES C, Das A, Pai V, Laughlin S, et al
    Imaging assessment of immunotherapy in pediatric brain tumors.
    J Neurooncol. 2026;177:30.
    >> Share

  136. JEISING S, Reinken J, Rapp M, Sabel M, et al
    Can we make it up? - second-look surgery due to post-operative residual tumour in patients diagnosed with diffuse glioma.
    J Neurooncol. 2026;177:29.
    >> Share

  137. ONDER T, Ates O
    Biological aging enhances prognostic stratification beyond chronological age in breast cancer brain metastases.
    J Neurooncol. 2026;177:28.
    >> Share

  138. YENIDOGAN I, Tabori U, Das A
    Immune checkpoint inhibitors in pediatric central nervous system tumors: biology, clinical experience, and translational pathways to precision immunotherapy.
    J Neurooncol. 2026;177:27.
    >> Share

  139. FUKUDA S, Tamura K, Shimizu K, Orihara A, et al
    Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study.
    J Neurooncol. 2026;177:24.
    >> Share

  140. CHANG X, He Z, Wang H, Zhu H, et al
    Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study.
    J Neurooncol. 2026;177:26.
    >> Share

    February 2026
  141. BLUMS K, Kalra LP, Nerntengian N, Zylyftari S, et al
    Prospective evaluation of GFAP point-of-care testing for rapid diagnosis of glioblastoma.
    J Neurooncol. 2026;177:22.
    >> Share

  142. DUFFAU H
    Traveling large distances for awake functional-based surgery of IDH-mutated grade 2 glioma: outcomes comparison between loco-regional versus international patients.
    J Neurooncol. 2026;177:20.
    >> Share

  143. PICART T, Ducray F
    Comment on: "Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes".
    J Neurooncol. 2026;177:21.
    >> Share

  144. ZHENG S, Lin L, Ren G, Lan H, et al
    Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
    J Neurooncol. 2026;177:16.
    >> Share

  145. ALHALABI OT, Mironov K, Nabiev K, Kramer J, et al
    Repeat resection for recurrent glioblastoma - does timing matter?
    J Neurooncol. 2026;177:14.
    >> Share

  146. MENDOZA MIRELES EE, Blakstad H, Server A, Leske H, et al
    Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.
    J Neurooncol. 2026;177:15.
    >> Share

  147. NATH B, Bobholz SA, Kim DC, Lowman AK, et al
    Altered perivascular diffusivity in glioblastoma: integrating DTI-ALPS index with radio-pathomic and histopathologic correlates.
    J Neurooncol. 2026;177:12.
    >> Share

  148. RAUCH S, Wan Y, Halai A, Manly T, et al
    Multidimensional cognitive reserve and cognitive outcomes in glioblastoma: a pre- and postoperative analysis.
    J Neurooncol. 2026;177:11.
    >> Share

  149. LEE JY, Koo JY, Kim NI, Kim SS, et al
    HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types.
    J Neurooncol. 2026;177:10.
    >> Share

  150. MALHOTRA R, Moitra P, Chatterjee A, Kota PK, et al
    Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.
    J Neurooncol. 2026;177:9.
    >> Share

  151. SHIMIZU T, Sato H, Sanada T, Saito M, et al
    A voxel-based quantitative framework for analyzing the spatial redistribution and directionality of recurrence in glioblastoma.
    J Neurooncol. 2026;177:8.
    >> Share

  152. WONG CE, Kuo YC, Chen PW, Lee PH, et al
    Early withdrawal of systemic corticosteroid following malignant glioma craniotomy: a real-world population-based cohort study.
    J Neurooncol. 2026;177:5.
    >> Share

  153. SATGUNASEELAN L, Xian E, Madani D, Gamage KK, et al
    Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank.
    J Neurooncol. 2026;177:6.
    >> Share

  154. ILIKHAN A, Tasdemir S, Oral S, Kucuk A, et al
    Evaluation of NETosis-related biomarkers in glioblastoma multiforme: PAD4 as a potent diagnostic predictor.
    J Neurooncol. 2026;177:3.
    >> Share

  155. MENG W, Duan J, Guo C, Xu J, et al
    Multiomics integration of serum proteome and autoantibody profiles reveals diagnostic and prognostic biomarkers in glioma.
    J Neurooncol. 2026;177:2.
    >> Share

  156. WANG C, Xu H, Hu Y, Ma L, et al
    Tumor treating fields for newly diagnosed glioblastoma: a retrospective analysis.
    J Neurooncol. 2026;177:1.
    >> Share

  157. MC CARTHY L, Andersen BM, Wen PY, Reardon DA, et al
    Meta-analysis of treatment-emergent seizures in glioma vaccine trials.
    J Neurooncol. 2026;176:212.
    >> Share

  158. YAMASHITA S, Kanamori M, Kubozono M, Shimoda Y, et al
    Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma.
    J Neurooncol. 2026;176:211.
    >> Share

  159. DENIZ B, Arpaci MF, Pekmez H, Uzun GB, et al
    Investigation of the effects of radiotherapy and chemotherapy on brain volume in cancer patients: brain tumor study.
    J Neurooncol. 2026;176:210.
    >> Share

  160. TOLL SA, Rechberger JS, Chow WD, Biswas S, et al
    Update of NK cell therapy in pediatric brain tumors.
    J Neurooncol. 2026;176:209.
    >> Share

  161. LOUGHAN AR, Braun SE, Lanoye A, Willis K, et al
    Post-traumatic growth in patients and caregivers after a primary brain tumor diagnosis.
    J Neurooncol. 2026;176:208.
    >> Share

  162. BIYIKLI E, Aybal T, Aslan B, Gul D, et al
    Prognostic role of delta radiomics in pediatric pontine diffuse midline gliomas.
    J Neurooncol. 2026;176:206.
    >> Share

  163. RAMSEY KA, Byrne L, Taylor OB, Soliman A, et al
    High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome.
    J Neurooncol. 2026;176:207.
    >> Share

  164. PURI S, Sloan L, Doucet M, Katulis L, et al
    Radiation immunodynamics: association of baseline and longitudinal cytokine levels during radiotherapy in glioblastoma with survival.
    J Neurooncol. 2026;176:204.
    >> Share

  165. STEELE EM, Hall JT, Lui K, Darawsheh R, et al
    Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.
    J Neurooncol. 2026;176:203.
    >> Share

  166. MORAES FY, Isen J, Perry J, Laperriere N, et al
    Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
    J Neurooncol. 2026;176:200.
    >> Share

  167. MIRIAN C, Jensen LR, Hoffmann AG, Juratli TA, et al
    Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.
    J Neurooncol. 2026;176:201.
    >> Share

  168. JANKOVIC D, Thavarajasingam SG, Scurtu D, Baby MV, et al
    Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients.
    J Neurooncol. 2026;176:202.
    >> Share

  169. KITE T, Hanft S, Zeller S, Lee S, et al
    Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.
    J Neurooncol. 2026;176:199.
    >> Share

  170. MEL'NIKOV MY, Shakhzadayev R, Baiturlin Z, Batyrkhanov D, et al
    Frequency-specific resting state fMRI features in gliomas.
    J Neurooncol. 2026;176:198.
    >> Share

  171. ROUX A, Elia A, Nadler C, Hudelist B, et al
    Impact of Carmustine wafer implantation in epileptic seizures of newly diagnosed glioblastomas, IDH-wildtype in adults.
    J Neurooncol. 2026;176:196.
    >> Share

  172. HON JJ, Akbarzadeh Mostaghbal H, Akkara Y, Das JM, et al
    Socioeconomic disparities in glioma outcomes: a grade-specific analysis.
    J Neurooncol. 2026;176:195.
    >> Share

  173. BASARAN AE, Braune M, Barrantes-Freer A, Mueller WC, et al
    FOXC1 expression and radiological predictors of peritumoral brain edema in meningiomas.
    J Neurooncol. 2026;176:194.
    >> Share

  174. OKUBO T, Nagoshi N, Iga T, Takeda K, et al
    Clinical characteristics and surgical outcomes of intradural spinal metastases: a comparative analysis between intramedullary and extramedullary lesions.
    J Neurooncol. 2026;176:193.
    >> Share

    January 2026
  175. QIU H, Huang Y, Zhou J, Jiang Z, et al
    Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients.
    J Neurooncol. 2026;176:192.
    >> Share

  176. DIPASQUALE A, Giordano P, Bosio A, Wijnenga MMJ, et al
    Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
    J Neurooncol. 2026;176:186.
    >> Share

  177. GORWOOD W, Peciu-Florianu L, Strachowski O, Vannod-Michel Q, et al
    The neuropsychological outcome of patients undergoing intraoperative MRI surgery for insular infiltrating gliomas.
    J Neurooncol. 2026;176:187.
    >> Share

  178. DIXIT KS, Kumthekar P, Lukas RV, Williams A, et al
    A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.
    J Neurooncol. 2026;176:185.
    >> Share

  179. LOPES TLM, Balsells MD, Cavalcante MA, de Queiroz AGD, et al
    Awake surgery versus general anesthesia in the treatment of Diffuse Low-Grade Gliomas - and the role of supplementary intraoperative techniques: a systematic review and meta-analysis.
    J Neurooncol. 2026;176:184.
    >> Share

  180. NOZZOLI F, Ortenzi V, Nucci E, Morelli I, et al
    Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study.
    J Neurooncol. 2026;176:183.
    >> Share

  181. CHEN SH, Wang HN, Toh CH, Wei KC, et al
    PET RANO 1.0 criteria improve prognostic stratification in high-grade gliomas using (11)C-methionine PET/MR.
    J Neurooncol. 2026;176:180.
    >> Share

  182. CIOFFI G, Waite K, Baranova A, Barnholtz-Sloan JS, et al
    Individualized prediction of brain metastasis risk in patients with breast cancer.
    J Neurooncol. 2026;176:179.
    >> Share

  183. BEKELMAN NJ, Ghaith AK, Yang L, Momeni A, et al
    Rates of recurrence and symptom improvement following resection of spinal meningiomas in the pediatric population: individual participant data meta-analysis.
    J Neurooncol. 2026;176:178.
    >> Share

  184. PATEL SH, Mayorov S, Kim W, Singh K, et al
    Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4.
    J Neurooncol. 2026;176:177.
    >> Share

  185. BHANDARKAR S, Palermo M, Wu C, Myneni S, et al
    Profiling T-cell activity and exclusion in pediatric medulloblastoma highlights immunotherapy-responsive subgroups.
    J Neurooncol. 2026;176:176.
    >> Share

  186. MINNITI G, Tini P, Navarria P, Raza G, et al
    Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases.
    J Neurooncol. 2026;176:175.
    >> Share

  187. MORAES FY, Isen J, Perry J, Laperriere N, et al
    Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
    J Neurooncol. 2026;176:171.
    >> Share

  188. NOBRE L, Ramaswamy V, Coleman C, Dhall G, et al
    High-dose chemotherapy and craniospinal irradiation-sparing approach for WNT medulloblastoma of early childhood.
    J Neurooncol. 2026;176:172.
    >> Share

  189. GENSLER R, Ahmed AK, Alfonzo Horowitz M, Khalifeh JM, et al
    Differences in regional developmental origins of glioblastomas revealed by integrated molecular profiling.
    J Neurooncol. 2026;176:170.
    >> Share

  190. ZUBROWSKA J, Pieniazek M, Polakiewicz-Gilowska A, Kolarova I, et al
    Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.
    J Neurooncol. 2026;176:167.
    >> Share

  191. HIMIC V, Lu VM, Mayrand RC, Sass ER, et al
    Awake craniotomy for brain tumor resection in the elderly: an institutional experience.
    J Neurooncol. 2026;176:169.
    >> Share

  192. GRASSL N, Suwala AK, Kessler T, Bunse L, et al
    Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas.
    J Neurooncol. 2026;176:166.
    >> Share

  193. SHIREMAN JM, Ammanuel S, Cheng L, Distler E, et al
    Glioblastoma immunotherapy in the context of the aging immune system: a systematic review and meta-analysis.
    J Neurooncol. 2026;176:164.
    >> Share

  194. WANG Q, Wang H, Hong W, Bashir S, et al
    Correction to: Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis.
    J Neurooncol. 2026;176:163.
    >> Share

  195. NAKAJIMA R, Kinoshita M, Okita H, Tamai S, et al
    Surgical history and temporal muscle thickness as predictors of successful awake surgery in older patients with glioma.
    J Neurooncol. 2026;176:161.
    >> Share

  196. FORTUNATO JT, Scharf A, Shuman AG, Diamond EL, et al
    Staging prognostic discussions about glioblastoma.
    J Neurooncol. 2026;176:162.
    >> Share

  197. ROBINSON SD, Kingdon S, Williams ST, Hill CS, et al
    Understanding the difference in symptoms and outcomes between glioblastoma patients diagnosed based on histological or molecular criteria: a retrospective cohort analysis from the Histo-Mol GBM collaborative.
    J Neurooncol. 2026;176:157.
    >> Share

  198. HARPER SD, Alderete JA, Baisiwala S, Bergsneider BH, et al
    Vaccine therapy for pediatric high-grade glioma: current landscape, challenges, and future directions.
    J Neurooncol. 2026;176:158.
    >> Share

  199. HU W, Rao Q, Zhu D, Yao S, et al
    Clinicopathological features and outcomes in non-functioning pituitary neuroendocrine tumors: a transcription factor-driven subtype analysis.
    J Neurooncol. 2026;176:160.
    >> Share

  200. CHEN S, Jugl S, Jackson L, Rahman M, et al
    Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users.
    J Neurooncol. 2026;176:156.
    >> Share

  201. TINI P, Donnini F, Minniti G
    EGFR amplification and rapid early progression in glioblastoma: implications for timing and risk stratification.
    J Neurooncol. 2026;176:155.
    >> Share

  202. AKBAS S, Alan O, Yildiz O, Karakurt M, et al
    Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
    J Neurooncol. 2026;176:152.
    >> Share

  203. GU M, Luckett PH, Olufawo M, Dierker D, et al
    BOLD complexity characterizes glioblastoma survival via voxel-wise and localized sample entropy.
    J Neurooncol. 2026;176:151.
    >> Share

  204. SANIKOMMU S, Santos AN, Wipplinger C, Dawoud B, et al
    Patient-reported outcomes as prognostic indicators for overall survival and progression-free survival in brain tumor patients - a systematic review and meta-analysis of randomized clinical trials.
    J Neurooncol. 2026;176:154.
    >> Share

  205. ZHOU L, Xu Z, Fang C, Ren H, et al
    Multiomics reveals the mechanism of KNG1 in promoting tumor progression in adamantinomatous craniopharyngioma.
    J Neurooncol. 2026;176:150.
    >> Share

  206. HONG JP, Hong JB, Lee B, Choi RJ, et al
    Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres.
    J Neurooncol. 2026;176:148.
    >> Share

  207. LIU CM, Medeiros Geraldo LH, Xiao J, Sulman EP, et al
    Retrospective analysis of the impact of antidepressants with anti-acid sphingomyelinase activity on survival of patients with glioblastoma.
    J Neurooncol. 2026;176:147.
    >> Share

    December 2025
  208. KITE T, Wegner RE, Shepard MJ
    Comment on: "Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding".
    J Neurooncol. 2025;176:146.
    >> Share

  209. KERIC N, Krenzlin H, Lange F, Dauth A, et al
    Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy.
    J Neurooncol. 2025;176:145.
    >> Share

  210. JEUNG YS, Lee WT, Kim Y, Keam B, et al
    Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective study.
    J Neurooncol. 2025;176:142.
    >> Share

  211. CROUZEN J, Mast M, Kerkhof M, Vos M, et al
    Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapy.
    J Neurooncol. 2025;176:139.
    >> Share

  212. ST BRICE K, Parker T, Wouters K, Guzman-Rios ED, et al
    Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes.
    J Neurooncol. 2025;176:138.
    >> Share

  213. KIM J, Shin K, Lee A, Lee J, et al
    Prognostic impact of endocrine therapy and BDNF-TrkB axis in breast cancer brain metastases.
    J Neurooncol. 2025;176:140.
    >> Share

  214. MORAES FCA, Rodrigues PB, Vital LDS, Talah BAD, et al
    Prevalence of human cytomegalovirus in glioblastoma multiforme: a systematic review and meta-analysis.
    J Neurooncol. 2025;176:143.
    >> Share

  215. LIU J, Ha JH, Abikenari M, Sjoholm MA, et al
    Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation.
    J Neurooncol. 2025;176:144.
    >> Share

  216. NAHLS NS, Anttonen A, Kitti P, Leskela RL, et al
    Early palliative care decision in patients with primary brain tumor reduces emergency department visits and hospitalization at the end of life.
    J Neurooncol. 2025;176:137.
    >> Share

  217. RON GN, Ron IG, Kantor H, Fening E, et al
    Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC).
    J Neurooncol. 2025;176:135.
    >> Share

  218. AMIRKHANI N, Maroufi F, Pour-Rashidi A, Shirani M, et al
    Impact of anti-seizure medication duration on postoperative seizures following supratentorial high-grade glioma resection: a mixed-model and tree-based approach.
    J Neurooncol. 2025;176:134.
    >> Share

  219. EVERS SMITH JW, Alzate JD, Power L, Wei W, et al
    The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence.
    J Neurooncol. 2025;176:132.
    >> Share

  220. BELLOMO J, Gonel M, Sutter J, Zeitlberger AM, et al
    Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases.
    J Neurooncol. 2025;176:131.
    >> Share

  221. HUANG G, Wei Y, Hou X, Jia X, et al
    ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy.
    J Neurooncol. 2025;176:130.
    >> Share

  222. PALERMO M, Massimi L, Tamburrini G, Olivi A, et al
    Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma.
    J Neurooncol. 2025;176:128.
    >> Share

  223. SISTIAGA IL, Chen J, Mittelman L, Syed S, et al
    Connectomics in brain tumor surgery: large-scale clinical feasibility and hypothesis-generating tractometry findings.
    J Neurooncol. 2025;176:129.
    >> Share

  224. HU Y, Liu F, Mi R
    Glioma cells achieve malignant progression by fusion with macrophages to gain high SLC7A5 expression.
    J Neurooncol. 2025;176:126.
    >> Share

  225. LEISTNER T, Terrapon APR, Hostettler IC, Bozinov O, et al
    Adverse events in meningioma surgery classified using the therapy-disability-neurology (TDN) grading system.
    J Neurooncol. 2025;176:125.
    >> Share

  226. BOFFELLI L, Fimiani C, Nunez NG, Kienzler JC, et al
    Synergy of radiotherapy, focused ultrasound, and immunotherapy in the treatment of brain metastases.
    J Neurooncol. 2025;176:124.
    >> Share

  227. JHANDI S, Jhandi AS, Cannon DM, Burt LM, et al
    Stereotactic radiosurgery for radiation?induced meningiomas: long?term institutional outcomes with patient- and lesion?level analyses and an updated meta?analysis.
    J Neurooncol. 2025;176:122.
    >> Share

  228. SAMPATH SG, Manriquez AH, Haile H, Botkiss M, et al
    Socioeconomic disparities in patient-reported outcomes, health literacy, and access to care among patients with primary brain tumors: findings from the All of Us Research Program.
    J Neurooncol. 2025;176:123.
    >> Share

  229. PARKER M, Carmichael A, Arbuiso AG, Jiang K, et al
    Brain metastases from renal cell carcinoma: a large retrospective claims-based oncology cohort analysis of prevalence, chronicity, and survival outcomes.
    J Neurooncol. 2025;176:119.
    >> Share

  230. DAMANTE MA, Finger G, Juncker RB, Kreatsoulas DC, et al
    Management of intermediate-sized brain metastases of the primary motor cortex.
    J Neurooncol. 2025;176:120.
    >> Share

  231. SCAGLIOTTI E, Capetti B, Conti L, Fiore G, et al
    Effects of proton therapy on cognition in adults with brain tumors: a systematic review.
    J Neurooncol. 2025;176:121.
    >> Share

  232. DRAPPATZ J, Mantica M
    Treatment strategies and innovation for recurrent high-grade glioma.
    J Neurooncol. 2025;176:118.
    >> Share

  233. UYSAL E, Reinhardt P, Schmidhalter D, Wagner F, et al
    Oncological value of MRI in brain metastasis: exploring the potential of combining post-contrast T1 TSE (SPACE) and T1 GRE (MPRAGE) for stereotactic radiosurgery planning and surveillance.
    J Neurooncol. 2025;176:117.
    >> Share

  234. SARFRAZ Z, Ranjan T, Mustafayev FNA, Jaramillo M, et al
    Emerging therapies for glioblastoma.
    J Neurooncol. 2025;176:116.
    >> Share

  235. ZHOU DJ, Chang K, Jaskir M, Davis KA, et al
    Free water elimination tractometry reveals local and remote white matter alterations in diffuse gliomas.
    J Neurooncol. 2025;176:115.
    >> Share

  236. WANG D, Wang Z, Xu J, Cai Y, et al
    Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications.
    J Neurooncol. 2025;176:113.
    >> Share

  237. HSUEH B, Steuart SJ, Odukoya AO, Prager BC, et al
    Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
    J Neurooncol. 2025;176:112.
    >> Share

  238. SCHWENDNER M, Kram L, Zhang H, Krieg SM, et al
    Preoperative nTMS-based mapping of a verbal semantic association task allows for the identification of extensive bihemispheric cortical and subcortical networks.
    J Neurooncol. 2025;176:108.
    >> Share

  239. UWAMARIYA D, Niyodusenga E, Surwumwe JB, Umutesi A, et al
    Accuracy of intra-operative brain tumor squash cytology compared to large excision biopsy: a comparative study at the University Teaching Hospital of Kigali (CHUK), Rwanda.
    J Neurooncol. 2025;176:109.
    >> Share

  240. GRUTZA M, Mitschang D, Sydorenko V, Dugas M, et al
    Quantitative pupillometry as a sensitive tool for detecting tumor-related mass effect in the posterior fossa: a prospective feasibility study comparing metastatic versus skull base lesions.
    J Neurooncol. 2025;176:110.
    >> Share

  241. YANG C, Wang H, Liu M, Cai Y, et al
    Perovskite nanocrystal probes for intraoperative in vitro pathological detection of IDH1 mutation status in glioma.
    J Neurooncol. 2025;176:111.
    >> Share

  242. HARARY PM, Hori YS, Annagiri S, Abe K, et al
    Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review.
    J Neurooncol. 2025;176:106.
    >> Share

  243. ROCHE J, Guerra A, Remaud J, Liger C, et al
    Disruption of cognitive flexibility and planning skills after childhood brain tumor treatment: clinical issues and comprehensive assessment.
    J Neurooncol. 2025;176:104.
    >> Share

  244. SBAIH O, Singh A, Li A, Kolady R, et al
    Factors affecting postoperative seizure risk and perioperative outcomes in pediatric brain tumor resections.
    J Neurooncol. 2025;176:105.
    >> Share

  245. SUN L, Li J, Lv Y, Li L, et al
    Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis.
    J Neurooncol. 2025;175:1163-1176.
    >> Share

  246. JIANG Z, Jin X, Xue H, Zhang J, et al
    TMEM164 enhances radioresistance of GBM cells by inhibiting the FASN-NADPH-ROS axis.
    J Neurooncol. 2025;175:1011-1026.
    >> Share

  247. SONKSEN M, Bison B, Bussenius L, Rascon J, et al
    One-year follow-up of the new European reference network for pediatric cancers (ERN PaedCan) tumor board for pediatric CNS tumors: lessons learnt and future prospects.
    J Neurooncol. 2025;175:1415-1423.
    >> Share

  248. BRAND A, Agolli L, Tas KT, Lishwiski P, et al
    Long-term outcomes of modern radiation therapy for pituitary adenoma - different techniques: single institute experience.
    J Neurooncol. 2025;175:1039-1050.
    >> Share

  249. ZHAO J, Liang L, Li J, Li Q, et al
    Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.
    J Neurooncol. 2025;175:1103-1113.
    >> Share

  250. CHAKRAVARTI S, Oak A, Tang L, Mao Y, et al
    Community-level social capital and postoperative outcomes following intracranial tumor surgery: an exploration of the Social Capital Atlas in neurosurgical oncology.
    J Neurooncol. 2025;175:1455-1463.
    >> Share

  251. ARRIETA O, Diaz-Alba A, Moreno-Jimenez S, Rodriguez-Camacho A, et al
    Real-world experience outcome in patients with central nervous system metastases: information on 2,226 patients during a 15-year period.
    J Neurooncol. 2025;175:1227-1234.
    >> Share

  252. MAHAPATRA S, Seltzer L, Osorio N, Miller M, et al
    A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases.
    J Neurooncol. 2025;175:1051-1064.
    >> Share

  253. RYBA A, Mohme T, Kerschbaumer J, von Bronewski E, et al
    Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma.
    J Neurooncol. 2025;176:102.
    >> Share

    November 2025
  254. ROLDAN URGOITI G, de Robles P, Tsang RY, Willson M, et al
    A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.
    J Neurooncol. 2025;176:101.
    >> Share

  255. YOO J, Jung IH, Chang WS, Jung HH, et al
    Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding.
    J Neurooncol. 2025;176:100.
    >> Share

  256. VARGAS LO, Himic V, Otaner F, Abikenari M, et al
    Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications.
    J Neurooncol. 2025;176:99.
    >> Share

  257. DARKO K, Chen J, Eckel-Passow JE, Fonkem E, et al
    Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival.
    J Neurooncol. 2025;176:98.
    >> Share

  258. PAHWA B, Pahwa N, Sheehan JP
    Single session versus hypofractionated stereotactic radiosurgery for large meningiomas (> 8 cc): a systematic review and meta analysis.
    J Neurooncol. 2025;176:97.
    >> Share

  259. BASARAN AE, Fahsold L, Lordick F, Nicolay NH, et al
    Treatment modalities in recurrent brain metastases: a combined institutional and individual patient data meta-analysis of post-recurrence survival and local progression-free survival.
    J Neurooncol. 2025;176:96.
    >> Share

  260. MASTRONUZZI A, Franceschi E, D'Antonio F, Bennicelli E, et al
    Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.
    J Neurooncol. 2025;176:95.
    >> Share

  261. RICHARDSON GE, Mustafa MA, Clynch AL, Islim AI, et al
    Immunohistochemistry markers of molecular subtype do not correlate with the growth behaviour for recurrent meningiomas - a cohort study.
    J Neurooncol. 2025;176:94.
    >> Share

  262. YAMANISHI S, Nagashima H, Tanaka K, Ikeuchi Y, et al
    Tumor-associated M2 macrophages shape the cerebrospinal fluid immunoprofile, and the soluble CD163/type I interferon ratio correlates with prognosis in high grade glioma.
    J Neurooncol. 2025;176:93.
    >> Share

  263. GULSUNA B, Stevens B, Gulsuyu B, Wood E, et al
    Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review.
    J Neurooncol. 2025;176:90.
    >> Share

  264. RAGHU A, Killar S, Cohen AL
    Effects of temozolomide dosing on outcome in glioblastoma.
    J Neurooncol. 2025;176:89.
    >> Share

  265. VEGH L, Benninger F, Tamir I
    Seizure characteristics in epilepsy patients with a primary brain tumor.
    J Neurooncol. 2025;176:92.
    >> Share

  266. BUCCILLI B, Lucke-Wold B
    Performance of artificial intelligence for brain tumor segmentation, treatment planning, and outcome prediction: a comprehensive systematic review and meta-analysis.
    J Neurooncol. 2025;176:88.
    >> Share

  267. MANORANJAN B, Zeller S, Demere Z, Reiner AS, et al
    Clinical and genomic characterization of brain metastasis in thyroid cancer.
    J Neurooncol. 2025;176:87.
    >> Share

  268. WACH J, Weber F, Wende T, Vychopen M, et al
    GLIMMER: an interim subgroup analysis from an ongoing prospective study evaluating hyperspectral imaging for MGMT promoter methylation in gliomas.
    J Neurooncol. 2025;176:86.
    >> Share

  269. DONG J, Liu L, Zhao Z, Huang G, et al
    China National Glioma Registry (CNGR): protocol for a prospective observational registry study.
    J Neurooncol. 2025;176:83.
    >> Share

  270. TERRY F, Brito A, Vascones-Roman FF, Rivera V, et al
    Post-ablation volume threshold for brain metastasis control using LITT: a systematic review and critical appraisal.
    J Neurooncol. 2025;176:85.
    >> Share

  271. DUFFAU H
    Return to intensive sport activities following awake functional-guided surgical resection of IDH-mutated low-grade glioma.
    J Neurooncol. 2025;176:82.
    >> Share

  272. KANN MR, Srinivasan ES, Benedetti JR, Ostrom QT, et al
    Epidemiology and survival of adolescent and young adults with brain metastases compared to older adults.
    J Neurooncol. 2025;176:81.
    >> Share

  273. TOTH AJ, Robert SM, Fahy T, Wang SY, et al
    Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis.
    J Neurooncol. 2025;176:80.
    >> Share

  274. BUCCILLI B, Yoon J, Hussein A, Faraji AH, et al
    Correction to: Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
    J Neurooncol. 2025;176:79.
    >> Share

  275. YANG X, Wang L, Wu H, Li C, et al
    GABA treatment promoting cell apoptosis in meningioma correlates with EGFR/BCL-2/BAX axis.
    J Neurooncol. 2025;176:78.
    >> Share

  276. CHOLE V, Moolchandani J, Verma S, Satone S, et al
    PSF-GRBM: brain tumor classification and grading using optimized gated recurrent unit-deep bidirectional long short-term memory.
    J Neurooncol. 2025;176:76.
    >> Share

  277. GUIMARAES MM, Matushita H
    Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy.
    J Neurooncol. 2025;176:75.
    >> Share

  278. SAMIMI K, Saini AS, Cullison K, Herr J, et al
    EGFR pathway alterations correlate with rapid early progression in glioblastoma.
    J Neurooncol. 2025;176:77.
    >> Share

  279. GAO F, Huang H, Zuo D, Zhuang R, et al
    Dual tumor control and neuroprotective efficacy of Boron Neutron Capture Therapy in orthotopic mouse glioma model.
    J Neurooncol. 2025;176:74.
    >> Share

  280. AKDEMIR EY, Gutierrez AN, Zhang Y, Yarlagadda S, et al
    Evaluating the efficacy of a federated AI algorithm in assisting in the detection and segmentation of brain metastases: limitations and opportunities.
    J Neurooncol. 2025;176:70.
    >> Share

  281. RAMAMURTHY K, Randazzo DM, Cort N, Herndon JE 2nd, et al
    Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.
    J Neurooncol. 2025;176:71.
    >> Share

  282. HO VKY, Gijtenbeek JMM, Maas SLN, Taal W, et al
    Adult ependymoma: results from the Dutch Brain Tumour Registry on primary treatment and survival.
    J Neurooncol. 2025;176:73.
    >> Share

  283. SHAHIN M, Singh J, Mansoori S, Vasant S, et al
    Expanding morphological spectrum of pilocytic astrocytomas: insights from integrated histopathological and multiomic profiling.
    J Neurooncol. 2025;176:69.
    >> Share

  284. YEBOA DN, Whitfield BT, Lin R, Ejezie CL, et al
    Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therap
    J Neurooncol. 2025;176:72.
    >> Share

  285. BIN-ALAMER O, Taori S, Abou-Al-Shaar H, Flickinger JC, et al
    Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale.
    J Neurooncol. 2025;176:67.
    >> Share

  286. CAN DDT, Giang NDH, Van ND, Tuan PA, et al
    Surgical characteristics and survival outcomes of pediatric pineal region tumors: a cohort study in Vietnam.
    J Neurooncol. 2025;176:68.
    >> Share

  287. CHUCK C, Teshome A, Lin A, Sayeed S, et al
    Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
    J Neurooncol. 2025;176:66.
    >> Share

  288. VAZIRI T, Liu IC, Bettegowda C, Croog V, et al
    Correction to: Stereotactic radiosurgery for patients with extensive brain metastases across the disease course.
    J Neurooncol. 2025;176:62.
    >> Share

  289. KATTAA AH, Persad AR, Hori YS, Harary PM, et al
    Peripheral neural crest tumor brain metastases management: a single-institution retrospective study.
    J Neurooncol. 2025;176:65.
    >> Share

  290. NAKAGAWA H, Yui Y, Suzuki T, Tamura M, et al
    Investigation of 6-thioguanine as a strategy to overcome methotrexate resistance in a mouse model of leptomeningeal carcinomatosis.
    J Neurooncol. 2025;176:64.
    >> Share

  291. GULSUNA B, Lopez R, Kemp RDW, Yurtluk MD, et al
    The current status of immune checkpoint inhibitors in pediatric CNS tumors: a systematic review with a representative case of CMMRD-associated glioma.
    J Neurooncol. 2025;176:63.
    >> Share

  292. CHANDLER KE, Grigorian JN, Pisharody VA, Chisango Z, et al
    Clinical and genomic factors differ in pediatric and adult pilocytic astrocytoma: a single-center experience with over 350 patients.
    J Neurooncol. 2025;175:539-547.
    >> Share

  293. KIM S, Son Y, Oh J, Kim S, et al
    Global burden of brain and central nervous system cancer in 185 countries, and projections up to 2050: a population-based systematic analysis of GLOBOCAN 2022.
    J Neurooncol. 2025;175:673-685.
    >> Share

  294. BLOBNER J, Ruf V, Weller J, Teske N, et al
    Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3.
    J Neurooncol. 2025;175:763-774.
    >> Share

  295. PAN Z, Ye X, Huang Y, Tai P, et al
    Intrathecal pemetrexed for newly diagnosed leptomeningeal metastases: a multicenter, open-label, phase I/II study.
    J Neurooncol. 2025;175:857-868.
    >> Share

  296. CARDONA JJ, Park DJ, Al Gharyani MF, Wang JY, et al
    Stereotactic radiosurgery for intracranial and spinal adenoid cystic carcinoma: systematic review and illustrative case presentation.
    J Neurooncol. 2025;175:493-505.
    >> Share

  297. IUSUPOVSKAIA E, Isaev N, Antonian A, Boromangnaeva AK, et al
    Enhancing the therapeutic effect on tumor cells through wireless optoelectronic stimulation.
    J Neurooncol. 2025;175:741-752.
    >> Share

  298. ZAYED S, Ruschin M, Atenafu EG, Chen H, et al
    Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysis.
    J Neurooncol. 2025;175:621-631.
    >> Share

  299. HUGHES JG, Cozzi FM, Phillips V, Price SJ, et al
    Shared decision-making interventions in neuro-oncology practice: a systematic review.
    J Neurooncol. 2025;175:471-479.
    >> Share

    October 2025
  300. ZHONG W, Li Z, Lv S, Chen G, et al
    Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma.
    J Neurooncol. 2025;176:59.
    >> Share

  301. BERTHOLD C, Boudreault A, Simonyan D, Fournier-Loiselle J, et al
    Hormonal factors predisposing to the development of meningiomas in men: a case-control study.
    J Neurooncol. 2025;176:61.
    >> Share

  302. CARMICHAEL A, Arshad U, Heinemann DM, Reddy SC, et al
    Radiologic characterization and clinical management of multinodular and vacuolating neuronal tumor (MVNT): a retrospective institutional cohort study.
    J Neurooncol. 2025;176:57.
    >> Share

  303. GULSUNA B, Stevens B, Gulsuyu B, Wood E, et al
    Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review.
    J Neurooncol. 2025;176:58.
    >> Share

  304. GECICI NN, Stepniak A, Habib A, Ghoche MT, et al
    Predictors and clinical implications of surgical site infections following glioma resection: a matched case-control study.
    J Neurooncol. 2025;176:55.
    >> Share

  305. CHEN ZHOU ZH, Hilario A, Salvador Alvarez E, Cardenas Del Carre A, et al
    Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery.
    J Neurooncol. 2025;176:53.
    >> Share

  306. PEETERS S, Kim WJ, Armellini A, Haist B, et al
    The activity of cold atmospheric plasma against high-grade glioma: a review.
    J Neurooncol. 2025;176:52.
    >> Share

  307. DEL BALDO G, Di Ruscio V, Cacchione A, Lo Sasso A, et al
    Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendations.
    J Neurooncol. 2025;176:54.
    >> Share

  308. BUCCILLI B, Yoon J, Hussein A, Faraji A, et al
    Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
    J Neurooncol. 2025;176:50.
    >> Share

  309. SUN Y, Hamo M, Atchley T, Markert JM, et al
    Survival outcomes associated with antidepressant use in glioblastoma: a cohort study.
    J Neurooncol. 2025;176:47.
    >> Share

  310. JI P, Li C, Wang Y, Guo S, et al
    Clinical and survival differences between thalamic glioblastoma and thalamic diffuse midline glioma, H3 K27-altered.
    J Neurooncol. 2025;176:46.
    >> Share

  311. LI L, Shao MY, Zou SC, Xiao ZF, et al
    Retraction Note: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
    J Neurooncol. 2025;176:44.
    >> Share

  312. MYNENI S, Bhandarkar S, Akbari H, Mayne R, et al
    The Craniopharyngioma Quality of Life (C-QOL) Index: a preliminary disease-specific, patient-centered tool for assessing patient reported outcomes in adult craniopharyngioma patients.
    J Neurooncol. 2025;176:45.
    >> Share

  313. TOPKAN E, Ozturk D
    Letter to the editor: a comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.
    J Neurooncol. 2025;176:48.
    >> Share

  314. ZHANG XF, Liang YZ, Wu HY, Chen JL, et al
    Navigating heterogeneity in resected brain metastases: molecular stratification and multimodal therapeutic strategies.
    J Neurooncol. 2025;176:43.
    >> Share

  315. TAS KT, Hoft FS, Agolli L, Mohamed TA, et al
    Long-term outcomes and toxicity of radiotherapy for WHO Grade II and III meningiomas: a retrospective analysis of 98 patients.
    J Neurooncol. 2025;176:41.
    >> Share

  316. GHALIBAFIAN M, Mirzaei S, Sadeghi Y, Afsar N, et al
    Diffuse pontine glioma (DPG): shorter or longer treatment time?
    J Neurooncol. 2025;176:40.
    >> Share

  317. HOOSEMANS LJN, Panayotopoulos LF, van Kuijk SMJ, Verduin M, et al
    Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
    J Neurooncol. 2025;176:42.
    >> Share

  318. REN L, Deng J, Xu J, Chan L, et al
    SUV-max of (68)Ga-DOTATATE PET/CT correlates with WHO grade and RNA risk classification in meningioma.
    J Neurooncol. 2025;176:37.
    >> Share

  319. TARIQ R, Dadario NB, Shlobin NA, Yeung J, et al
    Brain state theory as a comprehensive model for addressing the "non-eloquent" brain in glioma surgery.
    J Neurooncol. 2025;176:39.
    >> Share

  320. BAJWA MH, Sufiyan S, Amin W, Aftab K, et al
    Investigating glioblastoma chemoresistance: a meta-analysis of microRNA signatures and gene networks.
    J Neurooncol. 2025;176:38.
    >> Share

  321. LAGHARI AA, Sufiyan S, Amin W, Ilyas S, et al
    miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum expression analysis in a Pakistani cohort.
    J Neurooncol. 2025;176:34.
    >> Share

  322. PUCCIO DJ, Wei CZ, Pillai A, Deng H, et al
    Stereotactic radiosurgery for patients with brain metastases from nasopharyngeal carcinoma.
    J Neurooncol. 2025;176:35.
    >> Share

  323. GONZALEZ-APONTE MF, Huang Y, Leidig WA, Simon T, et al
    Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma.
    J Neurooncol. 2025;176:36.
    >> Share

  324. HOTSINPILLER WS, Thomas EM, Tsekouras I, Popple RA, et al
    Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity.
    J Neurooncol. 2025;176:33.
    >> Share

  325. SUN K, Wang J, Gao M, Zhang J, et al
    MiR-148a-3p/SIRT7 axis promotes glioma progression and regulates temozolomide chemosensitivity.
    J Neurooncol. 2025;176:31.
    >> Share

  326. MALIK N, Chow WD, Loron AG, You HB, et al
    Clinical utility of repeat brain biopsy in recurrent or refractory primary CNS lymphoma - a diagnostic dilemma.
    J Neurooncol. 2025;176:32.
    >> Share

  327. NICHOLS CS, Lesha E, Graham D, Laird DG, et al
    Post-operative events following elective craniotomy for tumor in children.
    J Neurooncol. 2025;176:28.
    >> Share

  328. HU Y, Liu X, Lv K, Geng D, et al
    Dynamic reorganization of individual-level morphological networks in unilateral frontal lobe low-grade gliomas: a longitudinal study.
    J Neurooncol. 2025;176:29.
    >> Share

  329. KRUPA P, Kotek F, Krupova M, Paulikova S, et al
    Perioperative leukocyte-plateletcrit shift as a prognostic signature in glioblastoma.
    J Neurooncol. 2025;176:27.
    >> Share

  330. VAZIRI T, Liu IC, Bettegowda C, Croog V, et al
    Stereotactic radiosurgery for patients with extensive brain metastases across the disease course.
    J Neurooncol. 2025;176:24.
    >> Share

  331. HARLAY V, Bequet C, Appay R, Bertucci A, et al
    Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
    J Neurooncol. 2025;176:20.
    >> Share

  332. DASGUPTA P, Dagher SA, Chi X, Soomro Z, et al
    Genomic determinants of the diffusely infiltrative gliomatosis cerebri phenotype.
    J Neurooncol. 2025;176:19.
    >> Share

  333. GOULENKO V, Sinha S, Madhugiri VS, Almeida ND, et al
    Modulating the pace: systemic targeted therapy, brain metastasis velocity, and outcomes after Gamma Knife radiosurgery in breast cancer brain metastases.
    J Neurooncol. 2025;176:21.
    >> Share

  334. ROUX A, Tauziede-Espariat A, Simboli GA, Elia A, et al
    High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape.
    J Neurooncol. 2025;176:22.
    >> Share

  335. BASELGA M, Berna S, Perez VMM, Soriano M, et al
    Three-dimensional ultrastructural analysis of glioblastoma reveals spheresome-mediated intercellular communication.
    J Neurooncol. 2025;176:23.
    >> Share

  336. NECHAEVA A, Ulitin A, Sitovskaya D, Yudintceva N, et al
    Fluorescence molecular imaging of high-grade gliomas and brain metastases using the RAS70 peptide targeting plasma membrane-bound Hsp70 on tumor cells.
    J Neurooncol. 2025;176:15.
    >> Share

  337. JHANDI S, Goold E, Jensen RL
    Meningioma grade and molecular markers of proliferation, hypoxia, and vascularity as predictors of outcome in a cohort with long-term patient follow-up.
    J Neurooncol. 2025;176:18.
    >> Share

  338. BHARDWAJ S, Singh J, Singh S, Roy C, et al
    Unveiling MMR deficiency in pediatric and AYA high-grade gliomas: insights from multiomic profiling.
    J Neurooncol. 2025;176:16.
    >> Share

  339. HONG S, Takami H, Umekawa M, Shinya Y, et al
    Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases.
    J Neurooncol. 2025;176:12.
    >> Share

  340. YUILE A, Wei JQ, McKelvey KJ, Colvin EK, et al
    Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
    J Neurooncol. 2025;176:10.
    >> Share

  341. EL GHALBOUNI A, Snijders TJ, Amerein A, Tolboom N, et al
    Efficacy of Intra-arterial [(177)Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma.
    J Neurooncol. 2025;176:8.
    >> Share

  342. NGUYEN TT, Pham TM, Quy PN, Chalise L, et al
    Premature mortality due to malignancies of the central nervous system in Japan: a nationwide descriptive analysis from 2000 to 2020.
    J Neurooncol. 2025;176:11.
    >> Share

  343. VAN DEN BERG L, Wilbers J, de Vos FYFL, van Kouwenhoven MCM, et al
    Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study.
    J Neurooncol. 2025;176:7.
    >> Share

  344. ANDREOTTI A, Ferroni E, Guzzinati S, Baracco S, et al
    Incidence and survival of adult central nervous system tumors in the Veneto region: a population-based registry study (2016-2020).
    J Neurooncol. 2025;176:9.
    >> Share

  345. GUZZINO J, Crompton DJ, Agarwal S, Kern S, et al
    Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarker.
    J Neurooncol. 2025;176:5.
    >> Share

  346. DAI X, He S, Qi Y, Li H, et al
    Predictive markers for molecular subtypes and WHO grade: T1rho-MRI in adult-type diffuse gliomas.
    J Neurooncol. 2025;176:6.
    >> Share

  347. KIM E, Lee HI, Roh TH, Kim YZ, et al
    Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean society for neuro-oncology.
    J Neurooncol. 2025;176:3.
    >> Share

  348. KOAY JM, Dion C, Michaelides L, Chaichana K, et al
    Cognitive impact of repeated surgical resections for the management of high-grade glioma.
    J Neurooncol. 2025;176:4.
    >> Share

  349. DAS S, Walker-Dilks C, Nicholas G, Sahgal A, et al
    Executive summary of organizational guidance for the care of patients with central nervous system tumours in Ontario: consensus recommendations.
    J Neurooncol. 2025;175:419-429.
    >> Share

  350. CHEN W, Yuan J, Liu G, Cui L, et al
    Metagenomic next-generation sequencing and chromosomal copy number variation analysis in cerebrospinal fluid for the detection of meningeal carcinomatosis.
    J Neurooncol. 2025;175:175-181.
    >> Share

  351. WEI CZ, Deng H, Ashwat E, Albano L, et al
    Tumor control and motor function in patients with metastases located in the primary motor cortex after stereotactic radiosurgery.
    J Neurooncol. 2025;175:63-70.
    >> Share

  352. ABIKENARI M, Liu J, Ha JH, Annagiri S, et al
    Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology.
    J Neurooncol. 2025;175:1-20.
    >> Share

  353. SARIKAYA C, Yaltirik CK, Varol E, Yuvruk E, et al
    The role of MRI patterns in predicting neurologic deficits in spinal ependymomas.
    J Neurooncol. 2025;175:313-322.
    >> Share

  354. ARENDT CT, Lohlau M, Roder L, Burger MC, et al
    Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations.
    J Neurooncol. 2025;175:231-241.
    >> Share

  355. IVREN M, Yalman D, Ishak B, Ille S, et al
    Beyond surgical radicality in intramedullary spinal cord metastases: neurological function and systemic disease burden drive patient outcomes.
    J Neurooncol. 2025;175:431-442.
    >> Share

  356. GENSLER R, Xia Y, Horowitz MA, Abdulrahim M, et al
    Outcomes of leptomeningeal disease after only vertebral osseous metastases: a real-world analysis using the TriNetX database.
    J Neurooncol. 2025;175:219-229.
    >> Share

  357. ORSMOND A, De Sousa SMC, McCormack A
    The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours.
    J Neurooncol. 2025;175:379-388.
    >> Share

  358. BECKHAM TH, Cha EE, Rooney MK, Tom MC, et al
    Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases.
    J Neurooncol. 2025;175:165-174.
    >> Share

  359. SHAH KH, Khalafallah AM, Knott MV, Berke CN, et al
    Predictors of prolonged length of stay in patients undergoing laser interstitial thermal therapy for intracranial tumors.
    J Neurooncol. 2025;175:91-99.
    >> Share

  360. RAMMELOO E, Young JS, Schouten JW, Bos EM, et al
    Preoperative assessment of tumor eloquence and resectability: an international survey.
    J Neurooncol. 2025;175:47-59.
    >> Share

    September 2025
  361. KHATRI VM, Mestres-Villanueva MA, Daniel S, Yarlagadda S, et al
    Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
    J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05230.
    >> Share

  362. SHIBAHARA I, Kumabe T
    Comment on: "Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma".
    J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05226.
    >> Share

  363. AN X, Wang J, Yuan J, Zhou X, et al
    Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3-12 years.
    J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05229.
    >> Share

  364. DIAZ LS, Agrup M, Asklid A, Embring A, et al
    Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
    J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05235.
    >> Share

  365. PEDERSEN V, Knudsen AM, Michaelsen SR, Dahlrot RH, et al
    Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype.
    J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05232.
    >> Share

  366. TINI P, Donnini F, Marampon F, Pastina P, et al
    Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.
    J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05215.
    >> Share

  367. BASHIR S, Jian S, Hong W, Wang H, et al
    Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery.
    J Neurooncol. 2025 Sep 18. doi: 10.1007/s11060-025-05220.
    >> Share

  368. GURANDA A, Guresir E, Ruder AM, Giordano FA, et al
    Intra-cavitary radiotherapy for surgically resected brain metastases: a comprehensive analysis including an individual patient data meta-analysis of intraoperative radiotherapy (IORT) and brachytherapy (IBT).
    J Neurooncol. 2025 Sep 17. doi: 10.1007/s11060-025-05227.
    >> Share

  369. DEBOEUF L, Keraudy A, Picart T, Haddad G, et al
    Prevalence, natural history and surgical outcome of spinal meningiomas in NF2-related schwannomatosis.
    J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05231.
    >> Share

  370. ROH H, Park C, Kim W, Choi J, et al
    Impact of EGFR mutation subtypes and TKI generations on clinical outcomes in lung adenocarcinoma patients with brain metastases treated with gamma knife radiosurgery.
    J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05149.
    >> Share

  371. OI Y, Minamoto H, Taniyama I, Fukuzawa M, et al
    Novel predictors of tumor growth by exploratory quantitative analysis of radiomics features from MRI data for incidentally discovered meningioma.
    J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05186.
    >> Share

  372. NAEWWAN N, Talabnin K, Trasaktaweesakul T, Khuansonthi P, et al
    Piperlongumine induces meningioma cell death via the ROS-mediated endoplasmic reticulum stress and the alteration of the ubiquitin-proteasome system.
    J Neurooncol. 2025 Sep 15. doi: 10.1007/s11060-025-05219.
    >> Share

  373. PAHWA B, Mahajan S, Pahwa N, Panico N, et al
    Linear regression models predict survival and complication rates in patients undergoing gamma knife radiosurgery for recurrent and residual craniopharyngiomas: a meta-analysis of 743 tumors.
    J Neurooncol. 2025 Sep 15. doi: 10.1007/s11060-025-05196.
    >> Share

  374. TREWIN-NYBRATEN CB, Lambert PC, Marienhagen K, Andreassen L, et al
    Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.
    J Neurooncol. 2025 Sep 11. doi: 10.1007/s11060-025-05218.
    >> Share

  375. RENOVANZ M, Hippler M, Kuchen R, Doerner L, et al
    Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).
    J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05223.
    >> Share

  376. SU M, Duan H, Lei Q, Tan Z, et al
    Utility and performance of cerebrospinal fluid cytology in discriminating central nervous system infections and brain tumors.
    J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05214.
    >> Share

  377. AKUTAGAWA K, Miki S, Yamada E, Sakamoto N, et al
    Correction to: PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05203.
    >> Share

  378. PRICE G, Frederico SC, Colan J, Rentzeperis F, et al
    Photodynamic therapy for glioblastoma: a narrative review.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05217.
    >> Share

  379. KOJUNDZIC I, Fritz JL, Said BI, Vuong S, et al
    Clinical-pathological patterns and prognosis of young women with breast cancer brain metastases: a single-center retrospective study.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05212.
    >> Share

  380. KAMBE A, Ochiai R, Makishima K, Yasuda S, et al
    Microvessel density as a prognostic and predictive biomarker in newly diagnosed glioblastoma: correlations with radiological features and bevacizumab efficacy.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05210.
    >> Share

  381. KESUMAYADI I, Kambe A, Amisaki H, Hosoya T, et al
    Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05209.
    >> Share

  382. EIBL T, Liebert A, Ritter L, Neher M, et al
    Role of patient frailty in resection of newly diagnosed motor eloquent glioblastomas guided by a navigated transcranial magnetic stimulation and tractography approach.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05206.
    >> Share

  383. DOIG M, Lee J, Kwok Y, MacEwan I, et al
    Impact of substructure radiation dose on health-related quality of life in children with brain tumors: a Pediatric Proton/Photon Consortium Registry (PPCR) study.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05211.
    >> Share

  384. SADAGOPAN NS, Gomez M, Tripathi S, Billingham LK, et al
    NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas.
    J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05208.
    >> Share

  385. HALL JC, Goel K, Lozko Y, Chang SD, et al
    Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery.
    J Neurooncol. 2025 Sep 7. doi: 10.1007/s11060-025-05201.
    >> Share

  386. HO A, Horbinski C, Sachdev S
    Thromboembolism in gliomas: an under-recognized danger.
    J Neurooncol. 2025 Sep 5. doi: 10.1007/s11060-025-05204.
    >> Share

  387. ZARE A, Zare A, Hajikarimloo B, Mohammadi B, et al
    Radiosurgery for central nervous system ependymomas: a systematic review and meta-analysis.
    J Neurooncol. 2025;174:315-327.
    >> Share

  388. XIE Q, Hu J, Liu Y, Tabengwa GT, et al
    Retrospective study of leptomeningeal metastasis: unveiling the indolent and rapid progression phases.
    J Neurooncol. 2025;174:357-368.
    >> Share

  389. LIPATNIKOVA A, Kling T, Denes A, Carstam L, et al
    CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?
    J Neurooncol. 2025;174:449-458.
    >> Share

  390. KRISCH JM, Ermoian RP, Indelicato DJ, Lee JY, et al
    Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR).
    J Neurooncol. 2025;174:369-380.
    >> Share

  391. GIANTINI-LARSEN AM, Brown S, Reiner AS, Giandalone SD, et al
    Financial toxicity in pediatric and adolescent neurosurgical oncology.
    J Neurooncol. 2025;174:349-356.
    >> Share

  392. KHALAFALLAH AM, Susic N, Shah KH, Knott MV, et al
    Evaluating safety and feasibility of same-day discharge after laser interstitial thermal therapy: a pilot study with a matched control group.
    J Neurooncol. 2025;174:341-347.
    >> Share

  393. AREGA G, Hailu D, Fikad G, Nigusie M, et al
    Patterns, clinical presentations, and time to diagnosis in pediatric central nervous system tumors: insights from a pediatric neuro-oncology tumor board team at a tertiary referral hospital in Ethiopia.
    J Neurooncol. 2025;174:587-598.
    >> Share

  394. WANG J, Yang Q, Li X, Li Q, et al
    Engineering overexpressing SYNGR1 inhibited the progression of GBM cells by suppressing the intracellular FGF1-mediated LDs accumulation and cytoskeleton remodeling.
    J Neurooncol. 2025;174:667-687.
    >> Share

  395. CHEN JY, Schultz A, Khoury NM, Rangavajhula K, et al
    Optimizing workflows for metastatic central nervous system disease: a systematic review and proposed guidelines.
    J Neurooncol. 2025;174:557-585.
    >> Share

    August 2025
  396. ARACELI T, Haj A, Doenitz C, Stoerr EM, et al
    Complete resection of brain metastases - when does it matter?
    J Neurooncol. 2025 Aug 22. doi: 10.1007/s11060-025-05193.
    >> Share

  397. SHIH JJ, Jain B, Patel R, Jain U, et al
    Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004-2020).
    J Neurooncol. 2025 Aug 22. doi: 10.1007/s11060-025-05178.
    >> Share

  398. GIORDANO C, Sassu CM, Marchetti C, Guerri G, et al
    Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases.
    J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05192.
    >> Share

  399. WANG CY, Lin CF, Yang HC, Liu CY, et al
    Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment.
    J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05188.
    >> Share

  400. LIN CA, Lin C, Rhodes CT, Moseley MC, et al
    Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.
    J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05205.
    >> Share

  401. YOGENDRAN LV, Kareddy A, Abbas SO, Scharf Z, et al
    Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.
    J Neurooncol. 2025 Aug 20. doi: 10.1007/s11060-025-05087.
    >> Share

  402. PENG TC, Hsieh MH, Lin CF, Kuan AS, et al
    Repeated stereotactic radiosurgery for high grade meningioma.
    J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05165.
    >> Share

  403. NEU M, Shiban E, Krauss P, Sommer B, et al
    Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis.
    J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05152.
    >> Share

  404. SUN MZ, Contreras E, Treger J, Imbroane M, et al
    Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells.
    J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05200.
    >> Share

  405. MAO M, Li Z, Zheng W, Xia H, et al
    Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy.
    J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05132.
    >> Share

  406. RAMIREZ FERRER E, Zuluaga-Garcia JP, Alzate JD, Mayorga-Corvacho J, et al
    Impact of healthcare disparities on the treatment and survival of patients with high-grade gliomas in Colombia: a multicenter inverse probability-weighted cohort analysis.
    J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05198.
    >> Share

  407. BRASCHI EL, Trumble O, Casper A, Amdur RJ, et al
    Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy.
    J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05195.
    >> Share

  408. NISHIWAKI T, Kudo U, Nakamura S, Kuse Y, et al
    Synergistic antitumor and radiosensitizing effects of alpha-sulfoquinovosyl-acylpropanediol (SQAP) via PI3K/Akt inhibition and DNA repair impairment in glioblastoma.
    J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05194.
    >> Share

  409. URIAS E, DeCesaris C
    Comment on "A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study".
    J Neurooncol. 2025 Aug 8. doi: 10.1007/s11060-025-05187.
    >> Share

  410. KHATUA S, Bouffet E
    Summary of the collection on 'immunotherapy in pediatric brain tumors-an update'.
    J Neurooncol. 2025 Aug 6. doi: 10.1007/s11060-025-05191.
    >> Share

  411. JENSEN LR, Maier AD, Juratli TA, Goutagny S, et al
    The concept, intention, and evaluation of the term treatment-refractory meningioma.
    J Neurooncol. 2025 Aug 4. doi: 10.1007/s11060-025-05154.
    >> Share

  412. CRISPI V, Peat S, Bolton WS, Chapman S, et al
    Mixed reality with 3D brain imaging for patient consultation in neurosurgery: an IDEAL stage 2a feasibility study.
    J Neurooncol. 2025;174:143-156.
    >> Share

  413. MO C, Liu X, Guo Y, Liang D, et al
    Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia.
    J Neurooncol. 2025;174:131-141.
    >> Share

  414. GARCIA CR, Highsmith K, Knight S, Andrade IP, et al
    Single center experience of IDH inhibitors in recurrent high-grade gliomas.
    J Neurooncol. 2025 Aug 1. doi: 10.1007/s11060-025-05183.
    >> Share

    July 2025
  415. HAGAN AJ, Hill RM, Kingston A, Bailey S, et al
    The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05177.
    >> Share

  416. BEVER N, Shukla IY, Ebada A, Wan B, et al
    Disparities in meningioma resection outcomes: a retrospective analysis of patients with public versus private insurance.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05179.
    >> Share

  417. LAN TL, Lin CF, Lee YY, Chang FC, et al
    Recurrent meningioma treated with boron neutron capture therapy: a feasibility study with dosimetric and clinical correlates.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05184.
    >> Share

  418. JAIN TK, Vohra M, Sharma BS, Loyal A, et al
    Is 18F-PSMA PET/CT a reliable imaging modality to evaluate the status of recurrent/residual brain tumors in post-treatment patients?
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05167.
    >> Share

  419. BANDOPADHAY J, Pichardo-Rojas PS, Cho R, Tavakkol E, et al
    Assessment of the RANO-resect criteria in elderly patients with glioblastoma.
    J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05168.
    >> Share

  420. CHEN D, Ye L, Yu Z, Lei T, et al
    Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases.
    J Neurooncol. 2025 Jul 29. doi: 10.1007/s11060-025-05061.
    >> Share

  421. LARIBI L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, et al
    Correction to: Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05147.
    >> Share

  422. MATSUDA R, Takatani T, Hayashi H, Matsuoka R, et al
    Intraoperative neuromonitoring with direct cortical stimulation motor-evoked potentials in supratentorial glioma surgeries with preoperative moderate-to-severe motor weakness.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05185.
    >> Share

  423. PICHARDO-ROJAS PS, Bandopadhay J, Nunez LC, Dono A, et al
    Impact of maximal and supramaximal resections on postoperative diffusion-weighted imaging changes and clinical outcomes in IDH-wildtype glioblastoma.
    J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05169.
    >> Share

  424. PIENKOWSKI T, Mojsak P, Kowalczyk T, Cysewski D, et al
    Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.
    J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05151.
    >> Share

  425. AYDEMIR I, Tutkun G, Akcit ET, Kocak O, et al
    Combined effects of escitalopram and vitamin E on phoenixin-20 secretion and neuroregulatory mechanisms in glioblastoma cells: a neuro-nutritional perspective.
    J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05176.
    >> Share

  426. LO SS, Halasz LM, Choi S, Kumthekar P, et al
    Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of radiotherapy in the management of patients with diffuse low grade glioma in adults: update.
    J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05074.
    >> Share

  427. LANMAN TA, Gross H, Faria CM, Miller JJ, et al
    Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors.
    J Neurooncol. 2025 Jul 23. doi: 10.1007/s11060-025-05155.
    >> Share

  428. DELGADO-LOPEZ PD, Montalvo-Afonso A, Garcia-Leal R, Martin-Garcia S, et al
    Surgical outcomes in octogenarian meningioma patients: a multicenter retrospective analysis of frailty and radiological predictors : Frailty in octogenarians undergoing meningioma resection.
    J Neurooncol. 2025 Jul 22. doi: 10.1007/s11060-025-05174.
    >> Share

  429. DU Z, Luo Y, Sun J, Long H, et al
    (18)F-NOTA-NFB PET/MRI in glioma recurrence: comparison with (11)C-methionine PET/MRI and contrast-enhanced MRI.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05159.
    >> Share

  430. KITE T, Bossinger B, Yadlapalli V, Jaffee S, et al
    Stereotactic radiosurgery for recurrent high-grade gliomas: a systematic review.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05156.
    >> Share

  431. ALFONZO HOROWITZ M, Li M, Parker M, Arbuiso A, et al
    Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05107.
    >> Share

  432. ISHIKAWA T, Matsuda M, Kaneda Y, Ishikawa E, et al
    Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05172.
    >> Share

  433. HAEDENKAMP TM, Gotz L, Ansafi T, Gerken M, et al
    Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort study.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05137.
    >> Share

  434. PICHARDO-ROJAS PS, Hajikarimloo B, Sheehan JP
    Further points to consider regarding the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05153.
    >> Share

  435. VENKATARATNAM Y, Mukherjee V, Rai N, Mahalingaswamy M, et al
    Tunneling nanotubes between glioblastoma cells and T cells and hijack of mitochondria.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05150.
    >> Share

  436. PARKER M, Jiang K, Kalluri A, Arbuiso AG, et al
    Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05139.
    >> Share

  437. CAO H, Yan Z, Li M, Wang J, et al
    SIN1 facilitates glioma progression and is associated with the KRAS/ERK pathway.
    J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05166.
    >> Share

  438. LIU J, Meng Z, Wang R, Zhao G, et al
    CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2.
    J Neurooncol. 2025 Jul 19. doi: 10.1007/s11060-025-05163.
    >> Share

  439. SEOL MY, Choi SH, Yoon HI
    Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma.
    J Neurooncol. 2025 Jul 17. doi: 10.1007/s11060-025-05128.
    >> Share

  440. CORAZZELLI G, Corvino S, Sigona L, Cioffi V, et al
    Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis.
    J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05158.
    >> Share

  441. LU MJS, Michaelsen SR, Locallo A, Eickhart-Dalboge CS, et al
    Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study.
    J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05162.
    >> Share

  442. CHEUNKARNDEE T, Ritter Z, Saint-Germain M, Ghanem P, et al
    Distinct size and spatial distribution patterns of ALK-inhibitor-naive versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases.
    J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05148.
    >> Share

  443. POUR-RASHIDI A, Zandpazandi S, Hsu S, Shakeri A, et al
    Comparative analysis of monotherapy versus duotherapy with antiseizure medications for intraoperative and early postoperative seizure control in glioma patients undergoing awake craniotomy.
    J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05133.
    >> Share

  444. HAISRAELY O, Vedala S, Al-Sharfeen A, Manzar GS, et al
    Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.
    J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05135.
    >> Share

  445. LAN R, Zhang N, Chen R, Chen J, et al
    Correction to: Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma.
    J Neurooncol. 2025 Jul 8. doi: 10.1007/s11060-025-05142.
    >> Share

  446. TORRES J, Bundrant BE, Dono A, Pichardo-Rojas PS, et al
    Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes.
    J Neurooncol. 2025 Jul 3. doi: 10.1007/s11060-025-05143.
    >> Share

  447. MALLEREAU CH, Dannhoff G, Todeschi J, Severac F, et al
    Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients.
    J Neurooncol. 2025;173:719-729.
    >> Share

  448. LESHA E, Laird DG, Nichols CS, Miller LE, et al
    Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population.
    J Neurooncol. 2025;173:759-767.
    >> Share

  449. DAGHER SA, Johnson JM, Mohamed RMM, Ansari S, et al
    Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy.
    J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05146.
    >> Share

  450. ZHAO C, Liang B, Li X, Ma P, et al
    Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma.
    J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05144.
    >> Share

    June 2025
  451. KOCYIGIT S, Chavez MM, Orhun O, O'Brien J, et al
    Posterior parasagittal meningiomas display aggressive features independent of size: a multicenter analysis.
    J Neurooncol. 2025 Jun 26. doi: 10.1007/s11060-025-05103.
    >> Share

  452. DASGUPTA P, Lin H, Kumar G, Soomro Z, et al
    Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma.
    J Neurooncol. 2025 Jun 25. doi: 10.1007/s11060-025-05131.
    >> Share

  453. LIKHOMANOVA R, Oganesyan E, Yudintceva N, Fofanov G, et al
    Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70.
    J Neurooncol. 2025 Jun 24. doi: 10.1007/s11060-025-05127.
    >> Share

  454. KRAUS LM, Goldberg M, Ursu E, Demirbag K, et al
    Postoperative hydrocephalus in patients with infratentorial brain metastases may be influenced by preoperative treatment: a single-center cohort study.
    J Neurooncol. 2025 Jun 23. doi: 10.1007/s11060-025-05125.
    >> Share

  455. NOCERA G, Sanvito F, Yao J, Oshima S, et al
    Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors.
    J Neurooncol. 2025 Jun 21. doi: 10.1007/s11060-025-05105.
    >> Share

  456. MADHUGIRI VS, Goulenko V, Seth L, Wang R, et al
    Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases.
    J Neurooncol. 2025 Jun 20. doi: 10.1007/s11060-025-05138.
    >> Share

  457. ZULUAGA-GARCIA JP, Ramirez-Ferrer E, Peeters SF, DeMonte F, et al
    Management of skull base meningiomas with extracranial extension: resection, recurrence, and prognostic factors.
    J Neurooncol. 2025 Jun 19. doi: 10.1007/s11060-025-05111.
    >> Share

  458. JUNG K, Sivadas SD, Fitzgerald X, Phillips C, et al
    Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases.
    J Neurooncol. 2025 Jun 19. doi: 10.1007/s11060-025-05121.
    >> Share

  459. ROSE ML, Bajaj BVM, Jimenez R, Dennehy S, et al
    Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomas.
    J Neurooncol. 2025 Jun 18. doi: 10.1007/s11060-025-05112.
    >> Share

  460. WANG Q, Wang H, Hong W, Bashir S, et al
    Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis.
    J Neurooncol. 2025 Jun 18. doi: 10.1007/s11060-025-05045.
    >> Share

  461. LOESCHNER D, Wagle PR, Jung A, Neumeister A, et al
    The communication of a high-grade glioma diagnosis- patients' reflections and perspectives based on a study-specific questionnaire.
    J Neurooncol. 2025 Jun 17. doi: 10.1007/s11060-025-05129.
    >> Share

  462. SHEN H, Li J, Jia Y, Liu F, et al
    The oncogenic role of CCDC34 in lower-grade gliomas: prognostic significance and therapeutic potential.
    J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05090.
    >> Share

  463. FAN H, Li X, Zhao Y, Song L, et al
    Decoding meningioma prognosis with multi-omics: macrophage diversity, immune-CNV interplay, and novel SPP1-targeted strategies.
    J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05116.
    >> Share

  464. SEIDEL JA, Alder L, Salama AKS, Anders CK, et al
    Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade.
    J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05120.
    >> Share

  465. CHAKRAVARTI S, Tang L, Shah HA, Singh A, et al
    Patient nutritional status is associated with surgical site infections in meningioma patients undergoing craniotomy for tumor resection.
    J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05123.
    >> Share

  466. MAO Y, Tang L, Horowitz MA, Myneni S, et al
    Automated feature learning and survival prognostication in grade 4 glioma using supervised machine learning models.
    J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05099.
    >> Share

  467. YARLAGADDA S, Zhang Y, Saxena A, Kutuk T, et al
    Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases.
    J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05092.
    >> Share

  468. TURAN T, Emmez OH, Kaymaz AM, Gonenc A, et al
    Clinical utility of GAL-8, ITGBeta-1, and HIF-1alpha as non-invasive diagnostic and prognostic biomarkers for assessing glioma.
    J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05110.
    >> Share

  469. GIDRON Y, Katan N, Mansour N, Grossman R, et al
    The prognostic and protective roles of heart-rate variability in glioblastoma: making GBM less vague.
    J Neurooncol. 2025 Jun 12. doi: 10.1007/s11060-025-05010.
    >> Share

  470. AKUTAGAWA K, Miki S, Yamada E, Sakamoto N, et al
    PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine.
    J Neurooncol. 2025 Jun 12. doi: 10.1007/s11060-025-05102.
    >> Share

  471. KREATSOULAS DC, Kim J, Damante M, Orr A, et al
    A novel lesion severity index to predict 90-day postoperative survival in brain metastasis patients.
    J Neurooncol. 2025 Jun 11. doi: 10.1007/s11060-025-05109.
    >> Share

  472. METWALLY SM, El-Ayadi M, Maher E, El-Minawi MS, et al
    Impact of partial substitution of cisplatin with cyclophosphamide on acute toxicities in standard-risk medulloblastoma.
    J Neurooncol. 2025 Jun 10. doi: 10.1007/s11060-025-05098.
    >> Share

  473. SAVIOLA F, Zigiotto L, Jovicich J, Sarubbo S, et al
    Predicting attention deficits and functional recovery after glioma resection through functional executive networks: insights from dynamic properties.
    J Neurooncol. 2025 Jun 10. doi: 10.1007/s11060-025-05079.
    >> Share

  474. LARIBI L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, et al
    Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.
    J Neurooncol. 2025 Jun 6. doi: 10.1007/s11060-025-05025.
    >> Share

  475. JACQUERIE A, Macamo A, Hoeben A, Eekers DBP, et al
    IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma.
    J Neurooncol. 2025 Jun 5. doi: 10.1007/s11060-025-05106.
    >> Share

  476. ROBERT SM, Toth A, Lev S, Bowden SG, et al
    Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges.
    J Neurooncol. 2025 Jun 5. doi: 10.1007/s11060-025-05083.
    >> Share

  477. WHITTLE IR
    Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas.
    J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05097.
    >> Share

  478. WEI CZ, Shanahan R, Puccio D, Deng H, et al
    A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.
    J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05093.
    >> Share

  479. MARINO S, Menna G, Doglietto F, Quaranta D, et al
    A white matter-centered approach to investigate recurrence pathways in high-grade gliomas: a single-center retrospective study.
    J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05050.
    >> Share

  480. RAYMOND C, Yao J, Kolkovsky ALL, Feiweier T, et al
    Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence.
    J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05094.
    >> Share

  481. TINKA P, Pokorna P, Kyr M, Pavelka Z, et al
    Individualized therapeutic approaches for relapsed and refractory pediatric ependymomas: a single institution experience.
    J Neurooncol. 2025;173:479-488.
    >> Share

  482. JIN J, Qin J, Qi X, Zhang J, et al
    Serum exosomal miRNA contributes to the diagnosis of leptomeningeal carcinomatosis.
    J Neurooncol. 2025;173:419-428.
    >> Share

  483. NOBEL H, Ofer J, Borenstein SF, Limon D, et al
    Long-term impact of bevacizumab for the treatment of brain radiation necrosis.
    J Neurooncol. 2025;173:289-296.
    >> Share

  484. WOO PYM, Pu JKS, Li LF, Wong DKK, et al
    Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter study.
    J Neurooncol. 2025;173:317-330.
    >> Share

    May 2025
  485. NAKHATE V, Ly I, Muzikansky A, Rapalino O, et al
    Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.
    J Neurooncol. 2025 May 28. doi: 10.1007/s11060-025-05020.
    >> Share

  486. YADAV N, Xiao A, Zhong Q, Kumar P, et al
    Synergistic activity of simvastatin and irinotecan chemotherapy against glioblastoma converges on TGF-beta signaling.
    J Neurooncol. 2025 May 28. doi: 10.1007/s11060-025-05089.
    >> Share

  487. IBANEZ-JULIA MJ, Bataller L, Cabello-Murgui FJ, Nguyen-Them L, et al
    Clinical and radiological features of pseudoprogression in brain tumors treated with immune checkpoint inhibitors.
    J Neurooncol. 2025 May 27. doi: 10.1007/s11060-025-05091.
    >> Share

  488. BERTOLINI G, Trombini T, Zenesini C, Mazza S, et al
    Prognostic impact of second surgical resection in IDH wildtype recurrent glioblastoma following chemo-radiation therapy: a propensity score analysis cohort study.
    J Neurooncol. 2025 May 27. doi: 10.1007/s11060-025-05096.
    >> Share

  489. SCHRODER C, Haghighi N, Phillips C, Udovicich C, et al
    A feasibility trial of delayed resection for brain metastases following pre-operative stereotactic radiosurgery.
    J Neurooncol. 2025 May 26. doi: 10.1007/s11060-025-05081.
    >> Share

  490. SENTURK YE, Canturk EM, Peker A, Yuzkan S, et al
    Predictive value of early DCE and DSC perfusion MRI parameters for midterm clinical outcomes in lung cancer brain metastases treated with stereotactic radiosurgery.
    J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05054.
    >> Share

  491. HANI L, Nasiri D, Gachter A, Klimov A, et al
    Reconsideration of the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy: a comparative analysis with non-eloquent metastasis.
    J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05075.
    >> Share

  492. VAN DIJCK JTJM, Ardon H, Balvers RK, Bos EM, et al
    Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.
    J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080.
    >> Share

  493. LI Y, Wang Y, Han X, Xu J, et al
    Correction to: Glioma-derived SPARCL1 promotes the formation of peritumoral neuron-glioma synapses.
    J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05069.
    >> Share

  494. TANG T, Wu Y, Dong X, Zhai X, et al
    Multimodal MRI radiomics enhances epilepsy prediction in pediatric low-grade glioma patients.
    J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05073.
    >> Share

  495. ZHOU M, Wu W, Wang Y, Zhang B, et al
    Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/beta-catenin signaling pathway.
    J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05036.
    >> Share

  496. WILLIAMS A, Neth B, Webb M, Schwartz J, et al
    Diffuse hemispheric glioma, H3 G34-mutant: defining the clinical picture through a single institution case series and literature analysis.
    J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05028.
    >> Share

  497. SHU Y, Dong Y, Li B, Wang Y, et al
    Knockdown of STK39 inhibits lung cancer brain metastasis by suppressing the CPSF4/NFkappaB/COX2 pathway.
    J Neurooncol. 2025 May 21. doi: 10.1007/s11060-025-05072.
    >> Share

  498. ABIKENARI M, Regev A, Himic V, Choi J, et al
    The hormonal nexus in PIK3CA-mutated meningiomas: implications for targeted therapy and clinical trial design.
    J Neurooncol. 2025 May 20. doi: 10.1007/s11060-025-05082.
    >> Share

  499. ALDEEVA IA, Glebova EV, Sarkisyan RA, Romanova EN, et al
    Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol.
    J Neurooncol. 2025 May 16. doi: 10.1007/s11060-025-05070.
    >> Share

  500. BOMMIREDDY A, Mayo ZS, Reddy CA, Billena C, et al
    Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.
    J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05062.
    >> Share

  501. IYER HG, Ariwodo OK, Mckevitt C, Meade PS, et al
    Predictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.
    J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05066.
    >> Share

  502. WEIDL D, Capper D, Onken J, Liu I, et al
    Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany.
    J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05068.
    >> Share

  503. SHUKLA IY, Ebada A, Bever N, Traylor JI, et al
    Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.
    J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057.
    >> Share

  504. BADVE C, Nirappel A, Lo S, Orringer DA, et al
    Congress of neurological surgeons systematic review and evidence-based guidelines for the role of imaging in newly diagnosed WHO grade II diffuse glioma in adults: update.
    J Neurooncol. 2025 May 8. doi: 10.1007/s11060-025-05043.
    >> Share

  505. NA MK, Oh Y, Lee D, Park J, et al
    Comparison of the biological characteristics of glioblastoma tumorspheres obtained from fresh and cryopreserved glioblastoma tissues.
    J Neurooncol. 2025 May 5. doi: 10.1007/s11060-025-05052.
    >> Share

  506. PICHARDO-ROJAS PS, Garcia-Torrico F, Espinosa-Cantu CB, Rodriguez-Elvir FA, et al
    Current trends in reoperation for recurrent glioblastoma: a meta-analysis (2007-2023).
    J Neurooncol. 2025 May 2. doi: 10.1007/s11060-025-05058.
    >> Share

  507. ZHENG GH, Zhang YW, Liu YX, Liu WH, et al
    Clinical characteristics and prognostic factors of primary spinal subependymoma: a single-center cohort study and systematic review.
    J Neurooncol. 2025;172:675-685.
    >> Share

  508. ANDEREGGEN L, Christ E
    Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas.
    J Neurooncol. 2025;172:613-623.
    >> Share

  509. GU W, Zhang W, Wu Z, Cai Y, et al
    Cabergoline-induced NDFIP1 upregulation in pituitary neuroendocrine tumor cells activates mTOR signaling and contributes to cabergoline resistance.
    J Neurooncol. 2025;172:587-597.
    >> Share

  510. FILHO AM, Znaor A, Sunguc C, Zahwe M, et al
    Cancers of the brain and central nervous system: global patterns and trends in incidence.
    J Neurooncol. 2025;172:567-578.
    >> Share

  511. MANSOORIAN S, Schmidt M, Weissmann T, Delev D, et al
    Reirradiation for recurrent glioblastoma: the significance of the residual tumor volume.
    J Neurooncol. 2025 May 1. doi: 10.1007/s11060-025-05042.
    >> Share

  512. FINK L, von Sass C, Golla H, Voltz R, et al
    Epidemiology and palliative care of in-patient cerebral metastases cases in Germany.
    J Neurooncol. 2025;173:37-48.
    >> Share

  513. THERKELSEN KE, Cao T, Roy-O'Reilly M, Stocksdale B, et al
    Molecular testing and targeting for solid tumors with CNS metastases.
    J Neurooncol. 2025;173:1-10.
    >> Share

  514. MENNA G, Riva D, Marino S, Garber J, et al
    Simulation tools in neuro-oncological surgery: a scoping review of perioperative and training applications.
    J Neurooncol. 2025;173:21-35.
    >> Share

  515. FRAZZINI V, Mathon B, Shor N, Nichelli L, et al
    The Mickey Mouse's hand sign in brain MRI points out multinodular and vacuolating neuronal tumors in mesial temporal lobe structures.
    J Neurooncol. 2025;173:217-223.
    >> Share

  516. LIU KX, Salans M, Easwaran TP, Phuong C, et al
    The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation.
    J Neurooncol. 2025;173:167-177.
    >> Share

  517. RYU H, Li X, Lee TH, Kim TM, et al
    Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: implications for hippocampal avoidance irradiation.
    J Neurooncol. 2025;173:95-104.
    >> Share

    April 2025
  518. WAGNER-BALLON C, Moreira A, Houessinon A, Boone M, et al
    Defining end-of-life in glioblastoma multiforme: a systematic review.
    J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05051.
    >> Share

  519. LA ROSA A, Mittauer KE, Rzepczynski AE, Chuong MD, et al
    Temporospatial tumor dynamic changes in glioblastoma during radiotherapy.
    J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05060.
    >> Share

  520. MICHEL A, Rauschenbach L, Karadachi H, Gumus M, et al
    Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival.
    J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05048.
    >> Share

  521. DIN SU, Sufiyan S, Shah AA, Fatima H, et al
    HMGA1 as a prognostic biomarker for gliomas: expression patterns, survival correlations, and clinical insights from a Pakistani cohort.
    J Neurooncol. 2025 Apr 28. doi: 10.1007/s11060-025-05031.
    >> Share

  522. MARWAHA AS, Shepard MJ, Karlovits SM, Herbst J, et al
    Advancements in adaptive MR-guided radiotherapy for high-grade gliomas.
    J Neurooncol. 2025 Apr 24. doi: 10.1007/s11060-025-05053.
    >> Share

  523. YI GZ, Lin JF, Lu YX, Li ZY, et al
    Clinical, pathological, radiological features and prognosis of epithelioid glioblastoma: a retrospective single center study.
    J Neurooncol. 2025 Apr 23. doi: 10.1007/s11060-025-05046.
    >> Share

  524. AKDEMIR EY, Gurdikyan S, Reyes TC, Odia Y, et al
    Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients.
    J Neurooncol. 2025 Apr 22. doi: 10.1007/s11060-025-05038.
    >> Share

  525. LALLY AR, Ghosh SR, Pecorari IL, Reynolds J, et al
    Do the benefits of IDH mutations in high-grade glioma persist beyond the first recurrence? A multi-institutional retrospective analysis.
    J Neurooncol. 2025 Apr 22. doi: 10.1007/s11060-025-05049.
    >> Share

  526. PERRON R, Iorio-Morin C, Chytka T, Simonova G, et al
    International multicenter study of stereotactic radiosurgery for bladder cancer brain metastases.
    J Neurooncol. 2025 Apr 18. doi: 10.1007/s11060-025-05039.
    >> Share

  527. YUN YC, Jende JME, Garhofer F, Wolf S, et al
    Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma.
    J Neurooncol. 2025 Apr 17. doi: 10.1007/s11060-025-05037.
    >> Share

  528. DUFFAU H
    The capability to successfully study and to be graduated in students who underwent awake surgical resection for a low-grade glioma.
    J Neurooncol. 2025 Apr 17. doi: 10.1007/s11060-025-05044.
    >> Share

  529. LAPIDUS AH, Devitt B, Herbison H, Tran S, et al
    A Delphi study of current practices and establishing consensus regarding assessment of fitness to drive among patients with brain tumours.
    J Neurooncol. 2025 Apr 16. doi: 10.1007/s11060-025-05030.
    >> Share

  530. LIU X, Hao S, Sun S, Xie J, et al
    Increased cortical iron deposition in glioma patients: a quantitative susceptibility mapping study.
    J Neurooncol. 2025 Apr 16. doi: 10.1007/s11060-025-05027.
    >> Share

  531. RASHID NS, Lamba N, Catalano PJ, Elhalawani H, et al
    Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis.
    J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05023.
    >> Share

  532. DIAZ LS, Agrup M, Askild A, Embring A, et al
    Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
    J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05016.
    >> Share

  533. ZSCHERNACK V, Pinto G, Friker LL, Klein R, et al
    Pitfalls in the evaluation of CDKN2A copy number status in meningioma.
    J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05029.
    >> Share

  534. LI Y, Wang Y, Han X, Xu J, et al
    Glioma-derived SPARCL1 promotes the formation of peritumoral neuron-glioma synapses.
    J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05007.
    >> Share

  535. SANVITO F, Kryukov I, Yao J, Teraishi A, et al
    Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response.
    J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05019.
    >> Share

  536. BAXTER SM, Bjorge T, Bjerkvig R, Cardwell C, et al
    Use of psychotropic medications among glioma patients in Denmark, Norway, Sweden, and Wales.
    J Neurooncol. 2025 Apr 10. doi: 10.1007/s11060-025-04996.
    >> Share

  537. SUFIYAN S, Salam H, Ilyas S, Amin W, et al
    Prognostic implications of DNA methylation machinery (DNMTs and TETs) expression in gliomas: correlations with tumor grading and patient survival.
    J Neurooncol. 2025 Apr 10. doi: 10.1007/s11060-025-05032.
    >> Share

  538. NOGUCHI M, Koide Y, Shindo Y, Aoyama T, et al
    Repeat stereotactic radiosurgery for recurrent brain metastases: a retrospective comparison of local progression and distant brain metastases after prior radiosurgery.
    J Neurooncol. 2025 Apr 9. doi: 10.1007/s11060-025-05035.
    >> Share

  539. PANDEY K, Mishra S, Garg K, Garg A, et al
    Patterns of response following gamma knife radiosurgery for tectal plate gliomas.
    J Neurooncol. 2025 Apr 9. doi: 10.1007/s11060-025-05034.
    >> Share

  540. SUN Y, Estevez-Ordonez D, Atchley TJ, Nabors B, et al
    The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study.
    J Neurooncol. 2025 Apr 7. doi: 10.1007/s11060-025-05002.
    >> Share

  541. FU AY, Bernstein K, Zhang J, Silverman J, et al
    Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.
    J Neurooncol. 2025 Apr 4. doi: 10.1007/s11060-025-05026.
    >> Share

  542. ZHUANG L, Yin X, Liu X, Liu D, et al
    Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single?center retrospective study.
    J Neurooncol. 2025;172:461-470.
    >> Share

  543. ZHAO X, Zhang Y, Wang Y, Ren X, et al
    Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.
    J Neurooncol. 2025;172:481-490.
    >> Share

  544. BAKES E, Cheng R, Manucat-Tan N, Ramaswamy V, et al
    Advances in molecular prognostication and treatments in ependymoma.
    J Neurooncol. 2025;172:317-326.
    >> Share

  545. LAN R, Zhang N, Chen R, Chen J, et al
    Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma.
    J Neurooncol. 2025 Apr 1. doi: 10.1007/s11060-025-05013.
    >> Share

    March 2025
  546. RIEGEL DC, Bureau BL, Conlon P, Chavez G, et al
    Long-term survival, patterns of progression, and patterns of use for patients with newly diagnosed glioblastoma treated with or without Tumor Treating Fields (TTFields) in a real-world setting.
    J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-04946.
    >> Share

  547. TAORI S, Wei Z, Hadjipanayis CG, Niranjan A, et al
    Long-term outcomes following upfront single-session gamma knife stereotactic radiosurgery for large volume meningiomas.
    J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05000.
    >> Share

  548. TOSI U, Schwartz TH
    Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation.
    J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05017.
    >> Share

  549. GUO H, Li X, Tong H, Fang J, et al
    Longitudinal analysis of radiologic progression patterns in glioblastoma: investigating prognosis using a multi-state model.
    J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05022.
    >> Share

  550. HOROWITZ MA, Brown NJ, Gendreau J, Pennington Z, et al
    The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database.
    J Neurooncol. 2025 Mar 28. doi: 10.1007/s11060-025-05011.
    >> Share

  551. SHEN H, Zhou Z, Zhang X, Xu M, et al
    Comparative analysis of pyrosequencing and next-generation sequencing for assessing MGMT methylation in glioma patients.
    J Neurooncol. 2025 Mar 26. doi: 10.1007/s11060-025-05015.
    >> Share

  552. GHOSH SR, Lally AR, Pecorari IL, Reynolds J, et al
    The impact of sociodemographic background on clinical presentation of high-grade gliomas: a multi-institutional retrospective analysis.
    J Neurooncol. 2025 Mar 25. doi: 10.1007/s11060-025-05012.
    >> Share

  553. MAZA EJL, Pavoni JF, Leoni RF
    Early and late structural brain changes after radiation therapy: an MRI study in glioma patients.
    J Neurooncol. 2025 Mar 21. doi: 10.1007/s11060-025-05008.
    >> Share

  554. NEIMANTAITE A, Carstam L, Gomez Vecchio T, Haggstrom I, et al
    Survival prediction with radiomics for patients with IDH mutated lower-grade glioma.
    J Neurooncol. 2025 Mar 18. doi: 10.1007/s11060-025-05006.
    >> Share

  555. MULLER HL
    Long-term quality of life and hypothalamic dysfunction after craniopharyngioma.
    J Neurooncol. 2025 Mar 17. doi: 10.1007/s11060-025-04987.
    >> Share

  556. DE DOMENICO P, Gagliardi F, Roncelli F, Snider S, et al
    Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.
    J Neurooncol. 2025 Mar 13. doi: 10.1007/s11060-025-04989.
    >> Share

  557. MA ST, Ahn YC, Lim DH, Lee JI, et al
    Gamma Knife Radiosurgery for optic nerve sheath meningioma: comparison of efficacy and costs with radiotherapy under Korean health insurance system.
    J Neurooncol. 2025 Mar 11. doi: 10.1007/s11060-025-04986.
    >> Share

  558. CERRETTI G, Bosio A, Librizzi G, Pintacuda G, et al
    Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
    J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-04992.
    >> Share

  559. HARARY PM, Rajaram S, Hori YS, Park DJ, et al
    The spectrum of radiation therapy options for craniopharyngioma: a systematic review.
    J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-05001.
    >> Share

  560. SARIKONDA A, Quraishi D, Mitchell Self D, Sami A, et al
    Introducing the operative value index for glioma surgery: an integration of quality-adjusted life years with time-driven activity-based costing.
    J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-04997.
    >> Share

  561. NETH BJ, Kraft RM, Eschbacher KL, Johnson DR, et al
    Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis.
    J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04994.
    >> Share

  562. LAAJAVA J, Niemela M, Korja M
    Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma- a retrospective study of 279 meningioma patients.
    J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04964.
    >> Share

  563. TORRES-TENOR JL, Garcia-Leal A, Hui D, Bruera E, et al
    Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.
    J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04993.
    >> Share

  564. FARAJ CA, McCutcheon IE, Gubbiotti MA, Perni S, et al
    Extra-central nervous system metastasis from high-grade glioma: a single-institution experience.
    J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04977.
    >> Share

  565. FARES J, Wan Y, Gurung B, Nazar T, et al
    Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.
    J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04991.
    >> Share

  566. JOSHI N, Mueller S, Kline C
    Current clinical trials for craniopharyngiomas: what's on the horizon?
    J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-024-04899.
    >> Share

  567. SHIREMAN JM, Distler E, Schepp C, Tao Y, et al
    Impact of pregnancy on the treatment and outcomes of glioma: a cohort study.
    J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04961.
    >> Share

  568. AGNER KE, Larkins MC
    Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020.
    J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04988.
    >> Share

  569. SAINI S, Gadet JAMA, Freeman GJ, Chiocca EA, et al
    Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1.
    J Neurooncol. 2025 Mar 4. doi: 10.1007/s11060-025-04978.
    >> Share

  570. ADIDA S, Sefcik RK, Gerszten PC
    Comment on "The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management".
    J Neurooncol. 2025 Mar 3. doi: 10.1007/s11060-025-04983.
    >> Share

  571. VERMA O, Mishra S, Tripathi M, Sheehan JP, et al
    Role of stereotactic radiosurgery for intracranial epidermoid tumors: a systematic review to assess its safety, efficacy, and complication profile.
    J Neurooncol. 2025;172:13-30.
    >> Share

  572. ZHU JW, Shum M, Qazi MA, Sahgal A, et al
    Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease.
    J Neurooncol. 2025;172:31-40.
    >> Share

  573. DINAKARAN D, Moore-Palhares D, Yang F, Hill JB, et al
    Precision radiotherapy with molecular-profiling of CNS tumours.
    J Neurooncol. 2025;172:51-75.
    >> Share

  574. JALAL AHB, Gunn H, Gunasekara B, Gan HW, et al
    Endocrine effects of MEK and BRAF inhibitor therapy in paediatric patients: a tertiary centre experience.
    J Neurooncol. 2025;172:257-263.
    >> Share

  575. OSAKO R, Hayano A, Kawaguchi A, Yamanaka R, et al
    Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells.
    J Neurooncol. 2025;172:163-173.
    >> Share

  576. ONISHI S, Yamasaki F, Amatya VJ, Yonezawa U, et al
    Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.
    J Neurooncol. 2025;172:185-194.
    >> Share

  577. HASKELL-MENDOZA AP, Gonzalez AT, Reason EH, Flusche AM, et al
    The LITT Fit in neuro-oncology: indications, imaging, and adjunctive therapies.
    J Neurooncol. 2025;172:1-11.
    >> Share

    February 2025
  578. YU J, Ren L, Wu T, Hua L, et al
    Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines.
    J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-025-04966.
    >> Share

  579. WU Q, Chen S, Xie X, Yan H, et al
    Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1/AKT/NRF2 pathway.
    J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-024-04934.
    >> Share

  580. LI Y, Shi J, Liu C, Ma D, et al
    Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis.
    J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-024-04906.
    >> Share

  581. REDDY SC, Mao Y, Gendreau J, Ahmed AK, et al
    Clinical predictors of overall survival in very elderly meningioma patients: a surveillance, epidemiology, and end results (SEER) database analysis.
    J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-025-04982.
    >> Share

  582. KOSANAM AR, Ma J, White AJ, Murayi R, et al
    Comparison of adjuvant radiation versus observation and salvage radiation after subtotal resection of a WHO grade I skull base meningioma: a propensity score-adjusted analysis.
    J Neurooncol. 2025 Feb 25. doi: 10.1007/s11060-025-04980.
    >> Share

  583. KARSY M, Kshettry VR, Little AS
    RAPID, a multicenter collaboration for the study of craniopharyngiomas: challenges, opportunities, and future directions.
    J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04981.
    >> Share

  584. ZHU J, Wang T, Liu X, Lu T, et al
    Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a.
    J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04976.
    >> Share

  585. WACH J, Vychopen M, Guresir E
    Prognostic revalidation of RANO categories for extent of resection in glioblastoma: a reconstruction of individual patient data.
    J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04950.
    >> Share


  586. Correction to: Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
    J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-024-04924.
    >> Share

  587. DAMANTE M, Cua S, Kreatsoulas D, Giglio P, et al
    Papillary craniopharyngioma management in the era of BRAF and MEK inhibition.
    J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-025-04969.
    >> Share

  588. VAN DER WEIDE HL, Buunk AM, Siebenga FF, Langendijk JA, et al
    Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.
    J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-025-04973.
    >> Share

  589. DUBE CJ, Lai M, Zhang Y, Saha S, et al
    T-type calcium channels regulate medulloblastoma and can be targeted for therapy.
    J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04967.
    >> Share

  590. BALAGUER-LLUNA L, Olaciregui NG, Aschero R, Resa-Pares C, et al
    Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.
    J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04954.
    >> Share

  591. GAL O, Mehta MP, Kotecha R
    The role of upfront radiation therapy for brain metastases in the era of CNS-active systemic therapies: a narrative review of clinical trial design and lessons learned.
    J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04970.
    >> Share

  592. ZHU X, Yuan F, Sun Q, Yang C, et al
    N-acetylcysteine remodels the tumor microenvironment of primary and recurrent mouse glioblastoma.
    J Neurooncol. 2025 Feb 15. doi: 10.1007/s11060-025-04971.
    >> Share

  593. LIU J, Guo S, Li Q, Yang L, et al
    Correction to: Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1.
    J Neurooncol. 2025 Feb 14. doi: 10.1007/s11060-025-04960.
    >> Share

  594. STEC NE, Barker FG 2nd, Brastianos PK
    Targeted treatment for craniopharyngioma.
    J Neurooncol. 2025 Feb 14. doi: 10.1007/s11060-025-04942.
    >> Share

  595. ONG CV, Samlowski W
    Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice.
    J Neurooncol. 2025 Feb 11. doi: 10.1007/s11060-025-04951.
    >> Share

  596. WASILEWSKI D, Eitner C, Ates R, Murad S, et al
    Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charite LMD registry.
    J Neurooncol. 2025 Feb 11. doi: 10.1007/s11060-025-04937.
    >> Share

  597. SAKURADA K, Sato I, Ikeda M, Narita Y, et al
    Mental health status and associated factors of caregivers of patients with malignant brain tumors.
    J Neurooncol. 2025 Feb 7. doi: 10.1007/s11060-025-04963.
    >> Share

  598. JESSURUN CAC, Siddi F, Nawabi NLA, Hulsbergen AFC, et al
    Hyperprogression of brain metastases following initiation of immune checkpoint inhibitors.
    J Neurooncol. 2025 Feb 7. doi: 10.1007/s11060-025-04955.
    >> Share

  599. VIOZZI I, Hannink G, Ardon H, Balvers RK, et al
    Between-hospital variation in biopsy indication for patients with newly diagnosed glioblastoma in the Dutch Quality Registry for Neurosurgery.
    J Neurooncol. 2025 Feb 6. doi: 10.1007/s11060-025-04959.
    >> Share

  600. PHAM J, Cote DJ, Kang K, Briggs RG, et al
    Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database.
    J Neurooncol. 2025 Feb 5. doi: 10.1007/s11060-025-04952.
    >> Share

  601. STUMMER W, Gerwing M, Bilgin SS, Thomas C, et al
    Sonodynamic therapy with a single neoadjuvant, diffuse delivery of low-intensity ultrasound with 5-ALA in treatment naive glioblastoma results in tumor-specific cytotoxic edema and increased apoptosis.
    J Neurooncol. 2025 Feb 4. doi: 10.1007/s11060-025-04957.
    >> Share

  602. SHEEHAN JP
    Brain metastases from small cell lung cancer: focal therapies improve outcomes in the contemporary era.
    J Neurooncol. 2025 Feb 4. doi: 10.1007/s11060-025-04943.
    >> Share

  603. JANI JA, Cowan D, Ouonkap L, Adesina D, et al
    Missing the message to brain tumor patients: a 2023 twitter analysis among patients, informal caregivers, and healthcare professionals in glioblastoma multiforme.
    J Neurooncol. 2025 Feb 3. doi: 10.1007/s11060-025-04948.
    >> Share

  604. LESHA E, Roach JT, Miller LE, Nichols CS, et al
    Length of stay following elective craniotomy for tumor resection in children and young adults: a retrospective case series.
    J Neurooncol. 2025;171:651-658.
    >> Share

  605. RODRIGUEZ B, Rivera D, Zhang JY, Brown C, et al
    Innovations in intraoperative therapies in neurosurgical oncology: a narrative review.
    J Neurooncol. 2025;171:549-557.
    >> Share

    January 2025
  606. HUANG JY, Yeh TC, Liu HC, Hou JY, et al
    Computerized assessment of neuropsychological functioning in pediatric brain tumor patients.
    J Neurooncol. 2025 Jan 31. doi: 10.1007/s11060-025-04945.
    >> Share

  607. PETERSON RK, Choi JH, King TZ
    Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States.
    J Neurooncol. 2025 Jan 28. doi: 10.1007/s11060-025-04940.
    >> Share

  608. ROSENSTOCK T, Picht T, Engelhardt M, Grittner U, et al
    Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation.
    J Neurooncol. 2025 Jan 23. doi: 10.1007/s11060-024-04931.
    >> Share

  609. UMEDA T, Otani Y, Fujii K, Ishida J, et al
    Identification of factors related to functional prognoses in craniopharyngiomas.
    J Neurooncol. 2025 Jan 22. doi: 10.1007/s11060-024-04925.
    >> Share

  610. NAHLS NS, Anttonen A, Nuutinen M, Saarto T, et al
    The impact of palliative care contact on the use of hospital resources at the end of life for brain tumor patients; a nationwide register-based cohort study.
    J Neurooncol. 2025 Jan 20. doi: 10.1007/s11060-025-04939.
    >> Share

  611. YAKUBOV R, Kaloti R, Persaud P, McCracken A, et al
    It's all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma.
    J Neurooncol. 2025 Jan 16. doi: 10.1007/s11060-024-04930.
    >> Share

  612. ZHONG S, Zuo J, Fu X, Wu C, et al
    Leptomeningeal dissemination in H3 K27M- mutant diffuse midline gliomas: clinical characteristics, risk factors, and prognostic insights.
    J Neurooncol. 2025 Jan 15. doi: 10.1007/s11060-024-04933.
    >> Share

  613. REDJAL N, Ziu M, Choi S, Ng PR, et al
    Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.
    J Neurooncol. 2025 Jan 13. doi: 10.1007/s11060-024-04871.
    >> Share

  614. WACH J, Vychopen M, Basaran AE, Tatagiba M, et al
    Overall survival and progression-free survival in pediatric meningiomas: a systematic review and individual patient-level meta-analysis.
    J Neurooncol. 2025 Jan 9. doi: 10.1007/s11060-024-04917.
    >> Share

  615. TINI P, Donnini F, Minniti G
    Refining target delineation strategies for multifocal glioblastoma: a step towards personalized radiotherapy.
    J Neurooncol. 2025 Jan 7. doi: 10.1007/s11060-024-04926.
    >> Share

  616. NARSINH KH, Kumar K, Bankiewicz K, Martin AJ, et al
    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
    J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04904.
    >> Share

  617. WU Y, Chen Z, Shi M, Qiu S, et al
    Nimotuzumab and bevacizumab combined with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma multiforme: a retrospective single-arm study.
    J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04932.
    >> Share

  618. KAZEMI F, Gendreau JL, Parker M, Chakravarti S, et al
    Creating a predictive model and online calculator for high-value care outcomes following glioblastoma resection: incorporating neighborhood socioeconomic status index.
    J Neurooncol. 2025 Jan 4. doi: 10.1007/s11060-024-04927.
    >> Share

  619. DAI Q, Wei J, Li Z, Li T, et al
    Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells.
    J Neurooncol. 2025 Jan 3. doi: 10.1007/s11060-024-04918.
    >> Share

  620. MIAO Y, Wu D, Li Y, Ji Y, et al
    Radiation therapy for childhood-onset craniopharyngioma: systematic review and meta-analysis.
    J Neurooncol. 2025 Jan 3. doi: 10.1007/s11060-024-04914.
    >> Share

  621. MANDELBERG N, Hodges TR, Wang TJC, McGranahan T, et al
    Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update.
    J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04898.
    >> Share

  622. LIM S, Clarke NH, Maloney SL, Sener UT, et al
    Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas.
    J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04916.
    >> Share

  623. SHOSHAN Y, Gomori MJ, Moss L, Bari SE, et al
    Stereotactic implantation of diffusing alpha-emitters radiation therapy sources in the swine brain: a potential new focal therapy for brain tumors.
    J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04919.
    >> Share

  624. RANDRIAN V, Portales F, Bouche O, Thezenas S, et al
    The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.
    J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04905.
    >> Share

  625. MAROUFI SF, Maroufi SP, Fallahi MS, Sheehan JP, et al
    Long-term trends of publications in journal of neuro-oncology: a bibliographic study of a core journal in the field of neuro-oncology.
    J Neurooncol. 2025;171:329-341.
    >> Share

  626. KIM I, Yan M, Sourour M, Heaton R, et al
    Pituitary neuroendocrine tumors treated with stereotactic radiosurgery.
    J Neurooncol. 2025;171:423-430.
    >> Share

  627. ROMANOVA E, Deviaterikova A, Tolchennikova V, Karelin A, et al
    Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study.
    J Neurooncol. 2025;171:393-402.
    >> Share

  628. KLEIN BR, Levi DJ, Shah AH, Ivan ME, et al
    Social media "SoMe" in neuro-oncology: a review of the literature.
    J Neurooncol. 2025;171:11-19.
    >> Share

  629. RINCON-TORROELLA J, Rakovec M, Kalluri AL, Jiang K, et al
    Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.
    J Neurooncol. 2025;171:35-45.
    >> Share

  630. PAHWA B, Singh G, Kale SS
    The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary spinal astrocytomas.
    J Neurooncol. 2025;171:131-138.
    >> Share

  631. LIM-FAT MJ, Roberto K, Wen PY
    Clinical trial design for novel targeted agents in neuro-oncology.
    J Neurooncol. 2025;171:21-33.
    >> Share

    December 2024
  632. BANGASH AH, Poudel P, Alshuqayfi KM, Ahmed M, et al
    Treatment-induced ripple effect: a systematic review exploring the abscopal phenomenon in Glioblastoma multiforme.
    J Neurooncol. 2024 Dec 19. doi: 10.1007/s11060-024-04912.
    >> Share

  633. GREWAL EP, Nahed BV, Carter BS, Gerstner ER, et al
    Clinical progress in the development of CAR T cells to treat malignant glioma.
    J Neurooncol. 2024 Dec 18. doi: 10.1007/s11060-024-04909.
    >> Share

  634. CHEN H, Tan G, Zhong L, Hu Y, et al
    MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.
    J Neurooncol. 2024 Dec 17. doi: 10.1007/s11060-024-04910.
    >> Share

  635. BARRAGAN-PEREZ EJ, Alvarez-Amado DE, Dies-Suarez P, Tobon SH, et al
    Retraction Note: Compassionate use of Quantum Magnetic Resonance Therapy for treatment of children with Diffuse Brainstem Glioma in Mexico City: a single institutional experience.
    J Neurooncol. 2024 Dec 16. doi: 10.1007/s11060-024-04915.
    >> Share

  636. OBARA T, Blonski M, Forest-Dodelin M, Rech F, et al
    Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study.
    J Neurooncol. 2024 Dec 16. doi: 10.1007/s11060-024-04888.
    >> Share

  637. TAORI S, Habib A, Adida S, Gecici NN, et al
    Circulating biomarkers in high-grade gliomas: current insights and future perspectives.
    J Neurooncol. 2024 Dec 13. doi: 10.1007/s11060-024-04903.
    >> Share

  638. MONDIA MWL, Hooks RE, Maragkos GA, Smith VL, et al
    Primary diffuse leptomeningeal glioblastoma: a case report and literature review.
    J Neurooncol. 2024 Dec 12. doi: 10.1007/s11060-024-04908.
    >> Share

  639. MARWAHA AS, Liang Y, Shepard MJ, Yu A, et al
    Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era.
    J Neurooncol. 2024 Dec 7. doi: 10.1007/s11060-024-04895.
    >> Share

  640. MOTAMED-SANAYE A, Mortezaei A, Afshari AR, Saadatian Z, et al
    Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.
    J Neurooncol. 2024 Dec 5. doi: 10.1007/s11060-024-04865.
    >> Share

  641. WASILEWSKI D, Araceli T, Bischoff P, Fruh A, et al
    TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression.
    J Neurooncol. 2024 Dec 4. doi: 10.1007/s11060-024-04885.
    >> Share

  642. ZHEN J, Chen L, Wang H, Li D, et al
    Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence.
    J Neurooncol. 2024;170:665-673.
    >> Share

  643. YANG W, Chai X, Zhang N, Zhi Z, et al
    Predicting cerebellar mutism syndrome in children using lesion map combined with clinical features.
    J Neurooncol. 2024;170:591-599.
    >> Share

  644. BADARY A, Kertam A, El-Ramly TA, Abomera NE, et al
    Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes.
    J Neurooncol. 2024;170:495-507.
    >> Share

    November 2024
  645. LIU Y, Cai L, Wang H, Yao L, et al
    BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression.
    J Neurooncol. 2024 Nov 28. doi: 10.1007/s11060-024-04889.
    >> Share

  646. SHABO E, Potthoff AL, Zeyen T, Layer JP, et al
    Transient and permanent hydrocephalus following resection of brain metastases located in the posterior fossa: incidence, risk factors and the necessity of perioperative external ventricular drainage placement.
    J Neurooncol. 2024 Nov 28. doi: 10.1007/s11060-024-04890.
    >> Share

  647. DEVARAJAN A, Seah C, Zhang JY, Vasan V, et al
    A four-hit mechanism is sufficient for meningioma development.
    J Neurooncol. 2024 Nov 25. doi: 10.1007/s11060-024-04877.
    >> Share

  648. BHARDWAJ S, Sanjay, Yadav AK
    Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells.
    J Neurooncol. 2024 Nov 25. doi: 10.1007/s11060-024-04831.
    >> Share

  649. HERMELO I, Haapala I, Makela M, Jacome Sanz D, et al
    Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry.
    J Neurooncol. 2024 Nov 23. doi: 10.1007/s11060-024-04891.
    >> Share

  650. BADANI A, Ozair A, Khasraw M, Woodworth GF, et al
    Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions.
    J Neurooncol. 2024 Nov 21. doi: 10.1007/s11060-024-04881.
    >> Share

  651. ZIU M, Halasz LM, Kumthekar PU, McGranahan TM, et al
    Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.
    J Neurooncol. 2024 Nov 20. doi: 10.1007/s11060-024-04861.
    >> Share

  652. SUERO MOLINA E, Azemi G, Ozdemir Z, Russo C, et al
    Predicting intraoperative 5-ALA-induced tumor fluorescence via MRI and deep learning in gliomas with radiographic lower-grade characteristics.
    J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04875.
    >> Share

  653. KRENZLIN H, Jankovic D, Dauth A, Lange F, et al
    Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.
    J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04810.
    >> Share

  654. TANG L, Chakravarti S, Li E, Mao Y, et al
    Optimal treatment regimen for very elderly patients with atypical meningioma: an analysis of survival outcomes using the National Cancer Database (NCDB).
    J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04886.
    >> Share

  655. VAN OPIJNEN MP, Sadigh Y, Dijkstra ME, Young JS, et al
    The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review.
    J Neurooncol. 2024 Nov 18. doi: 10.1007/s11060-024-04874.
    >> Share

  656. PULCINI S, Beaussire-Trouvay L, Marguet F, Viailly PJ, et al
    The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
    J Neurooncol. 2024 Nov 16. doi: 10.1007/s11060-024-04879.
    >> Share

  657. WANG B, Bukowski A, Kaidar-Person O, Choi JM, et al
    Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases.
    J Neurooncol. 2024 Nov 15. doi: 10.1007/s11060-024-04866.
    >> Share

  658. HERR S, Kite T, Vyas P, Karlovits S, et al
    The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management.
    J Neurooncol. 2024 Nov 14. doi: 10.1007/s11060-024-04873.
    >> Share

  659. TINI P, Cinelli E, Yavorska M, Donnini F, et al
    Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol.
    J Neurooncol. 2024 Nov 14. doi: 10.1007/s11060-024-04862.
    >> Share

  660. PETITT JC, Murayi R, El-Abtah ME, Momin A, et al
    Outcomes of adjuvant radiation treatment following subtotal resection of world health organization grade II meningiomas.
    J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04878.
    >> Share

  661. SABAHI M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, et al
    CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws.
    J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04876.
    >> Share

  662. MOKOENA X, Mabeta P, Cordier W, Flepisi BT, et al
    Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro.
    J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04870.
    >> Share

  663. KALLURI AL, Lee JH, Lucas CG, Rincon-Torroella J, et al
    Implications of molecular classifications in glioma surgery.
    J Neurooncol. 2024 Nov 12. doi: 10.1007/s11060-024-04883.
    >> Share

  664. EL-HAJJ VG, Ranganathan S, Hoang H, Ghaith AK, et al
    The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis.
    J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04880.
    >> Share

  665. IRSHAD HA, Rizvi SBA, Bajwa MH, Khalid MU, et al
    Epidemiology of glioblastoma in Pakistan: a secondary analysis of the Pakistan Brain Tumor Epidemiology Study (PBTES).
    J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04872.
    >> Share

  666. LAWRENCE LSP, Maralani PJ, Das S, Sahgal A, et al
    Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy.
    J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04856.
    >> Share

  667. FAN Z, Gao A, Zhang J, Meng X, et al
    Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features.
    J Neurooncol. 2024 Nov 4. doi: 10.1007/s11060-024-04867.
    >> Share

  668. BAIG MIRZA A, Fayez F, Rashed S, Burn L, et al
    Ethnicity in neuro-oncology research: How are we doing and how can we do better?
    J Neurooncol. 2024;170:223-233.
    >> Share

  669. ROSE ML, Moen E, Ager B, Bajaj B, et al
    Radiotherapy dosing in intracranial ependymoma using the national cancer database.
    J Neurooncol. 2024;170:387-395.
    >> Share

    October 2024
  670. CHEN L, Rizk E, Sherief M, Chang M, et al
    Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma.
    J Neurooncol. 2024 Oct 30. doi: 10.1007/s11060-024-04859.
    >> Share

  671. ZHANG P, Li C, Wang Y, Chi X, et al
    Expression features of targets for anti-glioma CAR-T cell immunotherapy.
    J Neurooncol. 2024 Oct 28. doi: 10.1007/s11060-024-04855.
    >> Share

  672. CACCIOTTI C, Tabori U, Hawkins C, Bennett J, et al
    Targeting the RAS/MAPK pathway in children with glioma.
    J Neurooncol. 2024 Oct 25. doi: 10.1007/s11060-024-04857.
    >> Share

  673. WON YK, Kim ES, Jo IY, Oh HJ, et al
    Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database.
    J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04853.
    >> Share

  674. PHAM DQ, Sheehan DE, Sheehan KA, Katsos K, et al
    Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.
    J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04854.
    >> Share

  675. WETZEL EA, Nohman AI, Hsieh AL, Reuss D, et al
    A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.
    J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04852.
    >> Share

  676. MADHUGIRI VS, Prasad D
    Early experience with an artificial intelligence-based module for brain metastasis detection and segmentation.
    J Neurooncol. 2024 Oct 18. doi: 10.1007/s11060-024-04851.
    >> Share

  677. TERRELL D, Camarano J, Whipple S, Guthikonda B, et al
    Financial toxicity in patients with glioblastoma.
    J Neurooncol. 2024 Oct 16. doi: 10.1007/s11060-024-04835.
    >> Share

  678. ARMOCIDA D, Bianconi A, Zancana G, Jiang T, et al
    DTI fiber-tracking parameters adjacent to gliomas: the role of tract irregularity value in operative planning, resection, and outcome.
    J Neurooncol. 2024 Oct 15. doi: 10.1007/s11060-024-04848.
    >> Share

  679. GARDNER MM, Winter SF, Stahl F, Gerstner ER, et al
    Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
    J Neurooncol. 2024 Oct 14. doi: 10.1007/s11060-024-04850.
    >> Share

  680. MORROW K, Sloan A, Olson JJ, Ormond DR, et al
    Congress of Neurological Surgeons systematic review and evidence?based guidelines on the management of recurrent diffuse low-grade glioma: update.
    J Neurooncol. 2024 Oct 14. doi: 10.1007/s11060-024-04838.
    >> Share

  681. KAMP MA, Fink L, Forster MT, Weiss Lucas C, et al
    In-patient neurosurgical tumor treatments for malignant glioma patients in Germany.
    J Neurooncol. 2024 Oct 10. doi: 10.1007/s11060-024-04784.
    >> Share

  682. GRIESSMAIR M, Schramm S, Ziegenfeuter J, Canisius J, et al
    Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.
    J Neurooncol. 2024 Oct 10. doi: 10.1007/s11060-024-04849.
    >> Share

  683. YAMANISHI S, Nagashima H, Tanaka K, Uno T, et al
    Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma.
    J Neurooncol. 2024 Oct 8. doi: 10.1007/s11060-024-04837.
    >> Share

  684. PROVLOTSKAYA I, Minnigulova A, Zyryanov A, Takmakov M, et al
    How well can simple clinical features predict long-term language recovery after left-hemisphere glioma surgery?
    J Neurooncol. 2024 Oct 6. doi: 10.1007/s11060-024-04836.
    >> Share

  685. FAN KY, Jerzak KJ, Kumar S, Moravan V, et al
    Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy.
    J Neurooncol. 2024 Oct 4. doi: 10.1007/s11060-024-04834.
    >> Share

  686. NIEDER C, Aanes SG, Stanisavljevic L, Mannsaker B, et al
    Return to work in younger patients with brain metastases who survived for 2 years or more.
    J Neurooncol. 2024 Oct 1. doi: 10.1007/s11060-024-04840.
    >> Share

  687. YOUNG CC, Kan P, Chen SR, Lang FF, et al
    Endovascular surgical neuro-oncology: advancing a new subspecialty.
    J Neurooncol. 2024;170:31-40.
    >> Share

  688. GOMES FC, Ferreira MY, Larcipretti ALL, Freitas BCB, et al
    Sodium fluorescein and 5-aminolevulinic acid fluorescence- guided biopsy in brain lesions: a systematic review and meta-analysis.
    J Neurooncol. 2024;170:11-29.
    >> Share

  689. ZHAO S, Ni K, Xie J, Cheng C, et al
    Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.
    J Neurooncol. 2024;170:101-117.
    >> Share

  690. KANAMORI M, Mugikura S, Iizuka O, Mori N, et al
    Clinical significance of cerebral microbleeds in patients with germinoma who underwent long-term follow-up.
    J Neurooncol. 2024;170:173-184.
    >> Share

  691. ROGAWSKI D, Cao T, Ma Q, Roy-O'Reilly M, et al
    Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression.
    J Neurooncol. 2024;170:209-217.
    >> Share

    September 2024
  692. YAVORSKA M, Tomaciello M, Sciurti A, Cinelli E, et al
    Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
    J Neurooncol. 2024 Sep 27. doi: 10.1007/s11060-024-04832.
    >> Share

  693. OHNO M, Takahashi M, Yanagisawa S, Osawa S, et al
    Correction to: Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
    J Neurooncol. 2024 Sep 25. doi: 10.1007/s11060-024-04822.
    >> Share

  694. ZHU K, Li S, Yao H, Hei J, et al
    Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-beta/Smad signal pathway.
    J Neurooncol. 2024 Sep 25. doi: 10.1007/s11060-024-04797.
    >> Share

  695. KATZENDOBLER S, Niedermeyer S, Blobner J, Trumm C, et al
    Determinants of long-term survival in patients with IDH-mutant gliomas.
    J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04826.
    >> Share

  696. LAVIV Y, Regev O, Kanner AA, Fichman S, et al
    Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients.
    J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04828.
    >> Share

  697. AARONSON DM, Laing B, Singhal I, Boerger TF, et al
    Survival implications of postoperative restricted diffusion in high-grade glioma and limitations of intraoperative MRI detection.
    J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04767.
    >> Share

  698. LANDRY AP, Yefet LS, Wang JZ, Zadeh G, et al
    Methylation profiling in the contemporary management of meningioma.
    J Neurooncol. 2024 Sep 22. doi: 10.1007/s11060-024-04825.
    >> Share

  699. GAL O, Mehta MP, Kotecha R
    Radiotherapeutic advances in the management of glioblastoma.
    J Neurooncol. 2024 Sep 13. doi: 10.1007/s11060-024-04824.
    >> Share

  700. HAN JS, Wenger T, Demetriou AN, Dallas J, et al
    Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection.
    J Neurooncol. 2024 Sep 12. doi: 10.1007/s11060-024-04800.
    >> Share

  701. YAVORSKA M, Tomiciello M, Antonio S, Cinelli E, et al
    Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
    J Neurooncol. 2024 Sep 11. doi: 10.1007/s11060-024-04818.
    >> Share

  702. NANDOLIYA KR, Congivaram H, Youngblood MW, Chen WC, et al
    Clinical and methylomic features of spinal meningiomas.
    J Neurooncol. 2024 Sep 10. doi: 10.1007/s11060-024-04736.
    >> Share

  703. BASARAN AE, Arlt F, Guresir E, Vychopen M, et al
    Sexual dysfunction after surgery for primary sporadic cranial meningiomas: prevalence and risk factors.
    J Neurooncol. 2024 Sep 10. doi: 10.1007/s11060-024-04817.
    >> Share

  704. BARONE TA, Robinson DL, Qiu J, Gurova KV, et al
    FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair.
    J Neurooncol. 2024 Sep 9. doi: 10.1007/s11060-024-04819.
    >> Share

  705. PALAVANI LB, Mitre LP, Camerotte R, Nogueira BV, et al
    Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
    J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04813.
    >> Share

  706. SCHWARTZ C, Ueberschaer MF, Rautalin I, Grauvogel J, et al
    Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of age.
    J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04780.
    >> Share

  707. DONG J, Chen Q, Weng S, Liu L, et al
    The effect of depression and anxiety on survival in patients with glioma: a systematic review and meta-analysis.
    J Neurooncol. 2024 Sep 3. doi: 10.1007/s11060-024-04799.
    >> Share

  708. EMINOVIC S, Orth T, Dell'Orco A, Baumgartner L, et al
    Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview.
    J Neurooncol. 2024 Sep 2. doi: 10.1007/s11060-024-04811.
    >> Share

  709. LANDRY AP, Zuccato JA, Patil V, Voisin MR, et al
    Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours.
    J Neurooncol. 2024;169:233-239.
    >> Share

  710. SHEEHAN JP, Lee CC, Fadul CE
    Progression versus pseudoprogression: radiological differentiation with contrast clearance analysis on brain MRI.
    J Neurooncol. 2024;169:695-696.
    >> Share

  711. GHEZZI C, Ellingson BM, Lai A, Liu J, et al
    Effect of Jardiance on glucose uptake into astrocytomas.
    J Neurooncol. 2024;169:437-444.
    >> Share

  712. OZONO I, Onishi S, Yonezawa U, Taguchi A, et al
    Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.
    J Neurooncol. 2024;169:571-579.
    >> Share

  713. BAKER CR, Pease M, Sexton DP, Abumoussa A, et al
    Artificial intelligence innovations in neurosurgical oncology: a narrative review.
    J Neurooncol. 2024;169:489-496.
    >> Share

  714. AHMETI H, Kiese D, Freitag-Wolf S, Kalab M, et al
    IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas.
    J Neurooncol. 2024;169:423-435.
    >> Share

  715. STRACK M, Kuckelhaus J, Diebold M, Wuchter P, et al
    Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells.
    J Neurooncol. 2024;169:329-340.
    >> Share

  716. IVREN M, Cherkezov A, Reuss D, Haux D, et al
    Intracranial angioleiomyoma: a case series of seven patients and review of the literature.
    J Neurooncol. 2024;169:399-408.
    >> Share

    August 2024
  717. TANAKA T, Takei J, Sasaki H
    Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
    J Neurooncol. 2024 Aug 31. doi: 10.1007/s11060-024-04806.
    >> Share

  718. HO VKY, Anten MM, Garst A, Bos EM, et al
    Initial management of newly diagnosed WHO grade 2-3 adult meningioma following surgery: results from the Dutch Brain Tumour Registry (2016-2021).
    J Neurooncol. 2024 Aug 29. doi: 10.1007/s11060-024-04730.
    >> Share

  719. ZHU H, Allwin C, Bassous MG, Pouliopoulos AN, et al
    Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials.
    J Neurooncol. 2024 Aug 29. doi: 10.1007/s11060-024-04795.
    >> Share

  720. UCKERMANN O, Ziegler J, Meinhardt M, Richter S, et al
    Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors.
    J Neurooncol. 2024 Aug 28. doi: 10.1007/s11060-024-04809.
    >> Share

  721. MATHEW-SCHMITT S, Peindl M, Neundorf P, Dandekar G, et al
    Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier.
    J Neurooncol. 2024 Aug 28. doi: 10.1007/s11060-024-04760.
    >> Share

  722. HAINFELLNER A, Borkovec M, Seebrecht L, Neuhauser M, et al
    Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population.
    J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04808.
    >> Share

  723. PIKIS S, Mantziaris G, Protopapa M, Tos SM, et al
    Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study.
    J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04775.
    >> Share

  724. ALCICEK S, Pilatus U, Manzhurtsev A, Weber KJ, et al
    Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.
    J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04803.
    >> Share

  725. SHAABAN A, Pham D, Tos SM, Mantziaris G, et al
    Biological effective dose as a predictor of local tumor control in stereotactic radiosurgery treated parasellar meningioma patients.
    J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04804.
    >> Share

  726. CHEN H, Koul D, Zhang Y, Ghobadi SN, et al
    Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma.
    J Neurooncol. 2024 Aug 24. doi: 10.1007/s11060-024-04801.
    >> Share

  727. RIVERA CA, Bhatia S, Morell AA, Daggubati LC, et al
    Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning.
    J Neurooncol. 2024 Aug 24. doi: 10.1007/s11060-024-04812.
    >> Share

  728. ZHOU WT, Niu JH, Liao C, Ren SK, et al
    Visual deterioration outcomes following optic pathway glioma treatment: a 12-year single institution retrospective study.
    J Neurooncol. 2024 Aug 21. doi: 10.1007/s11060-024-04802.
    >> Share

  729. WONG CE, Chang Y, Chen PW, Huang YT, et al
    Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis.
    J Neurooncol. 2024 Aug 21. doi: 10.1007/s11060-024-04798.
    >> Share

  730. PICHARDO-ROJAS PS, Vazquez-Alva D, Alvarez-Castro JA, Flores-Patino B, et al
    Comparative effectiveness of frame-based and mask-based Gamma Knife stereotactic radiosurgery in brain metastases: A 509 patient meta-analysis.
    J Neurooncol. 2024 Aug 17. doi: 10.1007/s11060-024-04738.
    >> Share

  731. TSUJI S, Kudo U, Takahashi K, Nakamura S, et al
    The role of progranulin in macrophages of a glioblastoma model.
    J Neurooncol. 2024 Aug 14. doi: 10.1007/s11060-024-04793.
    >> Share

  732. ONISHI S, Yamasaki F, Akiyama Y, Kawahara D, et al
    Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.
    J Neurooncol. 2024 Aug 12. doi: 10.1007/s11060-024-04794.
    >> Share

  733. KITE T, Shepard MJ
    Comment on "Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients".
    J Neurooncol. 2024 Aug 9. doi: 10.1007/s11060-024-04796.
    >> Share

  734. XU H, Cao Y, Ruan J, Wang F, et al
    The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells.
    J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04789.
    >> Share

  735. LEE M, Karschnia P, Park YW, Choi K, et al
    Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.
    J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04737.
    >> Share

  736. WANG B, Qiu B, Deng X
    Comment on the paper: Wang B, Liu Y, Zhang J, Yin S, Liu B, Ding S, Qiu B, Deng X. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study. J Neurooncol 167(1):12
    J Neurooncol. 2024 Aug 7. doi: 10.1007/s11060-024-04791.
    >> Share


  737. Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
    J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04705.
    >> Share

  738. BELTRAN-BLESS AA, Alshamsan B, Jia J, Lo V, et al
    Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey.
    J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04764.
    >> Share

  739. RILINGER RG, Guo L, Sharma A, Volovetz J, et al
    Tumor-related epilepsy in high-grade glioma: a large series survival analysis.
    J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04787.
    >> Share

  740. OHNO M, Takahashi M, Yanagisawa S, Osawa S, et al
    Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
    J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04790.
    >> Share

  741. VANHAUWAERT D, Silversmit G, Vanschoenbeek K, Coucke G, et al
    Association of hospital volume with survival but not with postoperative mortality in glioblastoma patients in Belgium.
    J Neurooncol. 2024 Aug 2. doi: 10.1007/s11060-024-04776.
    >> Share

  742. MRUGALA MM, Shi W, Iwomoto F, Lukas RV, et al
    Global post?marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
    J Neurooncol. 2024;169:25-38.
    >> Share

  743. YU C, Xu T, Fang H, Wang X, et al
    High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer.
    J Neurooncol. 2024;169:203-213.
    >> Share

  744. ZHANG S, Patel K, Dusenbery K, Alshreef A, et al
    Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.
    J Neurooncol. 2024;169:11-23.
    >> Share

  745. SCHULZ N, Nichelli L, Schenone L, Ursu R, et al
    Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.
    J Neurooncol. 2024;169:51-60.
    >> Share

  746. YANG Y, Wadhwani N, Shimomura A, Zheng S, et al
    Long-term outcomes of central neurocytoma - an institutional experience.
    J Neurooncol. 2024;169:195-201.
    >> Share

  747. RAUSCHENBACH L, Kolbe P, Engel A, Ahmadipour Y, et al
    Predictors and surgical outcome of hemorrhagic metastatic brain malignancies.
    J Neurooncol. 2024;169:165-173.
    >> Share

  748. YOUSEFI Y, Nejati R, Eslahi A, Alizadeh F, et al
    Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O(6)-methylguanine DNA methyltransferase (MGMT).
    J Neurooncol. 2024;169:129-135.
    >> Share

  749. SCHLIEPER-SCHERF S, Hebach N, Hausmann D, Azorin DD, et al
    Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models.
    J Neurooncol. 2024 Aug 1. doi: 10.1007/s11060-024-04786.
    >> Share

  750. KAISMAN-ELBAZ T, Blumenfeld P, Wygoda M, Feldman J, et al
    Recovery of cranial nerve neuropathies after LINAC-based stereotactic radiosurgery for benign cavernous sinus meningioma.
    J Neurooncol. 2024 Aug 1. doi: 10.1007/s11060-024-04783.
    >> Share

    July 2024
  751. NATSUME K, Yoshida A, Sakakima H, Yonezawa H, et al
    Age-independent benefits of postoperative rehabilitation during chemoradiotherapy on functional outcomes and survival in patients with glioblastoma.
    J Neurooncol. 2024 Jul 30. doi: 10.1007/s11060-024-04785.
    >> Share

  752. FERREIRA MY, Antonia O M Pereira M, Hemais M, Bocanegra-Becerra JE, et al
    Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis.
    J Neurooncol. 2024 Jul 30. doi: 10.1007/s11060-024-04768.
    >> Share

  753. DU H, Sun J, Wang X, Zhao L, et al
    FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells.
    J Neurooncol. 2024 Jul 29. doi: 10.1007/s11060-024-04771.
    >> Share

  754. ASFAW ZK, Young T, Brown C, Germano IM, et al
    Charting the success of neuronavigation in brain tumor surgery: from inception to adoption and evolution.
    J Neurooncol. 2024 Jul 24. doi: 10.1007/s11060-024-04778.
    >> Share

  755. PANEK WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, et al
    The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
    J Neurooncol. 2024 Jul 24. doi: 10.1007/s11060-024-04766.
    >> Share

  756. BOCCUNI L, Roca-Ventura A, Buloz-Osorio E, Leno-Colorado D, et al
    Non-invasive prehabilitation to foster widespread fMRI cortical reorganization before brain tumor surgery: lessons from a case series.
    J Neurooncol. 2024 Jul 23. doi: 10.1007/s11060-024-04774.
    >> Share

  757. SCANLON SE, Shanahan RM, Bin-Alamer O, Bouras A, et al
    Sonodynamic therapy for adult-type diffuse gliomas: past, present, and future.
    J Neurooncol. 2024 Jul 23. doi: 10.1007/s11060-024-04772.
    >> Share

  758. FERNANDEZ-GIL BI, Schiapparelli P, Navarro-Garcia de Llano JP, Otamendi-Lopez A, et al
    Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach.
    J Neurooncol. 2024 Jul 22. doi: 10.1007/s11060-024-04765.
    >> Share

  759. YAMADA S, Umehara T, Sonehara K, Kijima N, et al
    Genome-wide association study on meningioma risk in Japan: a multicenter prospective study.
    J Neurooncol. 2024 Jul 13. doi: 10.1007/s11060-024-04727.
    >> Share

  760. KARABACAK M, Jagtiani P, Carrasquilla A, Jain A, et al
    Simplifying synthesis of the expanding glioblastoma literature: a topic modeling approach.
    J Neurooncol. 2024 Jul 11. doi: 10.1007/s11060-024-04762.
    >> Share

  761. PICHARDO-ROJAS PS, Pichardo-Rojas D, Marin-Castaneda LA, Palacios-Cruz M, et al
    Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis.
    J Neurooncol. 2024 Jul 11. doi: 10.1007/s11060-024-04752.
    >> Share

  762. JEISING S, Nickel AC, Trubel J, Felsberg J, et al
    A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.
    J Neurooncol. 2024 Jul 10. doi: 10.1007/s11060-024-04763.
    >> Share

  763. MAHAJAN A, Goldberg SL, Weiss SA, Tran T, et al
    Patterns of brain metastases response to immunotherapy with pembrolizumab.
    J Neurooncol. 2024 Jul 4. doi: 10.1007/s11060-024-04754.
    >> Share

  764. KAHL KH, Krauss PE, Neu M, Maurer CJ, et al
    Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment- update of the oncological outcome form a single center cohort after 117 procedures.
    J Neurooncol. 2024 Jul 4. doi: 10.1007/s11060-024-04691.
    >> Share

  765. WAGNER S, Ewald C, Freitag D, Herrmann KH, et al
    Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.
    J Neurooncol. 2024 Jul 3. doi: 10.1007/s11060-024-04725.
    >> Share

  766. ZHOU J, Sun W, Li H, Song X, et al
    Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results.
    J Neurooncol. 2024 Jul 3. doi: 10.1007/s11060-024-04759.
    >> Share

  767. SHETTY A, Wang S, Khan AB, English CW, et al
    Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
    J Neurooncol. 2024;168:515-524.
    >> Share

  768. TAN LF, Lim M
    Reply to "Elevating the findings by substituting in 'ISarcoPRM'".
    J Neurooncol. 2024;168:563-564.
    >> Share

  769. DA SILVA EB JR, Ramina R, Novak Filho JL, Jung GS, et al
    Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations.
    J Neurooncol. 2024;168:555-562.
    >> Share

  770. MATSUDA R, Maeoka R, Morimoto T, Nakazawa T, et al
    Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
    J Neurooncol. 2024;168:487-494.
    >> Share

  771. KNOBLAUCH AL, Blass BI, Steiert C, Neidert N, et al
    Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease.
    J Neurooncol. 2024;168:537-545.
    >> Share

  772. COLE KL, Earl ER, Findlay MC, Sherrod BA, et al
    Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era.
    J Neurooncol. 2024 Jul 1. doi: 10.1007/s11060-024-04749.
    >> Share

    June 2024
  773. GUIDARA S, Seyve A, Poncet D, Leonce C, et al
    Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
    J Neurooncol. 2024 Jun 27. doi: 10.1007/s11060-024-04733.
    >> Share

  774. IANNALFI A, Riva G, Lillo S, Ciccone L, et al
    Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
    J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04751.
    >> Share

  775. ERSOY TF, Brainman D, Coras R, Berger B, et al
    Defining the role of surgery for patients with multiple brain metastases.
    J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04739.
    >> Share

  776. ROUX A, Elia A, Hudelist B, Benzakoun J, et al
    Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.
    J Neurooncol. 2024 Jun 24. doi: 10.1007/s11060-024-04747.
    >> Share

  777. PARK J, Kim YJ, Lee M, Kim D, et al
    Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis.
    J Neurooncol. 2024 Jun 22. doi: 10.1007/s11060-024-04750.
    >> Share

  778. ROUX A, Zanello M, Pallud J
    Comment on "Clinical course after Carmustine wafer implantation for newly-diagnosed adult-type diffuse gliomas; a controlled propensity matched analysis of a single center cohort".
    J Neurooncol. 2024 Jun 21. doi: 10.1007/s11060-024-04756.
    >> Share

  779. NIEDERMEYER S, Schmutzer-Sondergeld M, Weller J, Katzendobler S, et al
    Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis.
    J Neurooncol. 2024 Jun 21. doi: 10.1007/s11060-024-04744.
    >> Share

  780. DECRAENE B, Coppens G, Spans L, Solie L, et al
    A novel methylation signature predicts extreme long-term survival in glioblastoma.
    J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04741.
    >> Share

  781. GELMERS F, Timmerman ME, Siebenga FF, van der Weide HL, et al
    Clusters of resilience and vulnerability: executive functioning, coping and mental distress in patients with diffuse low-grade glioma.
    J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04704.
    >> Share

  782. GOMEZ D, Feng JJ, Cheok S, Shah I, et al
    Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review.
    J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04748.
    >> Share

  783. CAI L, Liu Y, Li Y, Liu B, et al
    TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway.
    J Neurooncol. 2024 Jun 17. doi: 10.1007/s11060-024-04726.
    >> Share

  784. ZHU H, Li Y, Ding Y, Liu Y, et al
    Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.
    J Neurooncol. 2024 Jun 14. doi: 10.1007/s11060-024-04729.
    >> Share

  785. JOO B, Kim JH, Ahn SG, Park M, et al
    De novo versus recurrent metastatic breast cancer affects the extent of brain metastases.
    J Neurooncol. 2024 Jun 12. doi: 10.1007/s11060-024-04735.
    >> Share

  786. DHARNIPRAGADA R, Shah RA, Reynolds M, Dusenbery K, et al
    Laser interstitial thermal therapy followed by consolidation stereotactic radiosurgery (LITT-cSRS) in patients with newly diagnosed brain metastasis.
    J Neurooncol. 2024 Jun 12. doi: 10.1007/s11060-024-04712.
    >> Share

  787. DAGHER R, Gad M, da Silva de Santana P, Sadeghi MA, et al
    Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
    J Neurooncol. 2024 Jun 10. doi: 10.1007/s11060-024-04718.
    >> Share

  788. ZINSZ A, Ahrari S, Becker J, Mortada A, et al
    Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.
    J Neurooncol. 2024 Jun 6. doi: 10.1007/s11060-024-04722.
    >> Share

  789. TOYODA M, Shibahara I, Shigeeda R, Fujitani K, et al
    Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04687.
    >> Share

  790. KUTUK T, Zhang Y, Akdemir EY, Yarlagadda S, et al
    Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04706.
    >> Share

  791. HOCKING MC, Schultz RT, Yerys BE, Minturn JE, et al
    White matter connectivity and social functioning in survivors of pediatric brain tumor.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04724.
    >> Share

  792. PICART T, Hervey-Jumper S
    Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling.
    J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04719.
    >> Share

  793. BRAY DP, Stubbs NM, Chow J, Jahangiri A, et al
    Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
    J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04685.
    >> Share

  794. BELLOMO J, Zeitlberger AM, Padevit L, Stumpo V, et al
    Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
    J Neurooncol. 2024 Jun 3. doi: 10.1007/s11060-024-04728.
    >> Share

  795. CAPATINA C, Hanzu FA, Hinojosa-Amaya JM, Fleseriu M, et al
    Medical treatment of functional pituitary adenomas, trials and tribulations.
    J Neurooncol. 2024;168:197-213.
    >> Share

  796. LAWSON MCLEAN AC, Lawson McLean A, Ernst T, Forster MT, et al
    Benchmarking palliative care practices in neurooncology: a german perspective.
    J Neurooncol. 2024;168:333-343.
    >> Share

  797. BIELAMOWICZ KJ, Littrell MB, Albert GW, Parker LS, et al
    Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
    J Neurooncol. 2024;168:367-373.
    >> Share

  798. YAMAMURA T, Tamura K, Kobayashi D, Inaji M, et al
    Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of (11)C-methionine in IDH-mutant astrocytoma.
    J Neurooncol. 2024;168:355-365.
    >> Share

  799. DUAN L, He Y, Guo W, Du Y, et al
    Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
    J Neurooncol. 2024;168:283-298.
    >> Share

    May 2024
  800. HO CH, Shieh LT, Lin CH, Guo HR, et al
    The role of adjuvant radiotherapy for intracranial malignant meningiomas: analysis of a nationwide database.
    J Neurooncol. 2024 May 30. doi: 10.1007/s11060-024-04720.
    >> Share

  801. LI C, Long L, Wang Y, Chi X, et al
    Constitutive type-1 interferons signaling activity in malignant gliomas.
    J Neurooncol. 2024 May 24. doi: 10.1007/s11060-024-04601.
    >> Share

  802. LUCKETT PH, Olufawo MO, Park KY, Lamichhane B, et al
    Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning.
    J Neurooncol. 2024 May 24. doi: 10.1007/s11060-024-04715.
    >> Share

  803. ONO T, Suzuki H, Nanjo H, Shimizu H, et al
    Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort.
    J Neurooncol. 2024 May 23. doi: 10.1007/s11060-024-04679.
    >> Share

  804. SIMON M, Kuschel LP, von Hoff K, Yuan D, et al
    Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens.
    J Neurooncol. 2024 May 21. doi: 10.1007/s11060-024-04702.
    >> Share

  805. BLAKSTAD H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, et al
    The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients.
    J Neurooncol. 2024 May 19. doi: 10.1007/s11060-024-04709.
    >> Share

  806. HUDELIST B, Elia A, Roux A, Paun L, et al
    Impact of frailty on survival glioblastoma, IDH-wildtype patients.
    J Neurooncol. 2024 May 19. doi: 10.1007/s11060-024-04699.
    >> Share

  807. DORON O, Wong T, Ablyazova F, Singha S, et al
    Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
    J Neurooncol. 2024 May 17. doi: 10.1007/s11060-024-04701.
    >> Share

  808. RONSLEY R, Karvonen KA, Cole B, Paulson V, et al
    Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
    J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04645.
    >> Share

  809. PECIU-FLORIANU I, Vannod-Michel Q, Vauleon E, Bonneterre ME, et al
    Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240).
    J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04693.
    >> Share

  810. GOULENKO V, Madhugiri VS, Bregy A, Recker M, et al
    Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study.
    J Neurooncol. 2024 May 15. doi: 10.1007/s11060-024-04697.
    >> Share

  811. RALEIGH DR, Chen WC, Gondi V, Rogers L, et al
    Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.
    J Neurooncol. 2024 May 14. doi: 10.1007/s11060-024-04700.
    >> Share

  812. POLETES C, Amanirad B, Santiago AT, Yan M, et al
    The incidence of brain metastases in breast cancer according to molecular subtype and stage: a 10-year single institution analysis.
    J Neurooncol. 2024 May 13. doi: 10.1007/s11060-024-04707.
    >> Share

  813. COVELL MM, Roy JM, Gupta N, Raihane AS, et al
    Frailty in intracranial meningioma resection: the risk analysis index demonstrates strong discrimination for predicting non-home discharge and in-hospital mortality.
    J Neurooncol. 2024 May 7. doi: 10.1007/s11060-024-04703.
    >> Share

  814. OTTENHAUSEN M, Renovanz M, Bartz I, Poplawski A, et al
    Use of complementary therapies and supportive measures of patients with intracranial gliomas-a prospective evaluation in an outpatient clinic.
    J Neurooncol. 2024 May 6. doi: 10.1007/s11060-024-04696.
    >> Share

  815. SHIN I, Sim Y, Choi SH, Park YW, et al
    Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas.
    J Neurooncol. 2024 May 3. doi: 10.1007/s11060-024-04656.
    >> Share

  816. BAQRI W, Rzadki K, Habbous S, Das S, et al
    Treatment, healthcare utilization and outcomes in patients with glioblastoma in Ontario: a 10-year cohort study.
    J Neurooncol. 2024 May 3. doi: 10.1007/s11060-024-04690.
    >> Share

  817. GECICI NN, Gurses ME, Kaye B, Jimenez NLF, et al
    Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
    J Neurooncol. 2024;168:1-11.
    >> Share

  818. FEHRENBACH MK, Wilhelmy F, Wende T, Guresir E, et al
    Perioperative psychological distress in patients with intracranial tumors; a single center study.
    J Neurooncol. 2024;168:151-157.
    >> Share

  819. ABDULSALAM AJ, Kara M, Ozcakar L
    Elevating the findings by substituting in "ISarcoPRM".
    J Neurooncol. 2024;168:185-186.
    >> Share

  820. RODRIGUES AJ, Chernikova SB, Wang Y, Trinh TTH, et al
    Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
    J Neurooncol. 2024;168:125-138.
    >> Share

  821. WANG M, Chen M, Ge Y
    Comment on "Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control''.
    J Neurooncol. 2024;167:525.
    >> Share

  822. KASATKIN VN, Romanova EN, Glebova EV, Deviaterikova AA, et al
    Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study.
    J Neurooncol. 2024;168:57-67.
    >> Share

  823. LALANCETTE E, Cantin E, Routhier ME, Mailloux C, et al
    Impact of trametinib on the neuropsychological profile of NF1 patients.
    J Neurooncol. 2024;167:447-454.
    >> Share

  824. BARBOUR AB, Blouw B, Taylor LP, Graber JJ, et al
    Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
    J Neurooncol. 2024;167:509-514.
    >> Share

  825. TONG T, Chen H, Mo C, Zhong L, et al
    Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors.
    J Neurooncol. 2024;167:467-476.
    >> Share

  826. DAVISON MA, Lilly DT, Patel AA, Kashkoush A, et al
    Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
    J Neurooncol. 2024;167:437-446.
    >> Share

  827. NAKAGAWA K, Takano K, Nishino K, Ohe S, et al
    Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
    J Neurooncol. 2024;167:397-406.
    >> Share

    April 2024
  828. LI G, Tian Q, Wang S, Li K, et al
    Superficial meningioma with bone involvement: surgical strategies and clinical outcomes.
    J Neurooncol. 2024 Apr 30. doi: 10.1007/s11060-024-04604.
    >> Share

  829. BASREE MM, Li C, Um H, Bui AH, et al
    Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    J Neurooncol. 2024 Apr 30. doi: 10.1007/s11060-024-04669.
    >> Share

  830. DORON O, Wong T, Ablyazova F, Singha S, et al
    Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
    J Neurooncol. 2024 Apr 26. doi: 10.1007/s11060-024-04647.
    >> Share

  831. WANG S, Zhang D, Wang J, Peng X, et al
    PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
    J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04655.
    >> Share

  832. PARKER M, Kazemi F, Ahmed AK, Kuo CC, et al
    Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.
    J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04677.
    >> Share

  833. JOST J, Volker K, Brandt R, Stummer W, et al
    Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04686.
    >> Share

  834. MAIURI F, Corvino S, Corazzelli G, Del Basso De Caro M, et al
    Single versus multiple reoperations for recurrent intracranial meningiomas.
    J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04673.
    >> Share

  835. OKAMOTO T, Mizuta R, Takahashi Y, Otani Y, et al
    Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
    J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04628.
    >> Share

  836. SUN T, Liu B, Cai L, Zhou Y, et al
    Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.
    J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04689.
    >> Share

  837. KOIDE Y, Nagai N, Adachi S, Ito M, et al
    Impact of concurrent antibody-drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study.
    J Neurooncol. 2024 Apr 22. doi: 10.1007/s11060-024-04681.
    >> Share

  838. CZARNOTA GJ
    Comment in reply to Chen et al. Journal of Neuro-Oncology (2023) 165:535-545 "Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study".
    J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04675.
    >> Share

  839. CONRAD K, Lober-Handwerker R, Hazaymeh M, Rohde V, et al
    Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model.
    J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04683.
    >> Share

  840. DESAI J, Rajkumar S, Shepard MJ, Herbst J, et al
    National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario.
    J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04663.
    >> Share

  841. SALAME AAM, Charchar HLS, de Oliveira Dourado JP, Mendonca B, et al
    Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5- a case series.
    J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04680.
    >> Share

  842. MASHIACH E, Alzate JD, De Nigris Vasconcellos F, Adams S, et al
    Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
    J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04651.
    >> Share

  843. GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
    Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
    J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04668.
    >> Share

  844. KOCHER D, Cao L, Guiho R, Langhammer M, et al
    Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
    J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04672.
    >> Share

  845. WILSON L, Atallah A, Romero JM
    Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma.
    J Neurooncol. 2024 Apr 15. doi: 10.1007/s11060-024-04666.
    >> Share

  846. SHEEHAN JP, Trifiletti DM, Lehrer EJ
    Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?
    J Neurooncol. 2024 Apr 11. doi: 10.1007/s11060-024-04678.
    >> Share

  847. CHEN KT, Huang CY, Pai PC, Yang WC, et al
    Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
    J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04671.
    >> Share

  848. KONDO N, Kinouchi T, Natsumeda M, Matsuzaki J, et al
    Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy.
    J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04649.
    >> Share

  849. MIRZAYEVA L, Ucar M, Kaymaz AM, Temel E, et al
    Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience.
    J Neurooncol. 2024 Apr 3. doi: 10.1007/s11060-024-04660.
    >> Share

  850. MAHMOODIFAR S, Pangal DJ, Neman J, Zada G, et al
    Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04630.
    >> Share

  851. DMUKAUSKAS M, Cioffi G, Waite KA, Sloan AE, et al
    Sex differences in adverse events in Medicare individuals >/= 66 years of age post glioblastoma treatment.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04652.
    >> Share

  852. LU VM, Brun JD, Niazi TN, Brun JD, et al
    Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664.
    >> Share

  853. XIANG Y, Chen Y, Xu Z, Zhou S, et al
    Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662.
    >> Share

  854. JOST J, Volker K, Brandt R, Stummer W, et al
    Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04629.
    >> Share

  855. ROGERS JL, Wall T, Acquaye-Mallory AA, Boris L, et al
    Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
    J Neurooncol. 2024;167:349-359.
    >> Share

    March 2024
  856. TONG E, Horsley P, Wheeler H, Wong M, et al
    Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
    J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643.
    >> Share

  857. FLORES-PACO P, Vargas-Aliaga A, Guevara MG, Lopera I, et al
    A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
    J Neurooncol. 2024 Mar 27. doi: 10.1007/s11060-024-04618.
    >> Share

  858. WATANABE G, Young K, Rauber E, Khan MF, et al
    A systematic review of extraneural meningioma metastasis: timing, evolution and outlook.
    J Neurooncol. 2024 Mar 26. doi: 10.1007/s11060-024-04659.
    >> Share

  859. STRAUBE C, Combs SE, Bernhardt D, Gempt J, et al
    Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
    J Neurooncol. 2024 Mar 23. doi: 10.1007/s11060-024-04633.
    >> Share

  860. ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
    Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
    J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04635.
    >> Share

  861. ZAKI PG, Herr S, Shepard MJ
    Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
    J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04602.
    >> Share

  862. FINK L, van Oorschot B, von Sass C, Dibue M, et al
    Palliative care for in-patient malignant glioma patients in Germany.
    J Neurooncol. 2024 Mar 20. doi: 10.1007/s11060-024-04611.
    >> Share

  863. GEENS W, Vanlaer N, Nijland L, Van Laere S, et al
    Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    J Neurooncol. 2024 Mar 19. doi: 10.1007/s11060-024-04646.
    >> Share

  864. BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
    Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
    J Neurooncol. 2024 Mar 18. doi: 10.1007/s11060-024-04641.
    >> Share

  865. ZHU P, Pichardo-Rojas PS, Dono A, Tandon N, et al
    The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
    J Neurooncol. 2024 Mar 16. doi: 10.1007/s11060-024-04644.
    >> Share

  866. CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
    Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
    J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04640.
    >> Share

  867. JIANG J, Li WB, Xiao SW
    Correction to: Prognostic factors analysis of diffuse midline glioma.
    J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04634.
    >> Share

  868. PALAVANI LB, Silva GM, Borges PGLB, Ferreira MY, et al
    Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis.
    J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04621.
    >> Share

  869. DI NUNNO V, Lombardi G, Simonelli M, Minniti G, et al
    The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
    J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04589.
    >> Share

  870. GRAILLON T, Salgues B, Horowitz T, Padovani L, et al
    Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
    J Neurooncol. 2024 Mar 7. doi: 10.1007/s11060-024-04622.
    >> Share

  871. SINGH E, Gurses ME, Costello MC, Berke C, et al
    Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04619.
    >> Share

  872. YOKOGAMI K, Watanabe T, Yamashita S, Mizuguchi A, et al
    Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma.
    J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04625.
    >> Share

  873. CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
    Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
    J Neurooncol. 2024 Mar 4. doi: 10.1007/s11060-024-04627.
    >> Share

  874. LIM MJR, Zhang Z, Zheng Y, Khoo IWL, et al
    Effect of sarcopenia and frailty on outcomes among patients with brain metastases.
    J Neurooncol. 2024 Mar 2. doi: 10.1007/s11060-023-04542.
    >> Share

  875. CHEN Y, Ning J, Shu L, Wen L, et al
    CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.
    J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-023-04548.
    >> Share

  876. KEGOYA Y, Otani Y, Inoue Y, Mizuta R, et al
    Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review.
    J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-024-04587.
    >> Share

  877. SHEEHAN JP, Singh R, Trifiletti DM
    Stereotactic radiosurgery for intracranial adenoid cystic carcinoma.
    J Neurooncol. 2024;167:229-230.
    >> Share

  878. WILSON JS, Main C, Thorp N, Taylor RE, et al
    The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
    J Neurooncol. 2024;167:1-34.
    >> Share

  879. RANADE M, Epari S, Shetty O, Dhanavade S, et al
    CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
    J Neurooncol. 2024;167:189-198.
    >> Share

    February 2024
  880. YU M, Ge Y, Wang Z, Zhang Y, et al
    The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.
    J Neurooncol. 2024 Feb 29. doi: 10.1007/s11060-024-04609.
    >> Share

  881. CEPEDA S, Garcia-Garcia S, Arrese I, Sarabia R, et al
    Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery.
    J Neurooncol. 2024 Feb 28. doi: 10.1007/s11060-024-04614.
    >> Share

  882. JALLOH M, Kankam SB
    Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence.
    J Neurooncol. 2024 Feb 23. doi: 10.1007/s11060-024-04606.
    >> Share

  883. YILMAZ MT, Kahvecioglu A, Yazici G, Mohammadipour S, et al
    Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
    J Neurooncol. 2024 Feb 22. doi: 10.1007/s11060-024-04607.
    >> Share

  884. JIANG J, Li WB, Xiao SW
    Prognostic factors analysis of diffuse midline glioma.
    J Neurooncol. 2024 Feb 21. doi: 10.1007/s11060-024-04605.
    >> Share

  885. EHRET F, Zuhlke O, Schweizer L, Kahn J, et al
    Validation of a methylation-based signature for subventricular zone involvement in glioblastoma.
    J Neurooncol. 2024 Feb 20. doi: 10.1007/s11060-024-04570.
    >> Share

  886. DASGUPTA P, Ou A, Lin H, Gregory T, et al
    The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
    J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-023-04551.
    >> Share

  887. BACCILI CURY MEGID T, Baskurt Z, Ma LX, Barron CC, et al
    Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
    J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04576.
    >> Share

  888. BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
    Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
    J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04593.
    >> Share

  889. UMEKAWA M, Shinya Y, Hasegawa H, Morshed RA, et al
    Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery.
    J Neurooncol. 2024 Feb 18. doi: 10.1007/s11060-023-04537.
    >> Share

  890. ARNOLD LM, Hoshina Y, Lee H, Colman H, et al
    Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04588.
    >> Share

  891. SHEEHAN JP, Mantziaris G, Bunevicius A
    Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04592.
    >> Share

  892. SHIRAI Y, Ueno T, Kojima S, Ikeuchi H, et al
    The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
    J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04563.
    >> Share

  893. WASILEWSKI D, Onken J, Horicke P, Bukatz J, et al
    Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.
    J Neurooncol. 2024 Feb 15. doi: 10.1007/s11060-024-04590.
    >> Share

  894. DONO A, Torres J, Nunez L, Arevalo O, et al
    Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04575.
    >> Share

  895. KOAY JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A, et al
    Repeated surgical resections for management of high-grade glioma and its impact on quality of life.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04600.
    >> Share

  896. ANGELOVA P, Gicheva M
    Comment: Additional factors affecting cognitive function in low grade glioma patients.
    J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04598.
    >> Share

  897. WATANABE G, Wong JM, Estes B, Khan MF, et al
    Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
    J Neurooncol. 2024 Feb 12. doi: 10.1007/s11060-024-04584.
    >> Share

  898. FAIRCHILD A, Salama JK, Godfrey D, Wiggins WF, et al
    Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
    J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04594.
    >> Share

  899. MIRIAN C, Jensen LR, Juratli TA, Maier AD, et al
    The importance of considering competing risks in recurrence analysis of intracranial meningioma.
    J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04572.
    >> Share

  900. ALHALABI OT, Dao Trong P, Kaes M, Jakobs M, et al
    Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
    J Neurooncol. 2024 Feb 9. doi: 10.1007/s11060-024-04595.
    >> Share

  901. KERIC N, Krenzlin H, Kalasauskas D, Freyschlag CF, et al
    Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
    J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04585.
    >> Share

  902. AVERBUCH I, Tschernichovsky R, Yust-Katz S, Rotem O, et al
    Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
    J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04562.
    >> Share

  903. TRAN S, Lapidus A, Neal A, Peters KB, et al
    A systematic review of the impact of brain tumours on risk of motor vehicle crashes.
    J Neurooncol. 2024 Feb 6. doi: 10.1007/s11060-024-04586.
    >> Share

  904. SALANS M, Ni L, Morin O, Ziemer B, et al
    Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
    J Neurooncol. 2024 Feb 5. doi: 10.1007/s11060-024-04578.
    >> Share

  905. TANG JD, Mills MN, Nakashima J, Dohm AE, et al
    Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
    J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-023-04543.
    >> Share

  906. ZIMMERMANN MLM, Breedt LC, Centeno EGZ, Reijneveld JC, et al
    The relationship between pathological brain activity and functional network connectivity in glioma patients.
    J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-024-04577.
    >> Share

  907. HAMMER Y, Najjar W, Kahanov L, Joskowicz L, et al
    Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline.
    J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04580.
    >> Share

  908. WANG B, Liu Y, Zhang J, Yin S, et al
    Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
    J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04583.
    >> Share

  909. KHOWAL S, Zhang D, Yong WH, Heaney AP, et al
    Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas.
    J Neurooncol. 2024;166:471-483.
    >> Share

    January 2024
  910. SINGH E, Gurses ME, Costello MC, Lu VM, et al
    Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-024-04582.
    >> Share

  911. TANAKA T, Tamura R, Takei J, Morimoto Y, et al
    An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
    J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-023-04544.
    >> Share

  912. GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
    Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
    J Neurooncol. 2024 Jan 30. doi: 10.1007/s11060-024-04581.
    >> Share

  913. DASGUPTA P, Rousseau JF
    Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04574.
    >> Share

  914. PETRONEK MS, Bodeker KL, Lee CY, Teferi N, et al
    Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04571.
    >> Share

  915. VAN OPIJNEN MP, Broekman MLD, Cuppen E, Dubbink HJ, et al
    Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
    J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04568.
    >> Share

  916. YEKULA A, Gessler DJ, Ferreira C, Shah R, et al
    GammaTile((R)) (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.
    J Neurooncol. 2024 Jan 28. doi: 10.1007/s11060-023-04545.
    >> Share

  917. GONZALEZ-APONTE MF, Damato AR, Trebucq LL, Simon T, et al
    Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
    J Neurooncol. 2024 Jan 26. doi: 10.1007/s11060-023-04535.
    >> Share

  918. KREATSOULAS D, Damante M, Cua S, Lonser RR, et al
    Adjuvant convection-enhanced delivery for the treatment of brain tumors.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04552.
    >> Share

  919. MULLER SJ, Khadhraoui E, Ganslandt O, Henkes H, et al
    MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-024-04573.
    >> Share

  920. GARCIA MA, Turner A, Brachman DG
    The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
    J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04523.
    >> Share

  921. REESE JC, Fadel HA, Pawloski JA, Samir M, et al
    Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemia.
    J Neurooncol. 2024 Jan 19. doi: 10.1007/s11060-023-04546.
    >> Share

  922. RYNDA AY, Rostovthev DM, Zabrodskaya YM, Olyushin VE, et al
    Immunotherapy with autologous dendritic cells in the complex treatment of malignant gliomas - results.
    J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04559.
    >> Share

  923. ON J, Natsumeda M, Takahashi H, Koyama A, et al
    Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
    J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04555.
    >> Share

  924. ZAPANTA RINONOS S, Li T, Pianka ST, Prins TJ, et al
    dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
    J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04531.
    >> Share

  925. KUAH XYC, Lucas-Herald AK, McCarrison S, Boyle R, et al
    Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience.
    J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04490.
    >> Share

  926. DOGAN E, Yildirim Z, Akalin T, Ozgiray E, et al
    Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours.
    J Neurooncol. 2024 Jan 12. doi: 10.1007/s11060-023-04556.
    >> Share

  927. DAGHER R, Gad M, da Silva de Santana P, Sadeghi MA, et al
    Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
    J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-023-04528.
    >> Share

  928. MIYAKOSHI A, Ubukata N, Miyake H, Shoji-Asahina A, et al
    Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study.
    J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-024-04566.
    >> Share

  929. BERGER A, Mullen R, Bernstein K, Mashiach E, et al
    Volumetric growth rate of incidentally found meningiomas on immunotherapy.
    J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04558.
    >> Share

  930. HUDSON K, Mondia MW, Zhang Y, Saha S, et al
    The role of microRNAs in brain metastasis.
    J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04541.
    >> Share

  931. ZHANG Q, Dai Z, Chen Y, Li Q, et al
    Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
    J Neurooncol. 2024 Jan 8. doi: 10.1007/s11060-023-04527.
    >> Share

  932. ZEUNER S, Vollmer J, Sigaud R, Oppermann S, et al
    Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
    J Neurooncol. 2024 Jan 7. doi: 10.1007/s11060-023-04526.
    >> Share

  933. YADAV N, Purow BW
    Understanding current experimental models of glioblastoma-brain microenvironment interactions.
    J Neurooncol. 2024 Jan 5. doi: 10.1007/s11060-023-04536.
    >> Share

  934. ZHANG JF, Okai B, Iovoli A, Goulenko V, et al
    Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
    J Neurooncol. 2024 Jan 4. doi: 10.1007/s11060-023-04524.
    >> Share

  935. KAMBE A, Kitao S, Ochiai R, Hosoya T, et al
    The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
    J Neurooncol. 2024 Jan 2. doi: 10.1007/s11060-023-04550.
    >> Share

  936. HESHAM D, On J, Alshahaby N, Amer N, et al
    Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
    J Neurooncol. 2024;166:27-38.
    >> Share

  937. FADUL CE, Thakur A, Kim J, Kassay-McAllister J, et al
    Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
    J Neurooncol. 2024;166:321-330.
    >> Share

  938. OBRECHT-STURM D, Pfaff E, Mynarek M, Bison B, et al
    Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
    J Neurooncol. 2024;166:359-368.
    >> Share

  939. EBADI M, Morse M, Gooley T, Ermoian R, et al
    Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
    J Neurooncol. 2024;166:351-357.
    >> Share

  940. SHEEHAN JP, Michalopoulos GD, Katsos K, Bydon M, et al
    The NeuroPoint alliance SRS & tumor QOD registries.
    J Neurooncol. 2024;166:257-264.
    >> Share

  941. FENG J, Zhang J, Chen L, Li C, et al
    Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or beta-HCG level higher than 500 IU/L.
    J Neurooncol. 2024;166:331-339.
    >> Share

  942. HONG S, Garces YI, Price KA, Shinya Y, et al
    Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients.
    J Neurooncol. 2024;166:369-376.
    >> Share

    December 2023
  943. NORIKANE T, Mitamura K, Yamamoto Y, Manabe Y, et al
    Comparative evaluation of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma.
    J Neurooncol. 2023 Dec 31. doi: 10.1007/s11060-023-04534.
    >> Share

  944. GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
    A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
    J Neurooncol. 2023 Dec 28. doi: 10.1007/s11060-023-04513.
    >> Share

  945. ARORA H, Mammi M, Patel NM, Zyfi D, et al
    Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
    J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04549.
    >> Share

  946. YANG ZC, Yin CD, Yeh FC, Xue BW, et al
    Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
    J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04539.
    >> Share

  947. BENNEBROEK CA, Schouten CR, Montauban-van Swijndregt MC, Saeed P, et al
    Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
    J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04516.
    >> Share

  948. REN L, Chen J, Deng J, Qing X, et al
    The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.
    J Neurooncol. 2023 Dec 26. doi: 10.1007/s11060-023-04511.
    >> Share

  949. CHOU CJ, Yang HC, Chang PY, Chen CJ, et al
    Automated identification and quantification of metastatic brain tumors and perilesional edema based on a deep learning neural network.
    J Neurooncol. 2023 Dec 22. doi: 10.1007/s11060-023-04540.
    >> Share

  950. MIJAJLOVIC V, Miler M, Ilic R, Rasic D, et al
    Oncogene-induced senescence in meningiomas-an immunohistochemical study.
    J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04532.
    >> Share

  951. KINSLOW CJ, Siegelin MD, Iwamoto FM, Gallitto M, et al
    MGMT promoter methylation in 1p19q-intact gliomas.
    J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04515.
    >> Share

  952. LU VM, Khalafallah AM, Jaman E, Gurses ME, et al
    Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis.
    J Neurooncol. 2023 Dec 19. doi: 10.1007/s11060-023-04538.
    >> Share

  953. ABETE-FORNARA G, Bintintan Socaciu P, Fanizzi C, Fiore G, et al
    Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
    J Neurooncol. 2023 Dec 18. doi: 10.1007/s11060-023-04533.
    >> Share

  954. CHEN Q, Wang K, Ren X, Zhao X, et al
    Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [(11)C]methionine PET.
    J Neurooncol. 2023 Dec 14. doi: 10.1007/s11060-023-04529.
    >> Share

  955. CHANG CT, Chen HH, Chuang CC, Chang SH, et al
    Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis.
    J Neurooncol. 2023 Dec 8. doi: 10.1007/s11060-023-04503.
    >> Share

  956. CHEN KT, Huang CY, Pai PC, Yang WC, et al
    Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
    J Neurooncol. 2023 Dec 7. doi: 10.1007/s11060-023-04517.
    >> Share

  957. MIAO Q, Zheng X, Li L, Zheng X, et al
    Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
    J Neurooncol. 2023;165:517-525.
    >> Share

  958. WILLEMS YCP, Vaassen F, Zegers CML, Postma AA, et al
    Anatomical changes in resection cavity during brain radiotherapy.
    J Neurooncol. 2023;165:479-486.
    >> Share

  959. RAMMELOO E, Schouten JW, Krikour K, Bos EM, et al
    Preoperative assessment of eloquence in neurosurgery: a systematic review.
    J Neurooncol. 2023;165:413-430.
    >> Share

  960. SHEN CI, Chiang CL, Huang HC, Tseng YH, et al
    Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study.
    J Neurooncol. 2023;165:459-465.
    >> Share

  961. WIJAYA JH, Patel UD, Quintero-Consuegra MD, Aguilera-Pena MP, et al
    Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.
    J Neurooncol. 2023;165:431-438.
    >> Share

  962. LYNES J, Khan I, Aguilera C, Rubino S, et al
    Development of a "Geo-Tagged" tumor sample registry: intra-operative linkage of sample location to imaging.
    J Neurooncol. 2023;165:449-458.
    >> Share

  963. SELT F, El Damaty A, Schuhmann MU, Sigaud R, et al
    Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
    J Neurooncol. 2023;165:467-478.
    >> Share

    November 2023
  964. SHEEHAN J, Mantziaris G, Dumont C, Pikis S, et al
    Incidental meningiomas: a current and increasingly common challenge.
    J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04525.
    >> Share

  965. BAUMGARTEN P, Prange G, Kamp MA, Monden D, et al
    Treatment of very elderly glioblastoma patients >/= 75 years of age: whom to treat.
    J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04518.
    >> Share

  966. ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
    Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
    J Neurooncol. 2023 Nov 29. doi: 10.1007/s11060-023-04491.
    >> Share

  967. KLEINBERG L, Ye X, Supko J, Stevens GHJ, et al
    A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
    J Neurooncol. 2023 Nov 28. doi: 10.1007/s11060-023-04514.
    >> Share

  968. YAVUZ BB, Kilinc F, Kanyilmaz G, Aktan M, et al
    Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
    J Neurooncol. 2023 Nov 27. doi: 10.1007/s11060-023-04521.
    >> Share

  969. CHIANG CL, Yang HC, Liao YT, Luo YH, et al
    Treatment and survival of patients with small cell lung cancer and brain metastasis.
    J Neurooncol. 2023 Nov 20. doi: 10.1007/s11060-023-04512.
    >> Share

  970. QIU X, Gao J, Hu J, Yang J, et al
    Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center.
    J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04401.
    >> Share

  971. QIN N, Paisana E, Picard D, Leprivier G, et al
    The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
    J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04508.
    >> Share

  972. VOGLIS S, Padevit L, van Niftrik CHB, Kalin V, et al
    Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases.
    J Neurooncol. 2023 Nov 10. doi: 10.1007/s11060-023-04478.
    >> Share

  973. KHAN AB, Dang HQ, Gopakumar S, Lazaro T, et al
    Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma.
    J Neurooncol. 2023 Nov 9. doi: 10.1007/s11060-023-04475.
    >> Share

  974. KIM N, Lee J, Nam DH, Lee JI, et al
    Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
    J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04498.
    >> Share

  975. NASLUND O, Strand PS, Solheim O, Al Masri M, et al
    Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?
    J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04482.
    >> Share

  976. YAMAMOTO S, Okita Y, Arita H, Sanada T, et al
    Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions.
    J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04454.
    >> Share

  977. LIN HT, Lin CM, Wu YY, Chang WH, et al
    Predictors for delayed awakening in adult glioma patients receiving awake craniotomy under monitored anesthesia care.
    J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04494.
    >> Share

  978. CHEN YH, Moore D, Lee CC, Su YH, et al
    Focused ultrasound for brain metastases: an update on global clinical trials.
    J Neurooncol. 2023 Nov 1. doi: 10.1007/s11060-023-04492.
    >> Share

  979. HONG Y, Miao Q, Zheng X, Xu Y, et al
    Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
    J Neurooncol. 2023;165:301-312.
    >> Share

  980. PRICE M, Neff C, Kruchko C, Barnholtz-Sloan JS, et al
    Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
    J Neurooncol. 2023;165:279-290.
    >> Share

  981. KO MK, Kwak YK, Choi BO, Jeun SS, et al
    Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
    J Neurooncol. 2023;165:321-328.
    >> Share

  982. ZAMARUD A, Marianayagam NJ, Park DJ, Yener U, et al
    The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
    J Neurooncol. 2023;165:373-379.
    >> Share

    October 2023
  983. KRASSNIG S, Leber SL, Orthmann A, Golob-Schwarzl N, et al
    Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
    J Neurooncol. 2023 Oct 31. doi: 10.1007/s11060-023-04451.
    >> Share

  984. LEHRER EJ, Khosla AA, Ozair A, Gurewitz J, et al
    Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
    J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04413.
    >> Share

  985. MOHAMMAD AH, Jatana S, Ruiz-Barerra MA, Khalaf R, et al
    Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing.
    J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04485.
    >> Share

  986. MA S, Lee H, Jo WY, Byun YH, et al
    The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance.
    J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04486.
    >> Share

  987. CROMPTON D, Koffler D, Fekrmandi F, Lehrer EJ, et al
    Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
    J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04466.
    >> Share

  988. GROB ST, Miller KR, Sanford B, Donson AM, et al
    Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
    J Neurooncol. 2023 Oct 25. doi: 10.1007/s11060-023-04472.
    >> Share

  989. ELLIS EM, Drumm MR, Rai SM, Huang J, et al
    Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures.
    J Neurooncol. 2023 Oct 24. doi: 10.1007/s11060-023-04481.
    >> Share

  990. STROWD R, Ellingson B, Raymond C, Yao J, et al
    Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
    J Neurooncol. 2023 Oct 21. doi: 10.1007/s11060-023-04456.
    >> Share

  991. KIM N, Lee J, Nam DH, Lee JI, et al
    Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
    J Neurooncol. 2023 Oct 20. doi: 10.1007/s11060-023-04465.
    >> Share

  992. YU Y, Chen H, Tian Z, Zhang Q, et al
    Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastases.
    J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04459.
    >> Share

  993. NAKAJIMA R, Kinoshita M, Okita H, Nakada M, et al
    Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level.
    J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04479.
    >> Share

  994. HOU C, Shi S, Gao M, Ji J, et al
    Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
    J Neurooncol. 2023 Oct 11. doi: 10.1007/s11060-023-04449.
    >> Share

  995. DEJONCKHEERE CS, Layer JP, Hamed M, Layer K, et al
    Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
    J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04464.
    >> Share

  996. BORST GR, Post R
    Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis.
    J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04457.
    >> Share

  997. PANDYA SHESH B, Walter V, Palsa K, Slagle-Webb B, et al
    Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma.
    J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04415.
    >> Share

  998. ERNSTER AE, Body A, Deleyrolle P, St Clair J, et al
    Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors.
    J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04469.
    >> Share

  999. KOTCH C, Si SJ, Desai K, Caminada P, et al
    The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
    J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04468.
    >> Share

  1000. DADEY DYA, Medress ZA, Sharma M, Ugiliweneza B, et al
    Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    J Neurooncol. 2023 Oct 4. doi: 10.1007/s11060-023-04460.
    >> Share

  1001. COVELL MM, Warrier A, Rumalla KC, Dehney CM, et al
    RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.
    J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04461.
    >> Share

  1002. WELLER J, Zeyen T, Schafer N, Schaub C, et al
    The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
    J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04470.
    >> Share

  1003. VOLLMER J, Ecker J, Hielscher T, Valinciute G, et al
    Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
    J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04445.
    >> Share

  1004. QUE T, Huang G, Tan JE, Zhang P, et al
    Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
    J Neurooncol. 2023 Oct 2. doi: 10.1007/s11060-023-04399.
    >> Share

  1005. STOCKDILL ML, Mendoza T, Armstrong TS, Miaskowski C, et al
    Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors.
    J Neurooncol. 2023;165:181-190.
    >> Share

  1006. BAI K, Chen X, Qi X, Zhang Y, et al
    Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
    J Neurooncol. 2023;165:149-160.
    >> Share

  1007. ONISHI S, Yamasaki F, Amatya VJ, Takayasu T, et al
    Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence.
    J Neurooncol. 2023;165:171-179.
    >> Share

  1008. GUTIERREZ-VALENCIA E, Sanchez I, Valles A, Diaz O, et al
    Pachymeningeal disease: a systematic review and metanalysis.
    J Neurooncol. 2023;165:29-39.
    >> Share

    September 2023
  1009. VAN T HEK R, Ortiz-Herrera JL, Salazar-Pigeon A, Ramirez-Loera C, et al
    Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis.
    J Neurooncol. 2023 Sep 29. doi: 10.1007/s11060-023-04448.
    >> Share

  1010. KARABACAK M, Jagtiani P, Carrasquilla A, Shrivastava RK, et al
    Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models.
    J Neurooncol. 2023 Sep 28. doi: 10.1007/s11060-023-04463.
    >> Share

  1011. VAN DER MEER PB, Dirven L, Fiocco M, Vos MJ, et al
    Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
    J Neurooncol. 2023 Sep 27. doi: 10.1007/s11060-023-04450.
    >> Share

  1012. LI L, Shao MY, Zou SC, Xiao ZF, et al
    Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
    J Neurooncol. 2023 Sep 22. doi: 10.1007/s11060-023-04429.
    >> Share

  1013. MARWAH R, Xing D, Squire T, Soon YY, et al
    Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
    J Neurooncol. 2023 Sep 21. doi: 10.1007/s11060-023-04441.
    >> Share

  1014. SHEEHAN JP, Trifiletti DM
    Comments: neurosurgery and radiation oncology advances have improved visual outcomes for skull base meningioma patients.
    J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04400.
    >> Share

  1015. KUAN AS, Chiang CL, Wu HM, Yang HC, et al
    Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
    J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04452.
    >> Share

  1016. FURUTA T, Negoto T, Miyoshi H, Moritsubo M, et al
    Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
    J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04447.
    >> Share

  1017. IGLSEDER S, Iglseder A, Beliveau V, Heugenhauser J, et al
    Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
    J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04414.
    >> Share

  1018. KATLOWITZ KA, Athukuri P, Sharma H, Dang H, et al
    Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis.
    J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04446.
    >> Share

  1019. JABEHDAR MARALANI P, Stewart J, Hiremath S, Lawrence L, et al
    Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
    J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04440.
    >> Share

  1020. DIMOV D, Brainman D, Berger B, Coras R, et al
    The role of cytoreductive surgery in multifocal/multicentric glioblastomas.
    J Neurooncol. 2023 Sep 12. doi: 10.1007/s11060-023-04410.
    >> Share

  1021. NINATTI G, Pini C, Bono BC, Gelardi F, et al
    The prognostic power of [(11)C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.
    J Neurooncol. 2023 Sep 11. doi: 10.1007/s11060-023-04438.
    >> Share

  1022. ALZATE JD, Mullen R, Mashiach E, Bernstein K, et al
    EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease.
    J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04442.
    >> Share

  1023. SOHN B, Park K, Ahn SS, Park YW, et al
    Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
    J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04435.
    >> Share

  1024. HOU Z, Hu J, Liu X, Yan Z, et al
    Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis.
    J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04420.
    >> Share

  1025. WU YY, Chen KT, Chu YC, Yeh CC, et al
    Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study.
    J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04431.
    >> Share

  1026. MURTHA AN, Zaki PG, Shepard MJ
    Letter to the editor: outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
    J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04434.
    >> Share

  1027. LUCKETT PH, Olufawo M, Lamichhane B, Park KY, et al
    Predicting survival in glioblastoma with multimodal neuroimaging and machine learning.
    J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04439.
    >> Share

  1028. HUNG JS, Su YH, Chen CJ, Chiang CL, et al
    Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
    J Neurooncol. 2023 Sep 1. doi: 10.1007/s11060-023-04425.
    >> Share

  1029. CIFARELLI CP, Vargo JA, Sener U, Cifarelli DT, et al
    Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk.
    J Neurooncol. 2023;164:423-430.
    >> Share

  1030. MINNITI G, Paolini S, Antonelli M, Gianno F, et al
    Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.
    J Neurooncol. 2023;164:331-339.
    >> Share

  1031. HOU L, Chen X, Qiu G, Qi X, et al
    Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.
    J Neurooncol. 2023;164:367-376.
    >> Share

  1032. FIGUEREDO LF, Shelton WJ, Tagle-Vega U, Sanchez E, et al
    The state of art of awake craniotomy in Latin American countries: a scoping review.
    J Neurooncol. 2023;164:287-298.
    >> Share

  1033. ID SAID B, Soliman H, Moravan V, Myrehaug S, et al
    Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
    J Neurooncol. 2023;164:437-445.
    >> Share

  1034. ZENG C, Yang Q, Li Z, Wei Z, et al
    Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study.
    J Neurooncol. 2023;164:643-653.
    >> Share

  1035. ZEYEN T, Paech D, Weller J, Schafer N, et al
    Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
    J Neurooncol. 2023;164:607-616.
    >> Share

    August 2023
  1036. PERTZ M, Schlomer S, Seidel C, Hentschel B, et al
    Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
    J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04419.
    >> Share

  1037. JIA W, Zhai X, Jing X, Bao Q, et al
    Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.
    J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04426.
    >> Share

  1038. WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
    Publisher Correction to: Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
    J Neurooncol. 2023 Aug 29. doi: 10.1007/s11060-023-04424.
    >> Share

  1039. QURESHI HM, Tabor JK, Pickens K, Lei H, et al
    Frailty and postoperative outcomes in brain tumor patients: a systematic review subdivided by tumor etiology.
    J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04416.
    >> Share

  1040. DE PIETRO R, Zaccaro L, Marampon F, Tini P, et al
    The evolving role of reirradiation in the management of recurrent brain tumors.
    J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04407.
    >> Share

  1041. LEHRER EJ, Trifiletti DM, Sheehan JP
    Stereotactic radiosurgery in patients with extensive brain metastases - supporting evidence and knowledge gaps.
    J Neurooncol. 2023 Aug 21. doi: 10.1007/s11060-023-04422.
    >> Share

  1042. EBIKO Y, Tamura K, Hara S, Inaji M, et al
    T2-FLAIR mismatch sign correlates with (11)C-methionine uptake in lower-grade diffuse gliomas.
    J Neurooncol. 2023 Aug 17. doi: 10.1007/s11060-023-04417.
    >> Share

  1043. GURRIERI L, Mercatali L, Ibrahim T, Fausti V, et al
    Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
    J Neurooncol. 2023 Aug 16. doi: 10.1007/s11060-023-04357.
    >> Share

  1044. LAWSON MCLEAN A
    Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib.
    J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04408.
    >> Share

  1045. MIER-GARCIA JF, Ospina-Santa S, Orozco-Mera J, Ma R, et al
    Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.
    J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04409.
    >> Share

  1046. JABLONSKA PA, Muniz T, Ribeiro M, Liu ZA, et al
    Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
    J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04404.
    >> Share

  1047. OTANI R, Ikegami M, Yamada R, Yajima H, et al
    PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
    J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04411.
    >> Share

  1048. HOLDAWAY M, Ablyazova F, Huda S, D'Amico RS, et al
    First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial.
    J Neurooncol. 2023 Aug 7. doi: 10.1007/s11060-023-04412.
    >> Share

  1049. LANG A, Jeron RL, Lontzek B, Kiesel B, et al
    Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
    J Neurooncol. 2023 Aug 6. doi: 10.1007/s11060-023-04406.
    >> Share

  1050. NEUMANN B, Onken J, Konig N, Stetefeld H, et al
    Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
    J Neurooncol. 2023 Aug 2. doi: 10.1007/s11060-023-04403.
    >> Share

  1051. AKINDURO OO, Ghaith AK, El-Hajj VG, Ghanem M, et al
    Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors.
    J Neurooncol. 2023;164:75-85.
    >> Share

  1052. NETH BJ, Webb MJ, White J, Uhm JH, et al
    Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
    J Neurooncol. 2023;164:239-247.
    >> Share

    July 2023
  1053. NODA R, Kawashima M, Segawa M, Tsunoda S, et al
    Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis.
    J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04374.
    >> Share

  1054. HU T, Xuan R, Han E, Cai L, et al
    SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
    J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04394.
    >> Share

  1055. MANTICA M, Drappatz J, Lieberman F, Hadjipanayis CG, et al
    Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
    J Neurooncol. 2023 Jul 29. doi: 10.1007/s11060-023-04398.
    >> Share

  1056. VIOZZI I, Overduin CG, Rijpma A, Rovers MM, et al
    MR-guided LITT therapy in patients with primary irresectable glioblastoma: a prospective, controlled pilot study.
    J Neurooncol. 2023 Jul 28. doi: 10.1007/s11060-023-04371.
    >> Share

  1057. BALLO MT, Conlon P, Lavy-Shahaf G, Kinzel A, et al
    Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
    J Neurooncol. 2023 Jul 26. doi: 10.1007/s11060-023-04348.
    >> Share

  1058. RAVIN R, Suarez-Meade P, Busse B, Blank PS, et al
    Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.
    J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04349.
    >> Share

  1059. KHATRI VM, Mills MN, Oliver DE, Yu HM, et al
    Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
    J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04402.
    >> Share

  1060. SPILLE DC, Thomas C, Wagner A, Grauer OM, et al
    Molecular predictors for decitabine efficacy in meningiomas - a pilot study.
    J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04379.
    >> Share

  1061. LAYER JP, Hamed M, Potthoff AL, Dejonckheere CS, et al
    Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
    J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04380.
    >> Share

  1062. BUYUKTEPE M, Kaplan I, Bayatli E, Dogan H, et al
    Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay.
    J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04397.
    >> Share

  1063. ZHANG YT, Wang Y, Zhong XD, Chang J, et al
    Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center.
    J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04388.
    >> Share

  1064. TAORI S, Wei Z, Deng H, Hadjipanayis CG, et al
    Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers.
    J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04392.
    >> Share

  1065. YANG X, Ji C, Qi Y, Huang J, et al
    Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.
    J Neurooncol. 2023 Jul 18. doi: 10.1007/s11060-023-04390.
    >> Share

  1066. CHOJAK R, Fares J, Petrosyan E, Lesniak MS, et al
    Cellular senescence in glioma.
    J Neurooncol. 2023 Jul 17. doi: 10.1007/s11060-023-04387.
    >> Share

  1067. MALLICK S, Gupta S, Amariyil A, Kunhiparambath H, et al
    Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.
    J Neurooncol. 2023 Jul 15. doi: 10.1007/s11060-023-04391.
    >> Share

  1068. ONYIAH C, Shepard MJ
    Letter: are there incidences of clinically relevant psychiatric symptoms during glioblastoma treatment?
    J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04376.
    >> Share

  1069. MATSUI JK, Allen PK, Perlow HK, Johnson JM, et al
    Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
    J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04386.
    >> Share

  1070. OTANI R, Sadato D, Yamada R, Yajima H, et al
    CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer.
    J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04381.
    >> Share

  1071. LEI H, Tabor JK, O'Brien J, Qin R, et al
    Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis.
    J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04393.
    >> Share

  1072. INDHARTY RS, Japardi I, Irina RS, Tandean S, et al
    Comparison of direct cortical stimulation and transcranial magnetic stimulation in brain tumor surgery: systematic review and meta analyses.
    J Neurooncol. 2023 Jul 12. doi: 10.1007/s11060-023-04378.
    >> Share

  1073. YADAV N, Babu D, Madigubba S, Panigrahi M, et al
    Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
    J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04383.
    >> Share

  1074. MISHRA A, Koffler D, Calugaru E, Rowe N, et al
    Let's make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases.
    J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04365.
    >> Share

  1075. TANRIKULU B, Yasar AH, Canpolat C, Corapcioglu F, et al
    Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas.
    J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04347.
    >> Share

  1076. WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
    Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
    J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04344.
    >> Share

  1077. LUO M, Tang R, Wang H
    Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
    J Neurooncol. 2023;163:663-674.
    >> Share

  1078. LESKINEN S, Shah HA, Yaffe B, Schneider SJ, et al
    Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
    J Neurooncol. 2023;163:515-527.
    >> Share

    June 2023
  1079. JONNAKUTI VS, Ji P, Gao Y, Lin A, et al
    NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
    J Neurooncol. 2023 Jun 30. doi: 10.1007/s11060-023-04370.
    >> Share

  1080. MEISSNER AK, Gutsche R, Galldiks N, Kocher M, et al
    Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
    J Neurooncol. 2023 Jun 29. doi: 10.1007/s11060-023-04367.
    >> Share

  1081. MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
    Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    J Neurooncol. 2023 Jun 28. doi: 10.1007/s11060-023-04364.
    >> Share

  1082. ADILE AA, Bakhshinyan D, Suk Y, Uehling D, et al
    An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
    J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04372.
    >> Share

  1083. HOLDAWAY M, Starner J, Patel RR, Salama J, et al
    Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review.
    J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04366.
    >> Share

  1084. CHEN J, Li T, Zhou N, He Y, et al
    Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo.
    J Neurooncol. 2023 Jun 23. doi: 10.1007/s11060-023-04369.
    >> Share

  1085. TOM MC, DiFilippo FP, Jones SE, Suh JH, et al
    (18)F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.
    J Neurooncol. 2023 Jun 21. doi: 10.1007/s11060-023-04377.
    >> Share

  1086. MASSIMINO M, Vennarini S, Buttarelli FR, Antonelli M, et al
    Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
    J Neurooncol. 2023 Jun 16. doi: 10.1007/s11060-023-04361.
    >> Share

  1087. KHAN AB, Patel R, McDonald MF, Goethe E, et al
    Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.
    J Neurooncol. 2023 Jun 15. doi: 10.1007/s11060-023-04359.
    >> Share

  1088. JOST J, Muther M, Brandt R, Altuner U, et al
    Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience.
    J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04354.
    >> Share

  1089. MERENZON MA, Levy AS, Bhatia S, Rivera C, et al
    Towards the definition of progressive disease in brain metastasis treated with laser ablation: an evidence-based study.
    J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04360.
    >> Share

  1090. CHO NS, Sanvito F, Thakuria S, Wang C, et al
    Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
    J Neurooncol. 2023 Jun 9. doi: 10.1007/s11060-023-04363.
    >> Share

  1091. WELLER J, Katzendobler S, Niedermeyer S, Harter PN, et al
    Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
    J Neurooncol. 2023 Jun 8. doi: 10.1007/s11060-023-04362.
    >> Share

  1092. NAGAI N, Koide Y, Shindo Y, Hashimoto S, et al
    Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases.
    J Neurooncol. 2023 Jun 7. doi: 10.1007/s11060-023-04358.
    >> Share

  1093. TOKLU S, Kemerdere R, Kacira T, Gurses MS, et al
    Tissue and plasma free amino acid detection by LC-MS/MS method in high grade glioma patients.
    J Neurooncol. 2023 Jun 6. doi: 10.1007/s11060-023-04329.
    >> Share

  1094. MA J, Li D, Hong Y, Zhang Y, et al
    Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas.
    J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04351.
    >> Share

  1095. VAN SCHIE P, Rijksen BLT, Bot M, Wiersma T, et al
    Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
    J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04343.
    >> Share

  1096. CACCESE M, Desideri I, Padovan M, Bruno F, et al
    Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
    J Neurooncol. 2023 Jun 1. doi: 10.1007/s11060-023-04356.
    >> Share

  1097. BISWAS A, Salvucci M, Connor K, Dussmann H, et al
    Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
    J Neurooncol. 2023;163:327-338.
    >> Share

    May 2023
  1098. MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
    Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    J Neurooncol. 2023 May 31. doi: 10.1007/s11060-023-04340.
    >> Share

  1099. BANDER ED, Kelly A, Ma X, Christos PJ, et al
    Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
    J Neurooncol. 2023 May 30. doi: 10.1007/s11060-023-04352.
    >> Share

  1100. MCLAUGHLIN LA, Yildirim O, Rosenblum MK, Imber BS, et al
    Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.
    J Neurooncol. 2023 May 29. doi: 10.1007/s11060-023-04355.
    >> Share

  1101. SHEEHAN J, Cifarelli CP, Fadul C
    Contemporary care for brain metastasis patients: multidisciplinary approaches and the role of prospective national registries.
    J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04350.
    >> Share

  1102. BUSCH N, Wegner RE, Shepard MJ
    Letter to the editor: neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
    J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04345.
    >> Share

  1103. TINI P, Yavoroska M, Mazzei MA, Miracco C, et al
    Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
    J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04342.
    >> Share

  1104. JURATLI TA, Jungk C, Miller JJ
    Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
    J Neurooncol. 2023 May 22. doi: 10.1007/s11060-023-04317.
    >> Share

  1105. CROOMS RC, Taylor JW, Jette N, Morgenstern R, et al
    Palliative care referral across the disease trajectory in high-grade glioma.
    J Neurooncol. 2023 May 20. doi: 10.1007/s11060-023-04338.
    >> Share

  1106. FENG X, Zhu F, Dai L, Liu X, et al
    Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation.
    J Neurooncol. 2023 May 17. doi: 10.1007/s11060-023-04339.
    >> Share

  1107. KNIGHT A, Horsley P, Yuile A, Yim J, et al
    Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.
    J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04332.
    >> Share

  1108. VALINCIUTE G, Ecker J, Selt F, Hielscher T, et al
    Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
    J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04319.
    >> Share

  1109. BONOSI L, Marino S, Benigno UE, Musso S, et al
    Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.
    J Neurooncol. 2023 May 14. doi: 10.1007/s11060-023-04333.
    >> Share

  1110. ZILIOLI A, Misirocchi F, Mutti C, Pancaldi B, et al
    Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
    J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04315.
    >> Share

  1111. MA Y, Shi F, Sun T, Chen H, et al
    Histopathological auxiliary system for brain tumour (HAS-Bt) based on weakly supervised learning using a WHO CNS5-style pipeline.
    J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04306.
    >> Share

  1112. MERLIN MS, Schmitt E, Mezloy-Destracque M, Dufour C, et al
    Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol.
    J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04328.
    >> Share

  1113. PADILLA CS, Ho VKY, Mooijenkind TWAN, Louwman MWJ, et al
    Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
    J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04335.
    >> Share

  1114. ZABEK T, Szmatola T, Adamczyk-Grochala J, Lewinska A, et al
    Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells.
    J Neurooncol. 2023 May 11. doi: 10.1007/s11060-023-04304.
    >> Share

  1115. KALYVAS A, Gutierrez-Valencia E, Lau R, Ye XY, et al
    Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery.
    J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04325.
    >> Share

  1116. REGLI LKP, Huijs SMH, Pasmans RCOS, Leue C, et al
    Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.
    J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04326.
    >> Share

  1117. SAUNDERS JT, Kumar S, Benavides-Serrato A, Holmes B, et al
    Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET.
    J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04331.
    >> Share

  1118. LAZZARINI E, Silvestris DA, Benvenuto G, Osti D, et al
    Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
    J Neurooncol. 2023 May 4. doi: 10.1007/s11060-023-04287.
    >> Share

  1119. ZUO P, Li Y, Wang T, Lin X, et al
    A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
    J Neurooncol. 2023 May 3. doi: 10.1007/s11060-023-04323.
    >> Share

  1120. FISHMAN H, Monin R, Dor-On E, Kinzel A, et al
    Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
    J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04308.
    >> Share

  1121. TRAVERS SS, Fisher CM, Kabos P, Cittelly DM, et al
    Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience.
    J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04314.
    >> Share

  1122. DE GODOY LL, Chawla S, Brem S, Wang S, et al
    Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
    J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04324.
    >> Share

  1123. YE L, Wu BS, Xu ZA, Ji XF, et al
    Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes.
    J Neurooncol. 2023;163:133-142.
    >> Share

  1124. DEWAN MC, Isaacs AM, Cools MJ, Yengo-Kahn A, et al
    Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
    J Neurooncol. 2023;163:123-132.
    >> Share

  1125. LI Q, Ma Y, Lin Z, Ma J, et al
    A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
    J Neurooncol. 2023;163:39-46.
    >> Share

    April 2023
  1126. AMELOT A, Terrier LM, Cognacq G, Jecko V, et al
    Correction to: Natural history of spinal cord metastasis from brain glioblastomas.
    J Neurooncol. 2023 Apr 26. doi: 10.1007/s11060-023-04320.
    >> Share

  1127. SENGUPTA S
    Integrative neuro-oncology for brain tumor patients.
    J Neurooncol. 2023 Apr 25. doi: 10.1007/s11060-023-04309.
    >> Share

  1128. CHANG WH, Wei KC, Chen PY, Chen YC, et al
    The impact of patient factors and tumor characteristics on language neuroplasticity in left hemispheric diffuse gliomas prior to surgical resection.
    J Neurooncol. 2023 Apr 24. doi: 10.1007/s11060-023-04311.
    >> Share

  1129. TRACZ JA, Donnelly BM, Ngu S, Vojnic M, et al
    The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma.
    J Neurooncol. 2023 Apr 22. doi: 10.1007/s11060-023-04312.
    >> Share

  1130. SYED HR, Kilburn L, Fonseca A, Nazarian J, et al
    First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication.
    J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04269.
    >> Share

  1131. DEMETZ M, Krigers A, Moser P, Kerschbaumer J, et al
    Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival.
    J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04301.
    >> Share

  1132. ALTIERI R, Certo F, Pacella D, Cammarata G, et al
    Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
    J Neurooncol. 2023 Apr 11. doi: 10.1007/s11060-023-04305.
    >> Share

  1133. VOON NS, Manan HA, Yahya N
    Remote assessment of cognition and quality of life following radiotherapy for glioma: deep-learning-based predictive models and MRI correlates.
    J Neurooncol. 2023 Apr 4:1-9. doi: 10.1007/s11060-023-04303.
    >> Share

  1134. DINCER A, Morales-Valero SF, Robert SM, Tabor JK, et al
    Surgical strategies for intracranial meningioma in the molecular era.
    J Neurooncol. 2023 Apr 3. doi: 10.1007/s11060-023-04272.
    >> Share

  1135. YAMASHITA S, Takeshima H, Hata N, Uchida H, et al
    Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
    J Neurooncol. 2023;162:425-433.
    >> Share

  1136. FOO JC, Yaman Bajin I, Marushchak O, McKeown T, et al
    Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
    J Neurooncol. 2023;162:443-448.
    >> Share

  1137. ROEHRIG A, Indelicato DJ, Paulino AC, Ermoian R, et al
    Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
    J Neurooncol. 2023;162:353-362.
    >> Share

  1138. KEARNS K, Shepard MJ, Sheehan JP
    Social media and the Journal of Neuro-Oncology.
    J Neurooncol. 2023;162:453-454.
    >> Share

    March 2023
  1139. AYMERIC A, Louis-Marie T, Gabrielle C, Vincent J, et al
    Natural history of spinal cord metastasis from brain glioblastomas.
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04298.
    >> Share

  1140. QUAN G, Wang T, Ren JL, Xue X, et al
    Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04299.
    >> Share

  1141. CHAMPEAUX-DEPOND C, Jecko V, Weller J, Constantinou P, et al
    Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04295.
    >> Share

  1142. OZKARA BB, Federau C, Dagher SA, Pattnaik D, et al
    Correlating volumetric and linear measurements of brain metastases on MRI scans using intelligent automation software: a preliminary study.
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04297.
    >> Share

  1143. ZHA B, Yang J, Dang Q, Li P, et al
    A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma.
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04292.
    >> Share

  1144. POPPE JP, Schwartz C
    In reply to the letter to the editor by Busch et al. regarding "Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study".
    J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04302.
    >> Share

  1145. KIMURA K, Deguchi S, Mitsuya K, Mamesaya N, et al
    Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
    J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04300.
    >> Share

  1146. WAMELINK IJHG, Hempel HL, van de Giessen E, Vries MHM, et al
    The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study.
    J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04290.
    >> Share

  1147. IUS T, Sabatino G, Panciani PP, Fontanella MM, et al
    Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch(R)): a systematic review.
    J Neurooncol. 2023 Mar 24. doi: 10.1007/s11060-023-04274.
    >> Share

  1148. PARSONS MW, Sabsevitz DS
    Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology.
    J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04289.
    >> Share

  1149. LIANG L, Wen L, Qin S, He Z, et al
    Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
    J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04293.
    >> Share

  1150. SHAH DS, Reddy RV, Dogruel Y, Asfour MZ, et al
    Calcified spinal meningiomas: a systematic review of clinical characteristics, treatment strategies, and outcomes.
    J Neurooncol. 2023 Mar 17. doi: 10.1007/s11060-023-04291.
    >> Share

  1151. QUACH S, Schwartz C, Aumiller M, Foglar M, et al
    Interstitial photodynamic therapy for newly diagnosed glioblastoma.
    J Neurooncol. 2023 Mar 16. doi: 10.1007/s11060-023-04284.
    >> Share

  1152. BLEEKER L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, et al
    Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
    J Neurooncol. 2023 Mar 15. doi: 10.1007/s11060-023-04285.
    >> Share

  1153. YAN M, Lee M, Myrehaug S, Tseng CL, et al
    Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
    J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04265.
    >> Share

  1154. DUFFAU H
    Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
    J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04288.
    >> Share

  1155. KING AL, Roche KN, Leeper HE, Vera E, et al
    Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
    J Neurooncol. 2023 Mar 8:1-9. doi: 10.1007/s11060-023-04271.
    >> Share

  1156. JUSINO S, Fadul CE, Dillon P
    Systematic review of the management of brain metastases from hormone receptor positive breast cancer.
    J Neurooncol. 2023 Mar 8. doi: 10.1007/s11060-023-04276.
    >> Share

  1157. TRIFILETTI DM, Akinyelu T, Burri SH, Jeudy A, et al
    Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety.
    J Neurooncol. 2023 Mar 6. doi: 10.1007/s11060-023-04278.
    >> Share

  1158. MARTIN JA, Hart NH, Bradford N, Naumann F, et al
    Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review.
    J Neurooncol. 2023 Mar 2. doi: 10.1007/s11060-023-04270.
    >> Share

  1159. LI C, Guan N, Liu F
    T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
    J Neurooncol. 2023 Mar 1. doi: 10.1007/s11060-023-04257.
    >> Share

  1160. THIERHEIMER M, Cioffi G, Waite KA, Kruchko C, et al
    Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
    J Neurooncol. 2023;162:167-177.
    >> Share

  1161. SHARMA M, Do TH, Palzer EF, Huling JD, et al
    Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.
    J Neurooncol. 2023;162:147-156.
    >> Share

  1162. WEI Z, Pease M, Tang LW, Deng H, et al
    Radiosurgery outcomes in infratentorial juvenile pilocytic astrocytomas.
    J Neurooncol. 2023;162:157-165.
    >> Share

  1163. CACCIOTTI C, Chua IS, Cuadra J, Ullrich NJ, et al
    Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth.
    J Neurooncol. 2023;162:191-198.
    >> Share

  1164. WESSELS PH, Boelens MC, Monkhorst K, Sonke GS, et al
    A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
    J Neurooncol. 2023;162:1-13.
    >> Share

    February 2023
  1165. TRINGALE KR, Wolden SL, Karajannis M, Haque S, et al
    Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
    J Neurooncol. 2023 Feb 28. doi: 10.1007/s11060-022-04235.
    >> Share

  1166. MOLITERNO J, Brastianos PK
    Journal of Neuro-Oncology, Meningioma issue.
    J Neurooncol. 2023 Feb 27. doi: 10.1007/s11060-023-04251.
    >> Share

  1167. PARK YW, Han K, Kim S, Kwon H, et al
    Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities.
    J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-022-04233.
    >> Share

  1168. WANG JZ, Nassiri F, Landry AP, Patil V, et al
    The multiomic landscape of meningiomas: a review and update.
    J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-023-04253.
    >> Share

  1169. PATEL Z, Cho M, Das S
    The role of immune checkpoint inhibitors in patients with intracranial metastatic disease.
    J Neurooncol. 2023;161:469-478.
    >> Share

  1170. AK M, Lf N, Gm I, Av K, et al
    Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.
    J Neurooncol. 2023;161:573-582.
    >> Share

    November 2022
  1171. IGLESIAS P, Biagetti B, Araujo-Castro M, Alcazar V, et al
    Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
    J Neurooncol. 2022;160:351-359.
    >> Share

  1172. RAGHIB MF, Salim A, Angez M, Ghazi SM, et al
    Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.
    J Neurooncol. 2022;160:491-496.
    >> Share

  1173. SHE L, Deng D, Su L, Liu C, et al
    Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
    J Neurooncol. 2022;160:455-462.
    >> Share

  1174. WEBB M, Johnson DR, Mahajan A, Brown P, et al
    Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
    J Neurooncol. 2022;160:527-534.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016